
<html lang="en"     class="pb-page"  data-request-id="5e5cf776-1fe3-4e28-85c8-a5e2e8626940"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2020.63.issue-24;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.0c01328;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of a Potent Adenine–Benzyltriazolo–Pleuromutilin Conjugate with Pronounced Antibacterial Activity against MRSA" /></meta><meta name="dc.Creator" content="Christoffer V.  Heidtmann" /></meta><meta name="dc.Creator" content="Faidra  Voukia" /></meta><meta name="dc.Creator" content="Louise N.  Hansen" /></meta><meta name="dc.Creator" content="Stine H.  Sørensen" /></meta><meta name="dc.Creator" content="Brian  Urlund" /></meta><meta name="dc.Creator" content="Salli  Nielsen" /></meta><meta name="dc.Creator" content="Mona  Pedersen" /></meta><meta name="dc.Creator" content="Noor  Kelawi" /></meta><meta name="dc.Creator" content="Brian N.  Andersen" /></meta><meta name="dc.Creator" content="Maria  Pedersen" /></meta><meta name="dc.Creator" content="Peter  Reinholdt" /></meta><meta name="dc.Creator" content="Jacob  Kongsted" /></meta><meta name="dc.Creator" content="Carsten U.  Nielsen" /></meta><meta name="dc.Creator" content="Janne K.  Klitgaard" /></meta><meta name="dc.Creator" content="Poul  Nielsen" /></meta><meta name="dc.Description" content="Conjugation of pleuromutilin is an attractive strategy for the development of novel antibiotics and the fight against multiresistant bacteria as the class is associated with low rates of resistance..." /></meta><meta name="Description" content="Conjugation of pleuromutilin is an attractive strategy for the development of novel antibiotics and the fight against multiresistant bacteria as the class is associated with low rates of resistance..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 16, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01328" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01328" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01328" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01328" /></link>
        
    
    

<title>Discovery of a Potent Adenine–Benzyltriazolo–Pleuromutilin Conjugate with Pronounced Antibacterial Activity against MRSA | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01328" /></meta><meta property="og:title" content="Discovery of a Potent Adenine–Benzyltriazolo–Pleuromutilin Conjugate with Pronounced Antibacterial Activity against MRSA" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0013.jpeg" /></meta><meta property="og:description" content="Conjugation of pleuromutilin is an attractive strategy for the development of novel antibiotics and the fight against multiresistant bacteria as the class is associated with low rates of resistance and cross-resistance development. Herein, the preparation of 35 novel (+)-pleuromutilin conjugates is reported. Their design was based on a synthetically more efficient benzyl adaption of a potent lead but still relied on the Cu(I)-catalyzed alkyne–azide [3 + 2] cycloaddition for conjugation onto pleuromutilin. Their antibacterial activity was evaluated against the multiresistant Staphylococcus aureus strain USA300 for which they displayed moderate to excellent activity. Compound 35, bearing a para-benzyladenine substituent, proved particularly potent against USA300 and additional strains of MRSA and displayed as importantly no cytotoxicity in four mammalian cell lines. Structure–activity relationship analysis revealed that the purine 6-amino is essential for high potency, likely because of strong hydrogen bonding with the RNA backbone of C2469, as suggested by a molecular model based on the MM-GBSA approach." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01328"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01328">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01328&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01328&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01328&amp;href=/doi/10.1021/acs.jmedchem.0c01328" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 15693-15708</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01150" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01367" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of a Potent Adenine–Benzyltriazolo–Pleuromutilin Conjugate with Pronounced Antibacterial Activity against MRSA</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Christoffer V. Heidtmann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christoffer V. Heidtmann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, 5230 Odense M, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christoffer+V.++Heidtmann">Christoffer V. Heidtmann</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Faidra Voukia</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Faidra Voukia</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, 5230 Odense M, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Faidra++Voukia">Faidra Voukia</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Louise N. Hansen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Louise N. Hansen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, 5230 Odense M, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Louise+N.++Hansen">Louise N. Hansen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stine H. Sørensen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stine H. Sørensen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, 5230 Odense M, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stine+H.++S%C3%B8rensen">Stine H. Sørensen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Brian Urlund</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brian Urlund</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, 5230 Odense M, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brian++Urlund">Brian Urlund</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Salli Nielsen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Salli Nielsen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, 5230 Odense M, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Salli++Nielsen">Salli Nielsen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mona Pedersen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mona Pedersen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, 5230 Odense M, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mona++Pedersen">Mona Pedersen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Noor Kelawi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Noor Kelawi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, 5230 Odense M, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Noor++Kelawi">Noor Kelawi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Brian N. Andersen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brian N. Andersen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, 5230 Odense M, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brian+N.++Andersen">Brian N. Andersen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Maria Pedersen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Maria Pedersen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, 5230 Odense M, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Maria++Pedersen">Maria Pedersen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Peter Reinholdt</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Peter Reinholdt</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, 5230 Odense M, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Reinholdt">Peter Reinholdt</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2406-700X" title="Orcid link">http://orcid.org/0000-0003-2406-700X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jacob Kongsted</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jacob Kongsted</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, 5230 Odense M, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jacob++Kongsted">Jacob Kongsted</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7725-2164" title="Orcid link">http://orcid.org/0000-0002-7725-2164</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Carsten U. Nielsen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Carsten U. Nielsen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, 5230 Odense M, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Carsten+U.++Nielsen">Carsten U. Nielsen</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5776-6865" title="Orcid link">http://orcid.org/0000-0001-5776-6865</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Janne K. Klitgaard</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Janne K. Klitgaard</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Molecular Biology, Research Unit of Molecular Microbiology, University of Southern Denmark, 5230 Odense M, Denmark</div><div class="loa-info-affiliations-info">Institute of Clinical Research, Research Unit of Clinical Microbiology, University of Southern Denmark, 5230 Odense M, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Janne+K.++Klitgaard">Janne K. Klitgaard</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Poul Nielsen</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Poul Nielsen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, 5230 Odense M, Denmark</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#bcccd3c9d0d2fccfd8c992d8d7"><span class="__cf_email__" data-cfemail="dfafb0aab3b19facbbaaf1bbb4">[email protected]</span></a>. Phone: 65502565.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Poul++Nielsen">Poul Nielsen</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7946-311X" title="Orcid link">http://orcid.org/0000-0001-7946-311X</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01328&amp;href=/doi/10.1021%2Facs.jmedchem.0c01328" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 15693–15708</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 16, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>30 July 2020</li><li><span class="item_label"><b>Published</b> online</span>16 December 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 December 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01328" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01328</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D15693%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DChristoffer%2BV.%2BHeidtmann%252C%2BFaidra%2BVoukia%252C%2BLouise%2BN.%2BHansen%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D24%26contentID%3Dacs.jmedchem.0c01328%26title%3DDiscovery%2Bof%2Ba%2BPotent%2BAdenine%25E2%2580%2593Benzyltriazolo%25E2%2580%2593Pleuromutilin%2BConjugate%2Bwith%2BPronounced%2BAntibacterial%2BActivity%2Bagainst%2BMRSA%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D15708%26publicationDate%3DDecember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01328"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1047</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01328" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of a Potent Adenine–Benzyltriazolo–Pleuromutilin Conjugate with Pronounced Antibacterial Activity against MRSA&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Christoffer&quot;,&quot;last_name&quot;:&quot;V. Heidtmann&quot;},{&quot;first_name&quot;:&quot;Faidra&quot;,&quot;last_name&quot;:&quot;Voukia&quot;},{&quot;first_name&quot;:&quot;Louise&quot;,&quot;last_name&quot;:&quot;N. Hansen&quot;},{&quot;first_name&quot;:&quot;Stine&quot;,&quot;last_name&quot;:&quot;H. Sørensen&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;Urlund&quot;},{&quot;first_name&quot;:&quot;Salli&quot;,&quot;last_name&quot;:&quot;Nielsen&quot;},{&quot;first_name&quot;:&quot;Mona&quot;,&quot;last_name&quot;:&quot;Pedersen&quot;},{&quot;first_name&quot;:&quot;Noor&quot;,&quot;last_name&quot;:&quot;Kelawi&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;N. Andersen&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Pedersen&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Reinholdt&quot;},{&quot;first_name&quot;:&quot;Jacob&quot;,&quot;last_name&quot;:&quot;Kongsted&quot;},{&quot;first_name&quot;:&quot;Carsten&quot;,&quot;last_name&quot;:&quot;U. Nielsen&quot;},{&quot;first_name&quot;:&quot;Janne&quot;,&quot;last_name&quot;:&quot;K. Klitgaard&quot;},{&quot;first_name&quot;:&quot;Poul&quot;,&quot;last_name&quot;:&quot;Nielsen&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;15693-15708&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01328&quot;},&quot;abstract&quot;:&quot;Conjugation of pleuromutilin is an attractive strategy for the development of novel antibiotics and the fight against multiresistant bacteria as the class is associated with low rates of resistance and cross-resistance development. Herein, the preparation of 35 novel (+)-pleuromutilin conjugates is reported. Their design was based on a synthetically more efficient benzyl adaption of a potent lead but still relied on the Cu(I)-catalyzed alkyne–azide [3 + 2] cycloaddition for conjugation onto pleuromutilin. Their antibacterial activity was evaluated against the multiresistant Staphylococcus aureus strain USA300 for which they displayed moderate to excellent activity. Compound 35, bearing a para-benzyladenine substituent, proved particularly potent against USA300 and additional strains of MRSA and displayed as importantly no cytotoxicity in four mammalian cell lines. Structure–activity relationship analysis revealed that the purine 6-amino is essential for high potency, likely because of strong hydrogen bonding &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01328&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01328" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01328&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01328" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01328&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01328" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01328&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01328&amp;href=/doi/10.1021/acs.jmedchem.0c01328" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01328" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01328" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01328%26sid%3Dliteratum%253Aachs%26pmid%3D33325700%26genre%3Darticle%26aulast%3DHeidtmann%26date%3D2020%26atitle%3DDiscovery%2Bof%2Ba%2BPotent%2BAdenine%25E2%2580%2593Benzyltriazolo%25E2%2580%2593Pleuromutilin%2BConjugate%2Bwith%2BPronounced%2BAntibacterial%2BActivity%2Bagainst%2BMRSA%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D24%26spage%3D15693%26epage%3D15708%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291214" title="Bacteria">Bacteria</a>,</li><li><a href="/action/doSearch?ConceptID=292234" title="Chromatography">Chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291251" title="Sodium">Sodium</a>,</li><li><a href="/action/doSearch?ConceptID=291290" title="Conjugate acid-base pairs">Conjugate acid-base pairs</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/jmcmar.2020.63.issue-24/20201224/jmcmar.2020.63.issue-24.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/medium/jm0c01328_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01328&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Conjugation of pleuromutilin is an attractive strategy for the development of novel antibiotics and the fight against multiresistant bacteria as the class is associated with low rates of resistance and cross-resistance development. Herein, the preparation of 35 novel (+)-pleuromutilin conjugates is reported. Their design was based on a synthetically more efficient benzyl adaption of a potent lead but still relied on the Cu(I)-catalyzed alkyne–azide [3 + 2] cycloaddition for conjugation onto pleuromutilin. Their antibacterial activity was evaluated against the multiresistant <i>Staphylococcus aureus</i> strain USA300 for which they displayed moderate to excellent activity. Compound <b>35</b>, bearing a <i>para</i>-benzyladenine substituent, proved particularly potent against USA300 and additional strains of MRSA and displayed as importantly no cytotoxicity in four mammalian cell lines. Structure–activity relationship analysis revealed that the purine 6-amino is essential for high potency, likely because of strong hydrogen bonding with the RNA backbone of C2469, as suggested by a molecular model based on the MM-GBSA approach.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45867" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45867" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Antibiotic resistance poses an imminent threat to global health.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> The evolutionary ability of bacteria to develop resistance towards small molecules coupled with the heavy expenses of bringing a novel drug to the market has granted them one of the lowest financial rentabilities of commercially developed drugs. Consequently, many large pharmaceutical companies discontinued their antimicrobial projects around the new millennia. Academic research and development of new antibiotics with low inherent rates of resistance and cross-resistance are thus acute. The antibiotic class of pleuromutilins has proven to possess these resilient properties.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The diterpene natural product (+)-pleuromutilin (<b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), which the class is based upon, was first isolated in 1951.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> Since then, a large number of semisynthetic pleuromutilin conjugates have been synthesised, of which four have reached the market (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> These include two veterinary agents, tiamulin<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> (<b>2</b>, Denagard, 1975) and valnemulin<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> (<b>3</b>, Econor, 1998), and two clinical agents retapamulin<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> (<b>4</b>, Altargo, 2007) approved for short-term treatment of skin and soft tissue infections (SSTIs), and finally, the very recent lefamulin<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10−12)</a> (<b>5</b>, Xenleta, 2019) approved for the treatment of community-acquired pneumonia by oral and intravenous administration.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10−12)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/medium/jm0c01328_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of clinically approved and relevant pleuromutilins conjugates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01328&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The pleuromutilin class is especially potent towards Gram-positive pathogens of the <i>Staphylococcus</i>, <i>Mycoplasma,</i> and <i>Streptococcus</i> species.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The antibacterial effect of pleuromutilins arises from their ability to inhibit bacterial protein synthesis by binding to the A- and P-site of the peptidyl transferase center (PTC) located in the large ribosomal subunit (50S). The orientation and binding mode of pleuromutilins have been thoroughly elucidated by footprinting studies,<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13−15)</a> X-ray crystallography,<a onclick="showRef(event, 'ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18">(16−18)</a> and molecular modelling.<a onclick="showRef(event, 'ref16 ref19'); return false;" href="javascript:void(0);" class="ref ref16 ref19">(16,19)</a> From these, it has been established that the tricyclic mutilin core resides in the A-site of the PTC (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>; red circle), while the C14 substituent (glycolic ester or modifications thereof, blue ellipse) protrudes into the P-site.<a onclick="showRef(event, 'ref13 ref16 ref17 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref13 ref16 ref17 ref20 ref21">(13,16,17,20,21)</a> This hinders tRNA association and positioning as well as the crucial 3′-end tRNA A- to P-site rotary motion required for peptide bond formation (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A).<a onclick="showRef(event, 'ref13 ref16 ref17 ref18 ref19 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref13 ref16 ref17 ref18 ref19 ref22 ref23">(13,16−19,22,23)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/medium/jm0c01328_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Pleuromutilin mode of binding and actions. Tricyclic mutilin core: red circle; C14 substituent: blue ellipse. (A) Inhibition of tRNA association and peptide bond formation. (B) Inhibition of initiation complex formation by sterical hindrance.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01328&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Furthermore, pleuromutilins have also been shown to inhibit the formation of the 70S initiation complex (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). This is based on the fact that radiolabelled tiamulin is unable to bind once translational elongation has begun.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Second, the addition of tiamulin (<b>2</b>) to intact cells leads to ineffective initiation complexes,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and finally, retapamulin (<b>4</b>) has been shown to partially inhibit fMet-tRNA binding which in turn disrupts the formation of the 70S initiation complex.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Among protein synthesis inhibitors, the aforementioned ability is unique to pleuromutilins and may thus help explain their lack of clinically relevant cross-resistance.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p">In July 2018, retapamulin (<b>4</b>) was withdrawn by GlaxoSmithKline,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> which leaves the market without a pleuromutilin conjugate optimized for topical use. A promising candidate for potentially filling this gap is BC-7013 (<b>6</b>), currently in development by Nabriva Therapeutics for the treatment of uncomplicated skin and skin structure infections (uSSSIs).<a onclick="showRef(event, 'ref26 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28 ref29">(26−29)</a> It displays strong activity towards Gram-positive bacteria, including methicillin-resistant <i>Staphylococcus</i> aureus (MRSA), coagulase-negative <i>Staphylococci</i> (CoNS), and <i>Streptococcus Pyogenes</i> strains with minimal inhibitory concentrations (MICs) of 0.03, 0.06, and 0.03 μg mL<sup>–1</sup>, respectively. It has successfully passed phase I clinical trials.</div><div class="NLM_p">In 2014, we identified compound <b>7</b><a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) to possess excellent activity towards the clinically prevalent and virulent strain MRSA USA300<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30−32)</a> signified by a MIC of 0.06 μg mL<sup>–1</sup>.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Unfortunately, the synthesis of <b>7</b> was fairly inefficient and challenging, signified by a poor convergent total yield of 7% largely because of the Chan–Lam–Evans-modified Ullmann condensation used to form the adenine-phenyl bond.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> To evade this, we decided to exchange the phenyl scaffold for a benzyl layout (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) which allows for easier derivatization and thereby more efficient synthesis. All three substitution patterns were probed in combination with different benzylic modifications. These were primarily related to the lead <b>7</b>, that is, adenine and other nitrogen-containing heterocycles, as well as aromatics and more simple groups (e.g. alcohols, amines, and nitriles). We herein report the initial results of this endeavor.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/medium/jm0c01328_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of the lead (compound <b>7</b><a onclick="showRef(event, 'ref14 ref19'); return false;" href="javascript:void(0);" class="ref ref14 ref19">(14,19)</a>) and the benzyl adaption thereof.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01328&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86652" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86652" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Synthesis</h3><div class="NLM_p">The pleuromutilin conjugates were constructed by utilizing the same overall synthetic strategy as previously published (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref14 ref19 ref33'); return false;" href="javascript:void(0);" class="ref ref14 ref19 ref33">(14,19,33)</a> First, the glycolic ester of (+)-pleuromutilin <b>1</b> was activated by sulfonylation with mesyl chloride to grant <b>8</b>,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> followed by substitution with sodium azide to form <b>9</b>, in moderate and good yields, respectively. C22-functionalization of <b>9</b> and the synthesis of <b>10</b>–<b>44</b> was achieved via the Cu(I)-catalyzed alkyne–azide [3 + 2] cycloaddition (CuAAC) with yields ranging from very poor to excellent. The synthesis and derivatization of the alkynes employed for the cycloaddition are summarized in <a class="ref internalNav" href="#sch2" aria-label="Schemes 2">Schemes 2</a> and <a class="ref internalNav" href="#sch3" aria-label="3">3</a>, respectively, while the structures of the conjugates <b>10</b>–<b>44</b> are presented in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/medium/jm0c01328_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01328&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) mesyl-Cl, DCM, Et<sub>3</sub>N, 0 °C → rt.; (b) NaN<sub>3</sub>, acetone/H<sub>2</sub>O, 70 °C; (c) CuSO<sub>4</sub>·5H<sub>2</sub>O, sodium ascorbate, <i>t</i>-BuOH/H<sub>2</sub>O (1:1, v/v), 110 °C MW.</p></p></figure><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/medium/jm0c01328_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01328&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) trimethylsilylacetylene, Pd(PPh<sub>3</sub>)<sub>4</sub>, CuI, anh. piperidine 50 °C (<b>48</b>, <b>49</b>) or anh. Et<sub>3</sub>N at rt. (<b>50</b>). (b) DBU, PBr<sub>3</sub>, DCM, 0 °C → rt.; (c) tetrabutylammonium fluoride (TBAF), THF, rt. (<b>51</b>) or K<sub>2</sub>CO<sub>3</sub>, MeOH, rt. (<b>52</b>); (d) anh. THF, 55 °C, diethylamine (<b>57</b>, <b>58</b>) or 1-methylpiperazine (<b>59</b>, <b>60</b>) followed by K<sub>2</sub>CO<sub>3</sub>, MeOH, rt. (<b>57</b>, <b>59</b>); (e) appropriate boronic acid, Pd(OAc)<sub>2</sub>, PPh<sub>3</sub>, K<sub>3</sub>PO<sub>4</sub>, toluene 80 °C (<b>61</b>) or Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, THF/H<sub>2</sub>O (2:1, v/v) (<b>62</b>–<b>65</b>) followed by K<sub>2</sub>CO<sub>3</sub>, MeOH/DCM 2:1 (v/v), rt. (<b>61</b>–<b>65</b>)<sub>;</sub> (f) NaBH<sub>4</sub>, MeOH, 0 °C → rt. (<b>66</b>) or diethylamine, NaBH<sub>4</sub>, MeOH, 0 °C followed by K<sub>2</sub>CO<sub>3</sub>, MeOH/DCM 2:1 (v/v), rt. (<b>67</b>); (g) appropriate nucleobase (B) or chloropurine, K<sub>2</sub>CO<sub>3</sub>, DMF, rt. (<b>68</b>–<b>72</b>, <b>74</b>, <b>77</b>, <b>78</b>) or NaH, DMF, rt. (<b>73</b>, <b>76</b>) followed by tetrabutylammonium fluoride (TBAF), THF, rt. (<b>69</b>, <b>70</b>, <b>75, 78</b>); (h) appropriate amino species, anh. EtOH, 75 °C (<b>79</b>–<b>86</b>) or i) guanidine·HCl, NaH, MeCN/DMF (2:1, v/v), rt. (ii) 1,4-diazabicyclo[2.2.2]octane (DABCO), rt. (<b>87</b>).</p></p></figure><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/medium/jm0c01328_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01328&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) K-phthalimide, DMF, rt.; (b) H<sub>2</sub>N–NH<sub>2</sub>·H<sub>2</sub>O 50–60% w/w, EtOH, 78 °C; (c) trimethylsilylacetylene, Pd(PPh<sub>3</sub>)<sub>4</sub>, CuI, anh. piperidine 80 °C; (d) K<sub>2</sub>CO<sub>3</sub>, MeOH, rt.; (e) (i) 1 M LiAlH<sub>4</sub> in THF, THF, −10 °C → rt. (ii) H<sub>2</sub>O, NaOH (sat.).</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. MIC towards MRSA USA300</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/medium/jm0c01328_0011.gif" alt="" id="GRAPHIC-d7e861-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/medium/jm0c01328_0012.gif" alt="" id="gr10" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/medium/jm0c01328_0015.gif" alt="" id="GRAPHIC-d7e863-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">MIC: lowest concentration of compound to fully inhibit visible growth of MRSA USA300.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">MIC-values ≥ 0.5 μg mL<sup>–1</sup> are <i>n</i> = 2, MIC-values ≤ 0.25 μg mL<sup>–1</sup> are <i>n</i> = 3.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">ChemDraw 18.2.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">Positive control. For structures see <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>.</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">Dreier et al. (2014).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></p></div></div><div></div></div><div class="NLM_p">The alkyne synthesis strategy involved the formation of the ethynylbenzyl scaffold initially by standard and efficient Sonogashira cross-coupling of iodobenzyl alcohols with trimethylsilylacetylene (<b>48</b>–<b>50</b>, <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). The benzylic position was then activated via bromination with PBr<sub>3</sub>, which granted the benzylbromides <b>53</b>–<b>56</b> in good yields. From here on, synthesis could easily diverge. The tertiary amines <b>57</b>–<b>60</b> were prepared by simple S<sub>N</sub>2 substitutions in the presence of diethylamine or 1-methylpiperazine in excellent yields. The benzylphenyl acetylenes <b>61</b>–<b>65</b> were synthesized via Suzuki cross-coupling with the appropriate boronic acids in poor to moderate yields. Subsequent reduction of <b>65</b> with NaBH<sub>4</sub> gave <b>66</b> in good yield, while reductive amination gave <b>67</b> in moderate yield.</div><div class="NLM_p">Alkylation of the nucleobases (thymine, adenine, 6-chloropurine, and 2-amino-chloropurine) was achieved in the presence of an inorganic base (K<sub>2</sub>CO<sub>3</sub> or NaH) in DMF. The yields for <b>68</b>–<b>78</b> were mainly deteriorated by lack of regioselectivity, that is, formation of the N3 isomer (thymines) or N7 isomer (purines), which in turn, also complicated their subsequent separation during flash chromatography. The strategy was overall still more efficient and straightforward than our previous approach.</div><div class="NLM_p">The chloropurins <b>74</b>–<b>78</b> were converted via nucleophilic aromatic substitution with various amines in anhydrous EtOH to grant <b>79</b>–<b>86</b>, generally in excellent yields. Compound <b>87</b> was prepared via guanidination in accordance with a procedure optimized by Česnek and co-workers.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><div class="NLM_p last">The primary benzylamines <b>89</b> and <b>96</b>–<b>97</b> were synthesized via two strategies (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>): The para analogue <b>89</b> was synthesized via standard Gabriel synthesis, which proved highly efficient, simultaneously also granting the phthalimide <b>88</b>. The second strategy involved reduction of ethynylbenzonitriles with LiAlH<sub>4</sub>,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> which also proved efficient, granting the nitriles <b>94</b> and <b>95</b> as well.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> MRSA Susceptibility and SAR</h3><div class="NLM_p">The antibacterial susceptibility (MIC) of conjugates <b>10</b>–<b>44</b> towards MRSA USA300 is listed in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. It should be stressed that the correlation between <i>in vitro</i> cell-based activity and raw binding affinity is indirect as additional barriers between the conjugate and its target are introduced by the bacterial cell. The overall physicochemical properties of each compound thus also affect the observed MIC value, where especially lipophilicity (often estimated by ClogP or PSA), solubility, and solution and metabolic stability of the antibacterial, are significant.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><div class="NLM_p">Baring no substituent, the phenyl <b>10</b> forms a natural baseline for comparison and discussion of the simple functionalizations incorporated in compounds <b>11</b>–<b>22</b>. The meta aniline <b>11</b> yielded a twofold decrease in MIC over <b>10</b>, while the benzonitriles displayed reasonable activity with higher toleration of the ortho <b>12</b> than the equivalent meta <b>13</b>, which in turn displayed the same activity as <b>11</b>. Introduction of ionizability via the primary benzyl amines <b>14</b>–<b>16</b> resulted in a loss of activity over <b>10</b> and the analogous but neutral aniline <b>11</b>. Increasing lipophilicity by replacement of the NH<sub>2</sub> protons with ethyl groups had no influence on activity between the meta analogues <b>15</b> and <b>17</b>, while a twofold increase in MIC was observed between the para <b>16</b> and <b>18</b>. Despite the increased size, strain, and ionizability of the piperazines <b>19</b> and <b>20</b>, the same activity and trend was observed (meta > para). Overall, the data clearly indicate that aliphatic, positively charged moieties are poorly accepted and confer a loss in susceptibility over the bare phenyl <b>10</b> irrespective of ring position and may thus be a consequence of either poor permeation or stability. Although as amines are present in the positive controls valnemulin (<b>3</b>) and retapamulin (<b>4</b>), this suggests that the combination of amines and the relatively inflexible benzyl-triazole scaffold may not be able to accommodate a conformation that confers favourable electrostatic interactions.</div><div class="NLM_p">The benzyl alcohols <b>21</b> and <b>22</b>, however, displayed good activity, with the para being twofold better than its meta equivalent and comparable to retapamulin (<b>4</b>, 0.25 μg mL<sup>–1</sup>). Despite a presumably lower desolvation penalty, the alcohols and primary amines would likely accept and donate the same hydrogen bonds, which further suggests that the modest activity of <b>14</b>–<b>20</b> may be attributed to their ionizability. Overall, the incorporation of an additional phenyl linker (<b>23</b>–<b>28</b>) did not enhance the antibacterial effect. Although the activity of the ortho anisole <b>23</b> was equal to that of <b>10</b>, anisoles <b>24</b> and <b>25</b> were almost inactive. Although the meta-positioned meta-benzyl alcohol <b>26</b> was accepted, it was less active than alcohol <b>21</b>, possibly because of decreased solubility. The activity of diethylamino <b>27</b> was moderate and in line with the trend observed for <b>14</b>–<b>20</b>. However, removal of the CH<sub>2</sub> and thereby ionizability resulted in a significant fourfold loss of activity for the diethylaniline <b>28</b>.</div><div class="NLM_p">Introduction of the heterocycles of <b>29</b>–<b>44</b> proved more successful and in agreement with our previous work, as all displayed good antibacterial effect, with several being pronounced. Despite its considerable lipophilicity, this unexpectedly also included the para-phthalimide <b>29</b> which was the only conjugate out of 12 with Clog <i>P</i> > 6 to go below 1 μg mL<sup>–1</sup>. Although both the ortho and meta thymines <b>30</b> and <b>31</b> were active, the para analogue <b>32</b> was more pronounced. This trend was repeated by the adenines <b>33</b>–<b>35</b>, however, to a greater extent as they were overall more active. Compound <b>35</b> proved to be exceptionally potent (MIC = 0.03 μg mL<sup>–1</sup>), especially in comparison to the fairer activity of ortho <b>33</b> and meta <b>34</b>. Again, to probe the influence of the NH<sub>2</sub> protons and increase lipophilicity, this time on the more hydrophilic purine scaffold, the 6-amino was exchanged for the diethylamino group of <b>36</b>–<b>38</b>. This was, however, poorly accepted across all three, with a significant eightfold difference in MIC between <b>35</b> and <b>38</b>. The introduction of an amino group in the 2-position retrieved some of the lost activity for the ortho <b>39</b> and meta <b>40</b> (two-fold). Further extension of the C6 position and introduction of basic functional groups (<b>41</b>–<b>44</b>) were again poorly accepted. The additional structure–activity relationship (SAR) revealed that substitution with a methylpiperazine (<b>41</b>–<b>42</b>) granted potencies equal to the diethylamines <b>37</b> and <b>38</b>. Exchange with the analogous but more flexible ethylene diamine <b>43</b> yielded an additional twofold increase in MIC over the piperazine <b>42</b> and a significant 16-fold increase over <b>35</b>. Probing the effect of increased polarity and ability to donate hydrogen bonds by the guanidine <b>44</b>, it too was poorly tolerated. In summary, across the thymines, adenines, and diethylaminopurines, a clear discrimination appears for both the ring position (para ≫ meta > ortho) and nucleobase (adenine > thymine ≥ diethylaminopurine). Because one can assume almost identical in-group physicochemical properties, preference for the para-position is a result of increased multivalency and optimal positioning in the P-site of the PTC. Moreover, the thorough purine-C6 SAR evidently shows that independent of the ring position, substitution of the 6-amino group by aliphatic groups, either cyclic or linear, neutral or basic, is not accepted and translates to a significant loss of activity. The SAR further suggests that the 6-aminopurine scaffold itself is able to occupy the available space, partake in hydrogen-bond donation, and likely also form π–π interactions as some level of activity is retained after adenine modification.</div><div class="NLM_p">For the time being, <b>35</b> is the only conjugate to display activity comparable to that of the lead <b>7</b>.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> To investigate why, a simple 2D pharmacophore fingerprint model of <b>7</b> and <b>33</b>–<b>35</b> was prepared (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), with the displayed conformations having the highest degree of adenine overlap, as the experimental data suggest that positioning and orientation of the nucleobase is the determining factor. Here, it is evident that the C22 substituent of <b>35</b> can achieve the same overall topology as <b>7</b> and vice versa, whereas <b>34</b> and <b>33</b> cannot, with increasing dissimilarity furthermore being positively correlated with MIC. This may also explain why <b>7a</b>, the para-analogue of <b>7</b>, displayed significantly lower activity, as it is likewise unable to accommodate the correct positioning of the 6-amino group.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/medium/jm0c01328_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. 2D pharmacophore fingerprints of adenine–phenyltriazolo–pleuromutilin conjugates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01328&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The fingerprints of <b>7</b> and <b>35</b> were reproduced by an MM-GBSA model (0 Å flexibility), signified by the highly similar posing of the two conjugates (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>), although in a more closed conformation than in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>. In addition, compound <b>35</b> seems to more or less fully occupy the available space, as speculated earlier (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). Noteworthy is also the small but potentially crucial detail displayed in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B, where the 6-amino of <b>35</b> has been simulated to be in close proximity of the backbone of C2469 (∼3 Å). As the 6-amino protons were identified as an essential part of the pharmacophore outlined in the SAR discussed earlier, this may, in fact, be because of the formation of strong anion-to-hydrogen bonding with the phosphate oxygens of C2469.</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/medium/jm0c01328_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) 3D superimposition of the lead <b>7</b> and <b>35</b> in the full PTC binding pocket (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HL7">5HL7</a>). (B) Top view of superimposition with nucleotides C2090, A2089, and G2088 removed to grant a better overview of the potential hydrogen bonding between <b>35</b> and C2469 (<i>S. aureus</i> accession numbers).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01328&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To the best of our knowledge, compound <b>35</b> is one of the most potent pleuromutilin conjugates against MRSA USA300 to be reported. To further verify its activity, compound <b>35</b> was screened against three additional clinical isolates of MRSA and a methicillin-resistant <i>Staphylococcus Epidermis</i> isolate (MRSE, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). High susceptibility of <b>35</b> was observed for all MRSA and also MRSE 933010, either outperforming or matching the activity of valnemulin (<b>3</b>). The activity of <b>35</b> against MRSA is thus likely to be on par with BC-7013 (<b>6</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), especially if the difference in molecular weight is considered (∼30%).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Antibacterial Activity of 35 against MRSA/MRSE</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">MRSA USA300<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">MIC [μg mL<sup>–1</sup>]<sup><u class="uu">a</u>,</sup><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char=".">MIC</th><th class="colsep0 rowsep0" align="center">MBC</th><th class="colsep0 rowsep0" align="center" char=".">MRSA 55508</th><th class="colsep0 rowsep0" align="center" char=".">MRSA 52518</th><th class="colsep0 rowsep0" align="center" char=".">MRSA 4828<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">MRSE 933010</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">0.06</td><td class="colsep0 rowsep0" align="left">0.12</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">0.06</td><td class="colsep0 rowsep0" align="char" char=".">0.06</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="left">>2</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="left">0.12</td><td class="colsep0 rowsep0" align="char" char=".">0.06</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.06</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">MIC: lowest concentration of compound to fully inhibit visible growth of bacteria minimal bactericidal concentration (MBC): lowest concentration required to kill 99.9% of initial inoculum.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Values are <i>n</i> = 3.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Mupirocin resistant.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">Positive control. For structure see <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>.</p></div></div></div><div class="NLM_p last">The antibacterial mechanism of action against MRSA USA300 was also investigated and was probed via a minimum bactericidal concentration (MBC) assay (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). As per convention,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> an antibacterial is considered bacteriostatic if the MBC-to-MIC ratio is above 4 or bactericidal if it is equal to or below 4. As the latter is true for <b>35</b>, it classifies as a bactericidal agent against MRSA, which was also the case for valnemulin (<b>3</b>) in accordance with a study reported by Siricilla et al.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> In Vitro Cytotoxicity Screening</h3><div class="NLM_p">To evaluate whether compound <b>35</b> can fare as a preclinical drug candidate, initial screening of mammalian <i>in vitro</i> cytotoxicity is key. This was therefore performed on four mammalian cell lines grown to confluency (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>), where valnemulin (<b>3</b>) and retapamulin (<b>4</b>) were included for comparison and SDS as the positive control. Noteworthy is the fact that no significant cytotoxicity was observed at any of the investigated concentrations apart from a single point (valnemulin in PC-3). For this reason, only the diagrams which constitute the upper limit have been included in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>. In fully differentiated human intestinal Caco-2 cells, compound <b>35</b>, valnemulin (<b>3</b>), and retapamulin (<b>4</b>) stimulated cellular ATP levels, whereas no stimulation took place in undifferentiated Caco-2 cells (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A,B). Because no cellular necrosis was observed, even at the highest concentration (108 μg mL<sup>–1</sup>), this suggests that <b>35</b> is not short-term cytotoxic towards Caco-2 cells. The increase in ATP levels in fully differentiated Caco-2 cells could be explained by an apoptotic element because it has been shown that increased ATP levels is a cellular event happening in cells entering an apoptotic phase.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> However, this was only observed in fully differentiated Caco-2 cells and not in undifferentiated Caco-2 cells or any of the other cell lines investigated. No short-term necrosis was observed in human prostate cancer cells (PC-3), human embryonic kidney cells expressing the organic anion transporter OAT3 (HEK-293 OAT3),<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and canine renal epithelial cells (MDCK I) (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>, C, D, and E), although a slight, yet significant, decrease in ATP levels was observed for valnemulin (<b>3</b>) in PC-3 cells at 100 μg mL<sup>–1</sup> (22–23% reduction).</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/medium/jm0c01328_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of compound <b>35</b>, valnemulin (<b>3</b>), retapamulin (<b>4</b>), and SDS on cell viability. Cell viability was assessed via the CellTiter-Glo 2.0 assay. ATP was measured in cells treated for 3 h with either 10 mM HEPES in HBSS buffer (control) or different concentrations of antibacterials (μg/mL). (A) Fully differentiated Caco-2 cells, (B) undifferentiated Caco-2 cells, (C) PC-3 cells, (D) HEK-293 OAT3 cells, (E) MDCK I cells, and (F) MTT assay in undifferentiated Caco-2 cells. Fit obtained via GraphPad Prism 7.01. Each bar depicts the mean ± SD of replicates in 3 cell containing wells from one cell passage.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01328&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The Caco-2 cell viability was also investigated using a thiazolyl blue tetrazolium bromide (MTT) assay (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> F). In the concentration range investigated, neither compound <b>35</b> nor valnemulin (<b>3</b>) and retapamulin (<b>4</b>) displayed any effects on cell viability, in line with the CellTiter-Glo results. A concentration-dependent decrease in Caco-2 cell viability was however observed for the positive control SDS with an estimated pIC<sub>50</sub> = 3.83 ± 0.14.</div><div class="NLM_p last">In summary, it seems reasonable to assume that compound <b>35</b> does not have an <i>in vitro</i> toxicity profile majorly different from two of the pleuromutilin conjugates approved for use in animals and humans, that is, valnemulin (<b>3</b>) and retapamulin (<b>4</b>), respectively.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32465" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32465" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Through CuAAC functionalization of the powerful (+)-pleuromutilin (<b>1</b>) scaffold, a series of 35 new pleuromutilin conjugates were successfully designed, synthesized, and subsequently screened on an MRSA USA300 <i>in vitro</i> susceptibility assay. This evaluation yielded several new SARs and thereby provides an increased understanding of the pharmacophores associated with the benzyl-triazole scaffold. Most notably is the clear preference for a para-substitution pattern of the benzyl system in combination with a nucleobase or modifications thereof. However, the introduction of a cationic moiety corresponded to a clear loss of <i>in vitro</i> activity, whether it be directly on the benzyl or its substituent.</div><div class="NLM_p">Among the new pleuromutilin conjugates, the para-adenine <b>35</b> displayed excellent antibacterial activity against USA300 (MIC = 0.03 μg mL<sup>–1</sup>, MBC = 0.12 μg mL<sup>–1</sup>) and also three other isolates of MRSA and one of MRSE. Adaption of the benzyl-triazole scaffold thus proved successful as it achieved not only a twofold increase in activity (USA300) but also a fourfold increase in total yield over the lead <b>7</b> (28 vs 7%). Extended SAR of the adenine C6 position revealed that the 6-amino is an integral part of the pharmacophore associated with our scaffold. A MM-GBSA molecular model suggests that this is likely because of hydrogen bonding with the backbone of C2469.</div><div class="NLM_p last">As the scaffold of <b>35</b> is easy to modify, retains activity after modification, and does not display significant levels of <i>in vitro</i> cytotoxicity<i>,</i> compound <b>35</b> or a derivative thereof may in the near future reveal itself as a highly promising drug candidate for the fight against multiresistant bacteria.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27517" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27517" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> General Methods</h3><div class="NLM_p last">Commercially available solvents and starting materials were used unless otherwise stated. TLC was performed using silica gel 60 F254 plates and visualized at 254 nm or by staining with PMA, ninhydrin, or KMnO<sub>4</sub> stains. For flash chromatography purification, silica gel 60 (0.040–0.063 mm, Merck) was used. <sup>1</sup>H and <sup>13</sup>C spectra were recorded at 400 and 101 MHz, respectively, on a Bruker Avance III 400 at 300 K. Purity of all test compounds is >95% and was determined by RPLC analysis performed using a Gemini C18 column (5 μm, 4.6 mm × 150 mm); flow, 1 mL/min; 10% MeCN in water (0 – 1 min), 10–100% MeCN in water (1 – 10 min), 100% MeCN (11 – 15 min), both solvents with 0.1% trifluoro acetic acid as the modifier and UV detection at 254 nm.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> General Procedure 1: CuAAC Reaction</h3><div class="NLM_p">A small microwave vial was charged with 22-azido-22-deoxypleuromutilin <b>9</b> (0.12–0.20 mmol), the appropriate alkyne (0.12–0.20 mmol), sodium ascorbate (0.025–0.040 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (0.012–0.020 mmol) before degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.00–2.25 mL) was added. The vial was sealed and irradiated in a microwave reactor at 110 °C (normal/high absorption mode) for 30 min. The reaction mixture was concentrated <i>in vacuo</i> and the resulting residue was purified by flash chromatography in either EtOAc/PE (0–100%), EtOAc/MeOH (0–20%), or MeOH/CH<sub>2</sub>Cl<sub>2</sub> (0–20%) to afford the product as white crystals/foam.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> 22-[4-Phenyl-1<i>H</i>-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>10</b>)</h4><div class="NLM_p last">General procedure 1 was applied with compound <b>9</b> (100.1 mg, 0.248 mmol), phenylacetylene (0.03 mL, 0.273 mmol), sodium ascorbate (4.8 mg, 0.024 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (5.8 mg, 0.023 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.6 mL). Flash chromatography (MeOH/DCM, 10%). Yield: 104 mg (83%, 0.206 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.88–7.81 (m, 3H), 7.47–7.41 (m, 2H), 7.38–7.33 (m, 1H), 6.42 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.84 (d, <i>J</i> = 8.5 Hz, 1H), 5.35 (dd, <i>J</i> = 11.0, 1.5 Hz, 1H), 5.22 (dd, <i>J</i> = 17.3, 1.5 Hz, 1H), 5.19–5.05 (m, 2H), 3.35 (dd, <i>J</i> = 10.7, 6.5 Hz, 1H), 2.32–2.06 (m, 5H), 1.80–1.38 (m, 8H), 1.36 (s, 3H), 1.33 (d, <i>J</i> = 16.3 Hz, 1H), 1.18 (s, 3H), 1.16–1.08 (m, 1H), 0.87 (d, <i>J</i> = 7.0 Hz, 3H), 0.74 (d, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 216.6, 165.2, 148.5, 138.8, 130.5, 129.0, 128.5, 126.0, 121.0, 117.7, 74.7, 71.2, 58.1, 51.8, 45.5, 44.9, 44.2, 42.0, 36.7, 36.2, 34.5, 30.5, 26.9, 26.5, 24.9, 17.0, 14.8, 11.6; HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>39</sub>N<sub>8</sub>O<sub>4</sub> (M + H<sup>+</sup>), 506.3013; found, 506.3003; HPLC purity at 254 nm: 100%</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> 22-[4-(3-Aminophenyl)-1,2,3-triazol-1-yl)]-22-deoxypleuromutilin (<b>11</b>)</h4><div class="NLM_p last">General procedure 1 was applied with compound <b>9</b> (90 mg, 0.22 mmol), 3-ethynylaniline (0.03 mL, 0.289 mmol), sodium ascorbate (4.6 mg, 0.023 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (6.1 mg, 0.024 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.5 mL). Flash chromatography (MeOH/DCM, 10%). Yield: 93 mg (80%, 0.179 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.80 (s, 1H), 7.25 (dd, <i>J</i> = 2.4, 1.5 Hz, 1H), 7.20 (t, <i>J</i> = 7.7 Hz, 1H), 7.13 (dt, <i>J</i> = 7.7, 1.3 Hz, 1H), 6.67 (ddd, <i>J</i> = 7.9, 2.4, 1.1 Hz, 1H), 6.42 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.82 (d, <i>J</i> = 8.5 Hz, 1H), 5.34 (dd, <i>J</i> = 11.0, 1.5 Hz, 1H), 5.25–5.02 (m, 3H), 3.77 (s, 2H), 3.35 (dd, <i>J</i> = 10.2, 6.5 Hz, 1H), 2.33–2.05 (m, 6H), 1.80–1.58 (m, 4H), 1.54–1.24 (m, 8H), 1.18 (s, 3H), 1.16–1.07 (m, 1H), 0.87 (d, <i>J</i> = 7.0 Hz, 3H), 0.72 (d, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 216.7, 165.2, 148.6, 147.1, 138.8, 131.4, 129.9, 121.0, 117.7, 116.3, 115.2, 112.5, 74.7, 71.1, 58.1, 51.8, 45.5, 44.9, 44.2, 42.0, 36.7, 36.2, 34.5, 30.5, 26.9, 26.5, 24.9, 17.0, 14.8, 11.6; HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>40</sub>N<sub>4</sub>O<sub>4</sub> (M + H<sup>+</sup>), 521.3122; found, 521.3129; HPLC purity at 254 nm: 99.6%</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> 22-[4-(2-Cyanophenyl)-1<i>H</i>-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>12</b>)</h4><div class="NLM_p last">General procedure 1 was applied with compound <b>9</b> (67 mg, 0.166 mmol), the alkyne <b>94</b> (21.1 mg, 0.166 mmol), sodium ascorbate (6.6 mg, 0.033 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (4.1 mg, 0.017 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.25 mL). Flash chromatography (EtOAc/PE, 2.5–50%). Yield: 84 mg (96%, 0.158 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.48 (s, 1H), 8.39 (dt, <i>J</i> = 7.8, 1.0 Hz, 1H), 7.79–7.66 (m, 2H), 7.45 (td, <i>J</i> = 7.7, 1.2 Hz, 1H), 6.43 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.83 (d, <i>J</i> = 8.5 Hz, 1H), 5.35 (dd, <i>J</i> = 11.0, 1.5 Hz, 1H), 5.26–5.10 (m, 3H), 3.35 (dd, <i>J</i> = 10.4, 6.5 Hz, 1H), 2.34–2.06 (m, 7H), 1.76 (dd, <i>J</i> = 14.5, 3.2 Hz, 1H), 1.72–1.59 (m, 2H), 1.58 (s, 2H), 1.55–1.36 (m, 5H), 1.34 (s, 4H), 1.19 (s, 3H), 1.12 (td, <i>J</i> = 14.0, 4.5 Hz, 1H), 0.87 (d, <i>J</i> = 7.0 Hz, 3H), 0.74 (d, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 216.5, 164.8, 144.1, 138.5, 133.6, 133.4, 128.3, 128.2, 123.7, 119.1, 117.7, 108.6, 74.6, 71.3, 58.0, 51.8, 45.4, 44.8, 44.0, 41.9, 36.6, 36.1, 34.4, 30.4, 26.8, 26.3, 24.8, 16.9, 14.6, 11.5; HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>39</sub>N<sub>4</sub>O<sub>4</sub> (M + H<sup>+</sup>), 531.2966; found, 531.2640; HPLC purity at 254 nm: 99.5%</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> 22-[4-(3-Cyanophenyl)-1<i>H</i>-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>13</b>)</h4><div class="NLM_p last">General procedure 1 was applied with compound <b>9</b> (53 mg, 0.131 mmol), the alkyne <b>95</b> (16.6 mg, 0.131 mmol), sodium ascorbate (5.2 mg, 0.026 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (3.3 mg, 0.013 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.00 mL). Flash chromatography (0–50% EtOAc/PE). Yield: 67 mg (96%, 0.126 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.11 (m, 2H), 7.95 (s, 1H), 7.64 (dt, <i>J</i> = 7.7, 1.4 Hz, 1H), 7.59–7.53 (m, 1H), 6.42 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.85 (d, <i>J</i> = 8.5 Hz, 1H), 5.35 (dd, <i>J</i> = 10.9, 1.5 Hz, 1H), 5.26–5.19 (m, 1H), 5.22–5.07 (m, 2H), 3.36 (dd, <i>J</i> = 10.6, 6.5 Hz, 1H), 2.35–2.02 (m, 7H), 1.83–1.06 (m, 22H), 0.87 (d, <i>J</i> = 0.8 Hz, 4H), 0.74 (d, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 216.5, 164.9, 146.2, 138.6, 131.7, 131.7, 129.9, 129.8, 129.3, 121.5, 118.5, 117.7, 113.2, 74.5, 71.3, 58.0, 51.7, 45.4, 44.8, 44.0, 41.9, 36.5, 36.1, 34.4, 30.3, 26.8, 26.4, 24.8, 16.9, 14.7, 11.5; HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>39</sub>N<sub>4</sub>O<sub>4</sub> (M + H<sup>+</sup>), 531.2966; found, 531.2942; HPLC purity at 254 nm: 98.5%</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 22-[4-(2-(Aminomethyl)phenyl)-1<i>H</i>-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>14</b>)</h4><div class="NLM_p last">A slightly altered general procedure 1 was applied with the alkyne <b>96</b> (20 mg, 0.153 mmol) as the limiting reagent, compound <b>9</b> (65 mg, 0.161 mmol), tris((1-<i>tert</i>-butyl-1<i>H</i>-1,2,3-triazolyl)methyl)amine (TTTA, 6.9 mg, 0.016 mmol), sodium ascorbate (6.4 mg, 0.032 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (4.0 mg, 0.016 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.25 mL). Flash chromatography (2–20% MeOH/DCM). Yield: 9 mg (11%, 0.017 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.97 (br s, 1H), 7.53 (m, 2H), 7.40 (m, 2H), 6.43 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.85 (d, <i>J</i> = 8.5 Hz, 1H), 5.39–5.33 (m, 1H), 5.26–5.08 (m, 3H), 3.56 (s, 2H), 3.37 (d, <i>J</i> = 6.4 Hz, 1H), 2.33–2.07 (m, 6H), 1.78 (d, <i>J</i> = 14.4 Hz, 1H), 1.74–1.60 (m, 3H), 1.58–1.40 (m, 3H), 1.38 (s, 3H), 1.33 (s, 1H), 1.25 (s, 1H), 1.19 (s, 3H), 1.13 (dt, <i>J</i> = 13.4, 6.7 Hz, 1H), 0.88 (d, <i>J</i> = 7.0 Hz, 3H), 0.74 (d, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 216.6, 165.0, 138.8, 129.4, 117.8, 74.7, 71.4, 58.1, 45.6, 44.9, 44.2, 42.0, 36.7, 36.2, 34.5, 30.5, 29.8, 27.0, 26.6, 25.0, 17.0, 14.8, 11.6; HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>43</sub>N<sub>4</sub>O<sub>4</sub> (M + H<sup>+</sup>), 535.3279; found, 535.3260; HPLC purity at 254 nm: 96.8%</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 22-[4-(3-(Aminomethyl)phenyl)-1<i>H</i>-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>15</b>)</h4><div class="NLM_p last">A slightly altered general procedure 1 was applied with the alkyne <b>97</b> (20 mg, 78% pure, 0.118 mmol) as the limiting reagent, compound <b>9</b> (50 mg, 0.124 mmol), sodium ascorbate (4.9 mg, 0.025 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (3.0 mg, 0.012 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.00 mL). The mixture was evaporated onto Celite. Flash Chromatography (2–20% MeOH/CH<sub>2</sub>Cl<sub>2</sub>). Yield: 26 mg (42%, 0.049 mmol); <sup>1</sup>H NMR (400 MHz, DMSO): δ 8.50 (s, 1H), 7.87 (s, 1H), 7.71 (d, <i>J</i> = 7.7 Hz, 1H), 7.39 (d, <i>J</i> = 7.6 Hz, 1H), 7.35–7.30 (m, 1H), 6.14 (dd, <i>J</i> = 17.8, 11.2 Hz, 1H), 5.59 (d, <i>J</i> = 8.3 Hz, 1H), 5.47–5.27 (m, 2H), 5.17–5.01 (m, 2H), 4.56 (d, <i>J</i> = 5.9 Hz, 1H), 3.83 (s, 2H), 3.44–3.40 (m, 2H), 2.41 (s, 1H), 2.24–1.98 (m, 4H), 1.70–1.26 (m, 7H), 1.24 (s, 3H), 1.08 (s, 3H), 0.81 (d, <i>J</i> = 6.9 Hz, 3H), 0.65 (d, <i>J</i> = 6.9 Hz, 3H); <sup>13</sup>C NMR (101 MHz, DMSO): δ 217.0, 165.6, 146.5, 146.5, 140.7, 130.4, 128.7, 126.9, 124.1, 123.5, 122.7, 115.4, 72.5, 70.6, 57.1, 51.3, 44.9, 44.1, 43.3, 41.5, 36.4, 36.2, 33.9, 30.0, 28.5, 26.5, 24.4, 16.1, 14.2, 11.5; HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>43</sub>N<sub>4</sub>O<sub>4</sub> (M + H<sup>+</sup>), 535.3279; found, 535.3289; HPLC purity at 254 nm: 96.8%</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 22-[4-(4-(Aminomethyl)phenyl)-1<i>H</i>-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>16</b>)</h4><div class="NLM_p last">A slightly altered general procedure 1 was applied with the alkyne <b>89</b> (20 mg, 0.153 mmol) as the limiting reagent, compound <b>9</b> (50 mg, 0.161 mmol), sodium ascorbate (6.4 mg, 0.032 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (4.0 mg, 0.016 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.25 mL). Flash chromatography (PE/EtOAc/MeOH, 1:1:0 → 0:9:1 → 0:4:1). Yield: 51 mg (62%, 0.095 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.88 (s, 1H), 7.81 (d, <i>J</i> = 7.5 Hz, 2H), 7.39 (d, <i>J</i> = 7.8 Hz, 2H), 6.42 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.83 (d, <i>J</i> = 8.4 Hz, 1H), 5.34 (dd, <i>J</i> = 11.0, 1.4 Hz, 1H), 5.23 (d, <i>J</i> = 1.5 Hz, 1H), 5.19–5.05 (m, 2H), 4.15 (s, 3H), 3.36 (d, <i>J</i> = 6.4 Hz, 1H), 2.34–1.96 (m, 9H), 1.82–1.38 (m, 7H), 1.35 (s, 4H), 1.32–1.23 (m, 2H), 1.18 (s, 3H), 0.87 (d, <i>J</i> = 7.0 Hz, 3H), 0.73 (d, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 216.5, 165.1, 148.0, 138.6, 129.5, 128.1, 126.2, 120.9, 118.8, 117.6, 77.2, 74.6, 71.1, 58.0, 51.7, 45.4, 44.8, 44.0, 41.9, 36.6, 36.1, 34.4, 30.4, 26.8, 26.4, 24.8, 16.8, 14.6, 11.5; HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>43</sub>N<sub>4</sub>O<sub>4</sub> (M + H<sup>+</sup>), 535.3279; found, 535.3268; HPLC purity at 254 nm: 96.3%</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 22-[4-(3-((Diethylamino)methyl)phenyl)-1<i>H</i>-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>17</b>)</h4><div class="NLM_p last">A slightly altered general procedure 1 was applied with the alkyne <b>57</b> (28 mg, 0.149 mmol) as the limiting reagent, compound <b>9</b> (65 mg, 0.161 mmol), sodium ascorbate (6.3 mg, 0.032 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (4.0 mg, 0.016 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.25 mL). Flash chromatography (PE/EtOAc/MeOH, 1:4:0 → 0:1:0 → 0:9:1 → 0:6:1). Yield: 81 mg (92%, 0.137 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.88 (s, 1H), 7.82 (s, 1H), 7.74 (dt, <i>J</i> = 7.3, 1.7 Hz, 1H), 7.41–7.32 (m, 2H), 6.43 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.84 (d, <i>J</i> = 8.5 Hz, 1H), 5.35 (dd, <i>J</i> = 11.0, 1.5 Hz, 1H), 5.22 (dd, <i>J</i> = 17.5, 1.5 Hz, 1H), 5.12 (q, <i>J</i> = 17.5 Hz, 2H), 3.66 (s, 2H), 3.36 (d, <i>J</i> = 6.4 Hz, 1H), 2.59 (q, <i>J</i> = 7.1 Hz, 4H), 2.35–2.03 (m, 6H), 1.77 (dt, <i>J</i> = 14.5, 3.1 Hz, 1H), 1.72–1.62 (m, 2H), 1.62–1.39 (m, 4H), 1.37 (s, 4H), 1.18 (s, 3H), 1.08 (t, <i>J</i> = 7.1 Hz, 6H), 0.88 (d, <i>J</i> = 7.0 Hz, 3H), 0.74 (d, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 216.5, 165.1, 148.5, 138.6, 130.2, 129.1, 128.8, 126.5, 124.5, 121.0, 117.6, 74.6, 71.0, 58.0, 57.4, 51.7, 46.7, 45.4, 44.8, 44.0, 41.9, 36.6, 36.1, 34.4, 30.4, 26.8, 26.4, 24.8, 16.9, 14.7, 11.5, 11.5; HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>51</sub>N<sub>4</sub>O<sub>4</sub> (M + H<sup>+</sup>), 591.3905; found, 591.3896; HPLC purity at 254 nm: 98.7%</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 22-[4-(4-((Diethylamino)methyl)phenyl)-1<i>H</i>-1,2,3-triazol-1-yl-22-deoxypleuromutilin (<b>18</b>)</h4><div class="NLM_p last">General procedure 1 was applied with compound <b>9</b> (60 mg, 0.149 mmol), the alkyne <b>58</b> (27.9 mg, 0.149 mmol), sodium ascorbate (5.9 mg, 0.030 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (3.0 mg, 0.015 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.25 mL). Flash chromatography (MeOH/EtOAc, 0% → 1% → 5% → 10%). Yield: 80 mg (91%, 0.135 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.85 (s, 1H), 7.79 (d, <i>J</i> = 8.2 Hz, 2H), 7.43 (d, <i>J</i> = 8.2 Hz, 2H), 6.43 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.83 (d, <i>J</i> = 8.5 Hz, 1H), 5.35 (dd, <i>J</i> = 11.0, 1.5 Hz, 1H), 5.22 (dd, <i>J</i> = 17.4, 1.5 Hz, 1H), 5.19–5.05 (m, 2H), 3.69 (s, 2H), 3.35 (d, <i>J</i> = 6.5 Hz, 1H), 2.62 (q, <i>J</i> = 7.1 Hz, 4H), 2.34–2.06 (m, 5H), 2.05 (d, <i>J</i> = 1.4 Hz, 1H), 1.82–1.39 (m, 6H), 1.36 (d, <i>J</i> = 1.9 Hz, 4H), 1.18 (s, 3H), 1.10 (t, <i>J</i> = 7.1 Hz, 6H), 0.88 (d, <i>J</i> = 7.0 Hz, 3H), 0.73 (d, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 216.5, 165.1, 148.3, 138.6, 129.7, 129.2, 125.8, 120.7, 117.6, 77.2, 74.6, 71.1, 58.0, 57.0, 51.7, 46.5, 45.4, 44.8, 44.0, 41.9, 36.6, 36.1, 34.4, 30.4, 26.8, 26.4, 24.8, 16.8, 14.7, 11.5, 11.3; HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>51</sub>N<sub>4</sub>O<sub>4</sub> (M + H<sup>+</sup>), 591.3905; found, 591.3893; HPLC purity at 254 nm: 96.3%</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 22-[4-(3-((4-Methylpiperazin-1-yl)methyl)phenyl)-1<i>H</i>-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>19</b>)</h4><div class="NLM_p last">A slightly altered general procedure 1 was applied with the alkyne <b>59</b> (32.8 mg, 0.153 mmol) as the limiting reagent, compound <b>9</b> (65 mg, 0.161 mmol), sodium ascorbate (6.4 mg, 0.032 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O 4.0 mg, 0.016 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.25 mL). Flash chromatography (MeOH/DCM, 2–15%). Yield: 65 mg (69%, 0.105 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.87 (s, 1H), 7.80 (s, 1H), 7.73 (dt, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.37 (d, <i>J</i> = 7.5 Hz, 1H), 7.35–7.29 (m, 1H), 6.43 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.84 (d, <i>J</i> = 8.5 Hz, 1H), 5.35 (dd, <i>J</i> = 11.0, 1.5 Hz, 1H), 5.22 (dd, <i>J</i> = 17.4, 1.5 Hz, 1H), 5.12 (q, <i>J</i> = 17.5 Hz, 2H), 3.56 (s, 2H), 3.36 (s, 1H), 2.51 (s, 8H), 2.35–2.06 (m, 9H), 1.77 (dt, <i>J</i> = 14.6, 3.2 Hz, 1H), 1.73–1.39 (m, 6H), 1.37 (s, 3H), 1.34 (d, <i>J</i> = 16.4 Hz, 1H), 0.88 (d, <i>J</i> = 7.0 Hz, 3H), 0.74 (d, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 216.5, 165.1, 148.4, 139.0, 138.6, 130.3, 129.2, 128.8, 126.6, 124.7, 120.9, 117.6, 77.2, 74.6, 71.1, 62.9, 58.0, 55.1, 53.0, 51.7, 46.0, 45.4, 44.8, 44.1, 41.9, 36.6, 36.1, 34.4, 30.4, 26.8, 26.4, 24.8, 16.9, 14.7, 11.5; HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>52</sub>N<sub>5</sub>O<sub>4</sub> (M + H<sup>+</sup>), 618.4014; found, 618.4002; HPLC purity at 254 nm: 99.5%</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 22-[4-(4-((4-Methylpiperazin-1-yl)methyl)phenyl)-1<i>H</i>-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>20</b>)</h4><div class="NLM_p last">A slightly altered general procedure 1 was applied with the alkyne <b>60</b> (32.8 mg, 0.153 mmol) as the limiting reagent, compound <b>9</b> (65 mg, 0.161 mmol), sodium ascorbate (6.4 mg, 0.032 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O 4.0 mg, 0.016 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.25 mL). Flash chromatography (MeOH/DCM, 2–15%). Yield: 82 mg (87%, 0.133 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.84 (s, 1H), 7.78 (d, <i>J</i> = 8.2 Hz, 2H), 7.39 (d, <i>J</i> = 8.3 Hz, 2H), 6.42 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.83 (d, <i>J</i> = 8.5 Hz, 1H), 5.35 (dd, <i>J</i> = 11.0, 1.5 Hz, 1H), 5.22 (dd, <i>J</i> = 17.4, 1.5 Hz, 1H), 5.19–5.04 (m, 2H), 3.54 (s, 2H), 3.34 (d, <i>J</i> = 7.4 Hz, 1H), 2.50 (s, 8H), 2.31 (s, 3H), 2.31–2.04 (m, 6H), 1.77 (dd, <i>J</i> = 14.5, 3.1 Hz, 1H), 1.72–1.39 (m, 6H), 1.35 (s, 3H), 1.31 (s, 1H), 1.18 (s, 3H), 1.17–1.08 (m, 1H), 0.88 (d, <i>J</i> = 7.0 Hz, 3H), 0.73 (d, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 216.5, 165.1, 148.3, 138.6, 138.6, 129.7, 129.2, 125.8, 120.7, 117.6, 77.2, 74.6, 71.1, 62.7, 58.0, 55.1, 53.0, 51.7, 46.0, 45.4, 44.8, 44.0, 41.9, 36.6, 36.1, 34.4, 30.4, 26.8, 26.4, 24.8, 16.8, 14.7, 11.5; HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>52</sub>N<sub>5</sub>O<sub>4</sub> (M + H<sup>+</sup>), 618.4014; found, 618.4025, HPLC purity at 254 nm: 95.6%.</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 22-[4-(3-(Hydroxymethyl)phenyl)-1<i>H</i>-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>21</b>)</h4><div class="NLM_p last">General procedure 1 was applied with compound <b>9</b> (81 mg, 0.201 mmol), the alkyne <b>51</b> (26.7 mg, 0.201 mmol), sodium ascorbate (5.8 mg, 0.029 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (5.0 mg, 0.020 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.25 mL). Flash chromatography (MeOH/EtOAc, 0 → 80%). Yield: 82 mg (76%, 0.153 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.88 (s, 1H), 7.87–7.85 (m, 1H), 7.77 (dt, <i>J</i> = 7.7, 1.5 Hz, 1H), 7.44 (t, <i>J</i> = 7.6 Hz, 1H), 7.39–7.34 (m, 1H), 6.42 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.84 (d, <i>J</i> = 8.5 Hz, 1H), 5.35 (dd, <i>J</i> = 11.0, 1.5 Hz, 1H), 5.22 (dd, <i>J</i> = 17.4, 1.5 Hz, 1H), 5.12 (q, <i>J</i> = 17.5 Hz, 2H), 4.77 (d, <i>J</i> = 5.5 Hz, 2H), 3.35 (dd, <i>J</i> = 10.6, 6.5 Hz, 1H), 2.34–2.18 (m, 4H), 2.16–2.07 (m, 2H), 1.81–1.59 (m, 3H), 1.56 (s, 2H), 1.55–1.39 (m, 2H), 1.36 (s, 4H), 1.20–1.08 (m, 4H), 0.88 (d, <i>J</i> = 7.1 Hz, 3H), 0.74 (d, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 216.5, 165.1, 148.2, 141.7, 138.6, 130.6, 129.2, 126.9, 125.1, 124.4, 120.9, 117.7, 74.6, 71.1, 65.2, 58.0, 51.7, 45.4, 44.8, 44.1, 41.9, 36.6, 36.1, 34.4, 30.4, 26.8, 26.4, 24.8, 16.9, 14.7, 11.5; HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>42</sub>N<sub>3</sub>O<sub>5</sub> (M + H<sup>+</sup>), 536.3119; found, 536.3100; HPLC purity at 254 nm: 96.7%</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 22-[4-(4-(Hydroxymethyl)phenyl)-1<i>H</i>-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>22</b>)</h4><div class="NLM_p last">General Procedure 1 was applied with compound <b>9</b> (80 mg, 0.198 mmol), the alkyne <b>52</b> (26.2 mg, 0.198 mmol), sodium ascorbate (7.9 mg, 0.040 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (5.0 mg, 0.020 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.25 mL). Flash chromatography (15–100% EtOAc/PE). Yield: 102 mg (96%, 0.191 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.86 (s, 1H), 7.85–7.80 (m, 2H), 7.47–7.41 (m, 2H), 6.42 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.84 (d, <i>J</i> = 8.5 Hz, 1H), 5.35 (dd, <i>J</i> = 11.0, 1.5 Hz, 1H), 5.22 (dd, <i>J</i> = 17.3, 1.5 Hz, 1H), 5.19–5.04 (m, 2H), 4.74 (s, 2H), 3.40–3.31 (m, 1H), 2.33–2.04 (m, 5H), 1.77 (dq, <i>J</i> = 14.4, 3.1 Hz, 1H), 1.66 (tdd, <i>J</i> = 13.8, 10.6, 6.6 Hz, 3H), 1.58–1.39 (m, 4H), 1.36 (s, 4H), 1.18 (s, 3H), 1.13 (td, <i>J</i> = 14.2, 4.7 Hz, 4H), 0.88 (d, <i>J</i> = 7.0 Hz, 3H), 0.73 (d, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 216.5, 165.1, 148.1, 141.1, 138.6, 129.7, 127.5, 126.0, 120.8, 117.6, 74.6, 71.1, 65.1, 58.0, 51.7, 45.4, 44.8, 44.0, 41.9, 36.6, 36.1, 34.4, 30.4, 26.8, 26.4, 24.8, 16.8, 14.6, 11.5; HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>42</sub>N<sub>3</sub>O<sub>5</sub> (M + H<sup>+</sup>), 536.3119; found, 536.3100 (App. 13.C); HPLC purity at 254 nm: 96.6%</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 22-[4-(2-(4-Methoxybenzyl)phenyl)-1<i>H</i>-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>23</b>)</h4><div class="NLM_p last">General procedure 1 was applied with compound <b>9</b> (81 mg, 0.201 mmol), the alkyne <b>61</b> (44 mg, 0.201 mmol), sodium ascorbate (3.7 mg, 0.015 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (5.0 mg, 0.025 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.5 mL). Flash chromatography (MeOH/CH<sub>2</sub>Cl<sub>2</sub>, 0% → 1% → 2%). Yield: 56.4 mg (45%, 0.090 mmol); <sup>1</sup>H NMR (400 MHz, DMSO): δ 7.74–7.68 (m, 1H), 7.45 (s, 1H), 7.36–7.30 (m, 2H), 7.24–7.19 (m, 1H), 7.02–6.96 (m, 2H), 6.82–6.76 (m, 2H), 6.42 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.81 (d, <i>J</i> = 8.5 Hz, 1H), 5.34 (dd, <i>J</i> = 11.0, 1.5 Hz, 1H), 5.21 (dd, <i>J</i> = 17.4, 1.5 Hz, 1H), 5.13–4.99 (m, 2H), 4.11 (s, 2H), 3.76 (s, 3H), 2.31–2.05 (m, 6H), 1.80–1.61 (m, 4H), 1.54–1.34 (m, 6H), 1.32 (s, 3H), 1.17 (s, 3H), 0.88 (d, <i>J</i> = 7.0 Hz, 3H), 0.67 (d, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (DMSO, 101 MHz): δ 211.2, 159.7, 152.7, 142.0, 133.4, 127.7, 125.6, 124.6, 124.4, 123.4, 121.3, 117.9, 112.3, 108.7, 69.3, 65.6, 52.9, 52.7, 50.0, 46.3, 40.2, 39.5, 38.8, 36.6, 33.2, 31.3, 30.8, 29.1, 25.1, 21.5, 21.1, 19.6, 11.5, 9.4; HRMS (ES) <i>m</i>/<i>z</i> calcd for C<sub>38</sub>H<sub>48</sub>N<sub>3</sub>O<sub>5</sub> (M + H<sup>+</sup>), 626.3594; found, 626.3575; HPLC purity at 254 nm: 96.7%</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 22-[4-(3-(4-Methoxybenzyl)phenyl)-1<i>H</i>-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>24</b>)</h4><div class="NLM_p last">General procedure 1 was applied with compound <b>9</b> (81 mg, 0.201 mmol), the alkyne <b>62</b> (44 mg, 0.201 mmol), sodium ascorbate (3.7 mg, 0.015 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (5.0 mg, 0.025 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.5 mL). Flash chromatography (MeOH/CH<sub>2</sub>Cl<sub>2</sub>, 0% → 1% → 2%). Yield: 111 mg (88%, 0.177 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.82 (s, 1H), 7.69 (d, <i>J</i> = 1.8 Hz, 1H), 7.67–7.62 (m, 1H), 7.34 (t, <i>J</i> = 7.6 Hz, 1H), 7.19–7.10 (m, 3H), 6.88–6.80 (m, 2H), 6.42 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.83 (d, <i>J</i> = 8.5 Hz, 1H), 5.34 (dd, <i>J</i> = 11.0, 1.5 Hz, 1H), 5.21 (dd, <i>J</i> = 17.4, 1.5 Hz, 1H), 5.10 (q, <i>J</i> = 17.5 Hz, 2H), 3.97 (s, 2H), 3.78 (s, 3H), 3.35 (d, <i>J</i> = 6.5 Hz, 1H), 2.92 (d, <i>J</i> = 5.6 Hz, 2H), 2.39 (s, 2H), 2.33–2.04 (m, 8H), 1.80–1.59 (m, 6H), 1.54–1.25 (m, 9H), 1.18 (s, 3H), 1.19–1.06 (m, 5H), 0.87 (d, <i>J</i> = 7.0 Hz, 3H), 0.73 (d, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 216.5, 165.1, 158.1, 148.4, 142.3, 138.6, 133.0, 130.4, 129.9, 129.0, 128.9, 126.3, 123.6, 120.9, 117.6, 114.0, 74.5, 71.0, 58.0, 55.3, 51.6, 46.7, 45.4, 44.8, 44.0, 41.9, 41.0, 36.6, 36.1, 34.4, 30.4, 26.8, 26.4, 24.8, 16.8, 14.6, 11.4; HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>38</sub>H<sub>48</sub>N<sub>3</sub>O<sub>5</sub> (M + H<sup>+</sup>), 626.3594; found, 626.3545; HPLC purity at 254 nm: 97.7%</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 22-[4-(4-(4-Methoxybenzyl)phenyl)-1<i>H</i>-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>25</b>)</h4><div class="NLM_p last">General procedure 1 was applied with compound <b>9</b> (50 mg, 0.124 mmol), the alkyne <b>63</b> (27 mg, 0.124 mmol), sodium ascorbate (2.2 mg, 0.013 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (3.3 mg, 0.013 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.5 mL). Flash chromatography (MeOH/CH<sub>2</sub>Cl<sub>2</sub>, 0% → 1% → 2% → 5%). Yield: 69 mg (84%, 0.110 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.81 (s, 1H), 7.73 (d, <i>J</i> = 8.2 Hz, 2H), 7.23 (d, <i>J</i> = 8.2 Hz, 2H), 7.12 (d, <i>J</i> = 8.6 Hz, 2H), 6.84 (d, <i>J</i> = 8.7 Hz, 2H), 6.41 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.81 (d, <i>J</i> = 8.5 Hz, 1H), 5.33 (dd, <i>J</i> = 10.9, 1.5 Hz, 1H), 5.20 (dd, <i>J</i> = 17.4, 1.5 Hz, 1H), 5.16–5.01 (m, 2H), 3.94 (s, 2H), 3.78 (s, 3H), 3.41–3.30 (m, 1H), 2.33–2.03 (m, 6H), 1.79–1.37 (m, 8H), 1.34 (s, 5H), 1.17 (s, 3H), 1.14–1.05 (m, 1H), 0.87 (d, <i>J</i> = 7.0 Hz, 3H), 0.71 (d, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 216.6, 165.1, 158.1, 148.2, 141.9, 138.7, 133.0, 129.9, 129.3, 128.1, 126.0, 120.7, 117.5, 114.0, 74.5, 71.0, 58.0, 55.3, 51.6, 45.4, 44.7, 44.0, 41.9, 40.8, 36.6, 36.1, 34.4, 30.3, 26.8, 26.5, 24.8, 16.8, 11.5; HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>38</sub>H<sub>48</sub>N<sub>3</sub>O<sub>5</sub> (M + H<sup>+</sup>), 626.8180; found, 626.3560; HPLC purity at 254 nm: 99.2%</div></div><div id="sec4_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 22-[4-(3-(3-(Hydroxymethyl)benzyl)phenyl)-1<i>H</i>-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>26</b>)</h4><div class="NLM_p last">General procedure 1 was applied with compound <b>9</b> (81 mg, 0.201 mmol), the alkyne <b>66</b> (44 mg, 0.201 mmol), sodium ascorbate (4.0 mg, 0.020 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (5.0 mg, 0.020 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.5 mL). Flash Chromatography (MeOH/CH<sub>2</sub>Cl<sub>2</sub>, 0% → 1% → 2% → 5%). Yield: 32 mg (26%, 0.051 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.82 (s, 1H), 7.70 (s, 1H), 7.65 (dd, <i>J</i> = 7.8, 1.4 Hz, 1H), 7.35 (t, <i>J</i> = 7.7 Hz, 1H), 7.28 (d, <i>J</i> = 8.0 Hz, 1H), 7.24–7.13 (m, 4H), 6.41 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.82 (d, <i>J</i> = 8.5 Hz, 1H), 5.34 (dd, <i>J</i> = 11.0, 1.5 Hz, 1H), 5.21 (dd, <i>J</i> = 17.4, 1.5 Hz, 1H), 5.17–5.02 (m, 2H), 4.66 (s, 2H), 4.03 (s, 2H), 3.34 (d, <i>J</i> = 8.1 Hz, 1H), 2.32–2.03 (m, 6H), 1.81–1.57 (m, 7H), 1.45 (m, 4H), 1.34 (s, 3H), 1.32–1.25 (m, 2H), 1.17 (s, 3H), 1.12 (d, <i>J</i> = 4.5 Hz, 1H), 0.87 (d, <i>J</i> = 7.0 Hz, 3H), 0.72 (d, <i>J</i> = 7.0 Hz, 3H).<sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 216.6, 165.1, 148.3, 141.7, 141.2, 138.6, 130.5, 129.1, 128.8, 128.3, 127.5, 126.5, 124.9, 123.8, 120.9, 117.6, 74.5, 71.0, 65.3, 58.0, 51.6, 45.4, 44.7, 44.0, 41.9, 41.9, 36.6, 36.1, 34.4, 30.3, 26.8, 26.4, 24.8, 16.8, 14.6, 11.4; HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>38</sub>H<sub>48</sub>N<sub>3</sub>O<sub>5</sub> (M + H<sup>+</sup>), 626.3594; found, 626.3568; HPLC purity at 254 nm: 95.7%</div></div><div id="sec4_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 22-[4-(3-(3-(<i>N</i>,<i>N</i>-Diethylaminomethyl)benzyl)phenyl)-1<i>H</i>-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>27</b>)</h4><div class="NLM_p last">General procedure 1 was applied with compound <b>9</b> (40 mg, 0.10 mmol), the alkyne <b>67</b> (27 mg, 0.10 mmol), sodium ascorbate (1.7 mg, 0.010 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (2.5 mg, 0.010 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.5 mL). Flash Chromatography (MeOH/CH<sub>2</sub>Cl<sub>2</sub>, 0% → 1% → 2% → 5%). Yield: 55 mg (81%, 0.081 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.83 (s, 1H), 7.71 (s, 1H), 7.65 (dd, <i>J</i> = 7.8, 1.4 Hz, 1H), 7.34 (t, <i>J</i> = 7.7 Hz, 1H), 7.25–7.15 (m, 4H), 7.08 (dt, <i>J</i> = 6.7, 1.7 Hz, 1H), 6.41 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.83 (d, <i>J</i> = 8.4 Hz, 1H), 5.33 (dd, <i>J</i> = 10.9, 1.5 Hz, 1H), 5.21 (dd, <i>J</i> = 17.4, 1.5 Hz, 1H), 5.18–5.02 (m, 2H), 4.02 (s, 2H), 3.56 (s, 2H), 3.35 (t, <i>J</i> = 7.3 Hz, 1H), 2.53 (m, 4H), 2.31–2.06 (m, 6H), 1.81–1.39 (m, 8H), 1.38–1.24 (m, 5H), 1.18 (s, 3H), 1.04 (t, <i>J</i> = 7.2 Hz, 6H), 0.87 (d, <i>J</i> = 7.0 Hz, 3H), 0.73 (d, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 216.6, 165.1, 148.4, 142.0, 140.7, 138.6, 130.4, 129.6, 129.0, 129.0, 128.4, 127.5, 126.9, 126.5, 123.7, 120.9, 117.6, 74.5, 71.0, 58.0, 57.4, 51.6, 46.7, 45.4, 44.8, 44.0, 41.9, 36.6, 36.1, 34.4, 30.4, 26.8, 26.4, 24.8, 16.8, 14.7, 11.6, 11.5jjffv; HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>42</sub>H<sub>57</sub>N<sub>4</sub>O<sub>4</sub> (M + H<sup>+</sup>), 681.4380; found, 681.6373; HPLC purity for 254 nm: 95.6%</div></div><div id="sec4_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 22-[4-(3-((4-<i>N</i>,<i>N</i>-Diethylamino)benzyl)phenyl)-1<i>H</i>-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>28</b>)</h4><div class="NLM_p last">General procedure 1 was applied with compound <b>9</b> (81 mg, 0.201 mmol), the alkyne <b>64</b> (53 mg, 0.201 mmol), sodium ascorbate (2.5 mg, 0.020 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (5.0 mg, 0.020 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.5 mL). Flash chromatography (MeOH/CH<sub>2</sub>Cl<sub>2</sub>, 0% → 1% → 2% → 5%). Yield: 95 mg (71%, 0.142 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.82 (s, 1H), 7.70 (d, <i>J</i> = 1.8 Hz, 1H), 7.64 (s, 1H), 7.33 (t, <i>J</i> = 7.7 Hz, 1H), 7.18 (dt, <i>J</i> = 7.8, 1.4 Hz, 1H), 7.06 (d, <i>J</i> = 8.2 Hz, 2H), 6.63 (d, <i>J</i> = 8.2 Hz, 2H), 6.42 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.83 (d, <i>J</i> = 8.5 Hz, 1H), 5.34 (dd, <i>J</i> = 11.0, 1.5 Hz, 1H), 5.30 (s, 2H), 5.21 (dd, <i>J</i> = 17.4, 1.5 Hz, 1H), 5.10 (q, <i>J</i> = 17.5 Hz, 2H), 3.92 (s, 2H), 3.32 (q, <i>J</i> = 7.2 Hz, 4H), 2.35–2.04 (m, 6H), 1.81–1.58 (m, 4H), 1.57–1.44 (m, 3H), 1.43–1.39 (m, 1H), 1.36 (s, 4H), 1.28 (d, <i>J</i> = 21.3 Hz, 1H), 1.18 (s, 3H), 1.13 (t, <i>J</i> = 7.1 Hz, 6H), 0.87 (d, <i>J</i> = 7.0 Hz, 3H), 0.73 (d, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 216.5, 165.1, 148.5, 138.6, 130.3, 129.7, 129.0, 128.9, 126.4, 123.4, 120.8, 117.6, 112.2, 74.5, 71.0, 58.0, 53.4, 51.6, 45.4, 44.7, 44.0, 41.9, 40.9, 36.6, 36.1, 34.4, 30.4, 26.8, 26.4, 24.8, 16.8, 14.7, 12.6, 11.5; HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>41</sub>H<sub>55</sub>N<sub>4</sub>O<sub>4</sub> (M + H<sup>+</sup>), 667.4223; found, 667.4185; HPLC purity at 254 nm: 95.9%</div></div><div id="sec4_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 22-[4-(4-(<i>N</i>-Phthalimidomethyl)phenyl)-1<i>H</i>-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>29</b>)</h4><div class="NLM_p last">General procedure 1 was applied with compound <b>9</b> (60 mg, 0.149 mmol), the alkyne <b>88</b> (38.9 mg, 0.149 mmol), sodium ascorbate (5.9 mg, 0.030 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (3.7 mg, 0.015 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.25 mL). Flash chromatography (30–60% EtOAc/PE). Yield: 98 mg (99%, 0.147 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.86 (dd, <i>J</i> = 5.5, 3.0 Hz, 2H), 7.83 (s, 1H), 7.80–7.77 (m, 2H), 7.74–7.69 (m, 2H), 7.53–7.47 (m, 2H), 6.41 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.82 (d, <i>J</i> = 8.5 Hz, 1H), 5.33 (dd, <i>J</i> = 11.0, 1.5 Hz, 1H), 5.21 (dd, <i>J</i> = 17.3, 1.5 Hz, 1H), 5.17–5.03 (m, 2H), 4.88 (s, 2H), 3.35 (dd, <i>J</i> = 9.9, 6.5 Hz, 1H), 2.34–2.05 (m, 7H), 1.76 (m, 1H), 1.71–1.59 (m, 3H), 1.57–1.37 (m, 4H), 1.34 (s, 3H), 1.17 (s, 3H), 0.87 (d, <i>J</i> = 7.0 Hz, 3H), 0.71 (d, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 216.4, 168.0, 165.0, 147.9, 138.6, 136.5, 134.0, 132.2, 130.0, 129.2, 126.2, 123.4, 120.9, 117.6, 74.6, 71.1, 58.0, 51.7, 45.4, 44.8, 44.0, 41.9, 41.4, 36.6, 36.1, 34.4, 30.4, 26.8, 26.4, 24.8, 16.8, 14.6, 11.4; HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>39</sub>H<sub>45</sub>N<sub>4</sub>O<sub>6</sub> (M + H<sup>+</sup>), 665.3334; found, 665.3301; HPLC purity at 254 nm: 99.3%</div></div><div id="sec4_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 22-[4-(2-((Thymine-1-yl)methyl)phenyl)-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>30</b>)</h4><div class="NLM_p last">A slightly altered general procedure 1 was applied with the alkyne <b>68</b> (45.2 mg, 0.188 mmol) as the limiting reagent, compound <b>9</b> (98 mg, 0.24 mmol), sodium ascorbate (4.5 mg, 0.023 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (5.7 mg, 0.023 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.6 mL). Flash chromatography (MeOH/DCM, 10%). Yield: 134 mg (86%, 0.162 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.90 (s, 1H), 7.86 (s, 1H), 7.50–7.43 (m, 1H), 7.44–7.34 (m, 3H), 7.30 (d, <i>J</i> = 1.3 Hz, 1H), 6.42 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.83 (d, <i>J</i> = 8.5 Hz, 1H), 5.33 (dd, <i>J</i> = 11.0, 1.5 Hz, 1H), 5.25–5.09 (m, 5H), 3.36 (dd, <i>J</i> = 10.5, 6.4 Hz, 1H), 2.32–2.05 (m, 6H), 1.85 (d, <i>J</i> = 1.2 Hz, 3H), 1.76 (dd, <i>J</i> = 14.6, 3.0 Hz, 1H), 1.73–1.58 (m, 3H), 1.57–1.29 (m, 8H), 1.18 (s, 3H), 1.13 (td, <i>J</i> = 14.1, 4.4 Hz, 1H), 0.88 (d, <i>J</i> = 7.0 Hz, 3H), 0.74 (d, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 101 MHz): δ 216.6, 165.1, 164.0, 151.4, 147.5, 140.8, 138.8, 134.2, 130.1, 129.7, 129.5, 129.4, 128.6, 123.7, 117.8, 110.9, 74.7, 71.4, 58.1, 51.8, 48.6, 45.6, 44.9, 44.2, 42.1, 36.7, 36.2, 34.5, 30.5, 27.0, 26.6, 25.0, 17.0, 14.8, 12.4, 11.6; HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>45</sub>N<sub>5</sub>O<sub>6</sub>(M + H<sup>+</sup>), 644.3443; found, 644.3413; HPLC purity at 254 nm: 99.7%</div></div><div id="sec4_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 22-[4-(3-((Thymine-1-yl)methyl)phenyl)-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>31</b>)</h4><div class="NLM_p last">General procedure 1 was applied with compound <b>9</b> (81 mg, 0.201 mmol), the alkyne <b>69</b> (48 mg, 0.201 mmol), sodium ascorbate (2.5 mg, 0.020 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (5.0 mg, 0.020 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.5 mL). Flash chromatography (MeOH/CH<sub>2</sub>Cl<sub>2</sub>, 0% → 1% → 2%). Yield: 102 mg (79%, 0.158 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.33 (br s, 1H), 7.95 (s, 1H), 7.82 (d, <i>J</i> = 1.7 Hz, 1H), 7.79 (d, <i>J</i> = 7.8 Hz, 1H), 7.44 (td, <i>J</i> = 7.7, 1.4 Hz, 1H), 7.31–7.27 (m, 1H), 7.05 (d, <i>J</i> = 1.4 Hz, 1H), 6.41 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.82 (d, <i>J</i> = 8.5 Hz, 1H), 5.32 (dd, <i>J</i> = 11.1, 1.7 Hz, 1H), 5.24–5.06 (m, 3H), 4.93 (s, 2H), 3.37 (dd, <i>J</i> = 10.5, 6.4 Hz, 1H), 2.36–2.04 (m, 6H), 1.88 (d, <i>J</i> = 1.3 Hz, 3H), 1.80–1.38 (m, 8H), 1.37–1.31 (m, 4H), 1.20–1.07 (m, 4H), 0.87 (d, <i>J</i> = 7.0 Hz, 3H), 0.72 (d, <i>J</i> = 6.9 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 216.6, 165.0, 164.0, 151.3, 147.6, 139.7, 138.6, 136.3, 131.2, 129.7, 127.9, 125.9, 125.6, 121.4, 117.5, 111.4, 74.5, 71.2, 58.0, 51.7, 51.0, 45.4, 44.7, 44.0, 41.9, 36.6, 36.1, 34.4, 30.3, 26.8, 26.4, 24.8, 16.8, 14.6, 12.4, 11.4; HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>46</sub>N<sub>5</sub>O<sub>6</sub> (M + H<sup>+</sup>), 644.3448; found, 644.3351; HPLC purity for 254 nm: 96.0%</div></div><div id="sec4_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 22-[4-(4-((Thymine-1-yl)methyl)phenyl)-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>32</b>)</h4><div class="NLM_p last">General procedure 1 was applied with compound <b>9</b> (50 mg, 0.124 mmol), the alkyne <b>70</b> (31 mg, 0.124 mmol), sodium ascorbate (2.2 mg, 0.013 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (3.3 mg, 0.013 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.5 mL). Flash chromatography (MeOH/CH<sub>2</sub>Cl<sub>2</sub>, 0% → 1% → 2% → 5%). Yield: 82 mg (97%, 0.127 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.80 (s, 1H), 7.88 (s, 1H), 7.85 (d, <i>J</i> = 8.3 Hz, 2H), 7.37 (d, <i>J</i> = 8.3 Hz, 2H), 7.01 (d, <i>J</i> = 1.3 Hz, 1H), 6.42 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.83 (d, <i>J</i> = 8.5 Hz, 1H), 5.34 (dd, <i>J</i> = 10.9, 1.5 Hz, 1H), 5.25–5.05 (m, 3H), 4.92 (s, 2H), 3.36 (dd, <i>J</i> = 10.5, 6.5 Hz, 1H), 2.33–2.05 (m, 5H), 1.90 (d, <i>J</i> = 1.2 Hz, 3H), 1.81–1.59 (m, 4H), 1.54–1.38 (m, 4H), 1.35 (s, 3H), 1.18 (s, 3H), 1.16–1.08 (m, 1H), 0.88 (d, <i>J</i> = 7.0 Hz, 3H), 0.72 (d, <i>J</i> = 7.1 Hz, 3H).; <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 11.4, 12.4, 14.6, 16.8, 24.8, 26.4, 26.8, 30.3, 34.4, 36.1, 36.6, 41.9, 44.0, 44.8, 45.4, 50.8, 51.7, 57.9, 71.1, 74.5, 111.4, 117.5, 121.1, 126.5, 128.5, 130.6, 138.5, 139.6, 147.6, 151.0, 163.8, 165.0, 216.5; HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>46</sub>N<sub>5</sub>O<sub>6</sub> (M + H<sup>+</sup>), 644.3448; found, 644.3321; HPLC purity at 254 nm: 97.5%</div></div><div id="sec4_2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 22-[4-(2-((Adenine-9-yl)methyl)phenyl)-1<i>H</i>-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>33</b>)</h4><div class="NLM_p last">General procedure 1 was applied with compound <b>9</b> (107 mg, 0.265 mmol), the alkyne <b>71</b> (66 mg, 0.265 mmol), sodium ascorbate (5.9 mg, 0.030 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (6.5 mg, 0.026 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.25 mL). Flash Chromatography (MeOH/DCM, 5–10%). Yield: 111 mg (64%, 0.170 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.38 (s, 1H), 7.99 (s, 1H), 7.86 (s, 1H), 7.57–7.48 (m, 1H), 7.42–7.30 (m, 3H), 6.43 (dd, <i>J</i> = 17.3, 11.0 Hz, 1H), 5.85 (d, <i>J</i> = 8.5 Hz, 1H), 5.75 (d, <i>J</i> = 7.6 Hz, 4H), 5.35 (dd, <i>J</i> = 11.0, 1.4 Hz, 1H), 5.26–5.07 (m, 3H), 3.37 (s, 1H), 2.36–2.06 (m, 5H), 1.81–1.31 (m, 11H), 1.22–1.08 (m, 4H), 0.89 (d, <i>J</i> = 7.0 Hz, 3H), 0.74 (d, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 216.5, 164.9, 155.5, 153.1, 147.4, 138.7, 134.0, 130.0, 129.7, 129.2, 129.0, 128.6, 123.4, 117.6, 74.6, 71.3, 58.0, 51.7, 45.4, 45.3, 44.8, 44.1, 41.9, 36.6, 36.1, 34.4, 30.4, 26.8, 26.5, 24.8, 16.8, 14.7, 11.5; HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>44</sub>N<sub>8</sub>O<sub>4</sub> (M + H<sup>+</sup>), 653.3558; found, 653.3596; HPLC purity at 254 nm: 99.1%</div></div><div id="sec4_2_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 22-[4-(3-((Adenine-9-yl)methyl)phenyl)-1<i>H</i>-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>34</b>)</h4><div class="NLM_p last">A slightly altered general procedure 1 was applied with the alkyne <b>72</b> (34.1 mg, 0.137 mmol) as the limiting reagent, compound <b>9</b> (60.8 mg, 0.15 mmol), sodium ascorbate (4.6 mg, 0.023 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (5.6 mg, 0.022 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.5 mL). Flash chromatography (MeOH/DCM, 10%). Yield: 70.7 mg (79%, 0.108 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.39 (s, 1H), 7.88–7.79 (m, 3H), 7.76 (dt, <i>J</i> = 7.8, 1.4 Hz, 1H), 7.41 (t, <i>J</i> = 7.7 Hz, 1H), 7.28–7.23 (m, 1H), 6.40 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.96–5.77 (m, 3H), 5.41 (s, 2H), 5.32 (dd, <i>J</i> = 11.0, 1.4 Hz, 1H), 5.23–5.02 (m, 3H), 3.36 (s, 1H), 2.30–1.95 (m, 7H), 1.79–1.58 (m, 4H), 1.44 (m, 2H), 1.34 (s, 4H), 1.17 (s, 3H), 1.15–1.07 (m, 1H), 0.87 (d, <i>J</i> = 7.0 Hz, 3H), 0.71 (d, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 101 MHz): δ 216.6, 165.1, 155.8, 153.4, 147.6, 140.4, 138.8, 136.5, 131.3, 129.8, 127.8, 126.0, 125.3, 121.3, 117.5, 74.7, 71.3, 58.1, 51.8, 47.2, 45.5, 44.9, 44.2, 42.0, 36.7, 36.2, 34.5, 31.0, 30.4, 26.9, 26.7, 24.9, 16.9, 14.7, 11.6, 1.1; HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>44</sub>N<sub>8</sub>O<sub>4</sub> (M + H<sup>+</sup>), 653.3558; found, 653.3559; HPLC purity at 254 nm: 99.1%</div></div><div id="sec4_2_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 22-[4-(4-((Adenine-9-yl)methyl)phenyl)-1<i>H</i>-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>35</b>)</h4><div class="NLM_p last">General procedure 1 was applied with compound <b>9</b> (65 mg, 0.161 mmol), the alkyne <b>73</b> (40 mg, 0.161 mmol), sodium ascorbate (6.4 mg, 0.032 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (4.0 mg, 0.016 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.25 mL). Flash chromatography (MeOH/DCM, 2–10%). Yield: 84 mg (80%, 0.129 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.42 (s, 1H), 7.86 (s, 1H), 7.82 (d, <i>J</i> = 7.8 Hz, 2H), 7.35 (d, <i>J</i> = 7.8 Hz, 2H), 6.41 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.82 (d, <i>J</i> = 8.5 Hz, 3H), 5.40 (br s, 2H), 5.33 (d, <i>J</i> = 11.1 Hz, 1H), 5.24–5.05 (m, 3H), 3.49 (s, 2H), 3.36 (d, <i>J</i> = 6.3 Hz, 1H), 2.23 (m, 4H), 2.09 (m, 2H), 1.84–1.37 (m, 9H), 1.34 (s, 4H), 1.32–1.24 (m, 1H), 1.17 (s, 3H), 1.15–1.07 (m, 1H), 0.87 (d, <i>J</i> = 6.9 Hz, 3H), 0.72 (d, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 101 MHz): δ 216.5, 165.0, 147.6, 138.6, 135.5, 130.6, 128.4, 126.5, 121.1, 117.6, 77.2, 74.6, 71.2, 58.0, 51.7, 45.4, 44.8, 44.1, 41.9, 36.6, 36.1, 34.4, 30.4, 26.8, 26.4, 24.8, 16.8, 14.6, 11.5; HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>45</sub>N<sub>8</sub>O<sub>4</sub> (M + H<sup>+</sup>), 653.3558; found, 653.3538; HPLC purity at 254 nm: 96.3%</div></div><div id="sec4_2_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 22-[4-(2-((6-(<i>N</i>,<i>N</i>-Diethylamino)-9<i>H</i>-purin-9-yl)methyl)phenyl)-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>36</b>)</h4><div class="NLM_p last">A slightly altered general procedure 1 was applied with the alkyne <b>79</b> (57.6 mg, 0.188 mmol) as the limiting reagent, compound <b>9</b> (93.4 mg, 0.231 mmol), sodium ascorbate (5.0 mg, 0.025 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (5.5 mg, 0.022 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.5 mL). Flash chromatography (MeOH/DCM, 0–4%). Yield: 95 mg (54%, 0.102 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.33 (s, 1H), 7.86 (s, 1H), 7.83 (s, 1H), 7.56–7.50 (m, 1H), 7.35 (td, <i>J</i> = 7.5, 1.6 Hz, 1H), 7.30 (td, <i>J</i> = 7.5, 1.6 Hz, 1H), 7.23–7.19 (m, 1H), 6.42 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.83 (d, <i>J</i> = 8.5 Hz, 1H), 5.68 (s, 2H), 5.34 (dd, <i>J</i> = 11.0, 1.5 Hz, 1H), 5.24–5.06 (m, 3H), 3.98 (s, 4H), 3.35 (dd, <i>J</i> = 10.5, 6.5 Hz, 1H), 2.31–2.19 (m, 3H), 2.18–2.10 (m, 1H), 2.09–2.07 (m, 1H), 1.84–1.38 (m, 8H), 1.37 (s, 3H), 1.28 (t, <i>J</i> = 7.0 Hz, 6H), 1.17 (s, 3H), 1.12 (td, <i>J</i> = 14.1, 4.5 Hz, 1H), 0.87 (d, <i>J</i> = 7.0 Hz, 3H), 0.73 (d, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 216.4, 164.9, 153.9, 152.6, 150.8, 147.3, 138.8, 138.6, 134.3, 129.7, 129.4, 129.1, 128.9, 128.3, 123.4, 119.5, 117.6, 74.5, 71.1, 58.0, 51.6, 45.4, 45.0, 44.8, 44.0, 43.0, 41.9, 36.5, 36.1, 34.4, 30.3, 26.8, 26.4, 24.8, 16.8, 14.7, 13.5, 11.5; HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>40</sub>H<sub>52</sub>N<sub>8</sub>O<sub>4</sub> (M + H<sup>+</sup>), 709.4184; found, 709.4215; HPLC purity at 254 nm: 99.6%</div></div><div id="sec4_2_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 22-[4-(3-((6-(<i>N</i>,<i>N</i>-Diethylamino)-9<i>H</i>-purin-9-yl)methyl)phenyl)-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>37</b>)</h4><div class="NLM_p last">A slightly altered general procedure 1 was applied with the alkyne <b>80</b> (58.7 mg, 0.192 mmol) as the limiting reagent, compound <b>9</b> (94.7 mg, 0.23 mmol), sodium ascorbate (5 mg, 0.025 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (5.3 mg, 0.021 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.5 mL). Flash chromatography (MeOH/DCM, 10%). Yield: 132 mg (97%, 0.186 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.38 (s, 1H), 7.85 (s, 1H), 7.83 (d, <i>J</i> = 1.8 Hz, 1H), 7.77 (dt, <i>J</i> = 7.8, 1.4 Hz, 1H), 7.74 (s, 1H), 7.40 (t, <i>J</i> = 7.7 Hz, 1H), 7.27–7.23 (m, 1H), 6.42 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.83 (d, <i>J</i> = 8.5 Hz, 1H), 5.40 (s, 2H), 5.34 (dd, <i>J</i> = 11.0, 1.5 Hz, 1H), 5.22 (dd, <i>J</i> = 17.4, 1.5 Hz, 1H), 5.18–5.03 (m, 2H), 4.00 (s, 4H), 3.36 (dd, <i>J</i> = 10.6, 6.5 Hz, 1H), 2.33–2.07 (m, 5H), 1.77 (dd, <i>J</i> = 14.4, 3.1 Hz, 1H), 1.72–1.59 (m, 5H), 1.57–1.36 (m, 6H), 1.30 (t, <i>J</i> = 7.0 Hz, 6H), 1.18 (s, 3H), 1.18–1.07 (m, 1H), 0.88 (d, <i>J</i> = 7.0 Hz, 3H), 0.73 (d, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 101 MHz): δ 216.5, 165.2, 154.1, 152.9, 150.9, 147.9, 138.8, 138.2, 137.0, 131.2, 129.7, 127.8, 125.8, 125.4, 121.3, 119.7, 117.7, 74.7, 71.3, 58.1, 51.8, 47.0, 45.6, 44.9, 44.2, 42.0, 36.7, 36.2, 34.5, 31.0, 30.5, 26.9, 26.5, 25.0, 17.0, 14.8, 13.7, 11.6; HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>40</sub>H<sub>52</sub>N<sub>8</sub>O<sub>4</sub> (M + H<sup>+</sup>), 709.4184; found, 709.4205; HPLC purity at 254 nm: 100%</div></div><div id="sec4_2_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 22-[4-(4-((6-(<i>N</i>,<i>N</i>-Diethylamino)-9<i>H</i>-purin-9-yl)methyl)phenyl)-1<i>H</i>-1,2,3-triazol-1-y]-22-deoxypleuromutilin (<b>38</b>)</h4><div class="NLM_p last">General procedure 1 was applied with compound <b>9</b> (60 mg, 0.149 mmol), the alkyne <b>81</b> (45.5 mg, 0.149 mmol), sodium ascorbate (5.9 mg, 0.030 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (3.7 mg, 0.015 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.00 mL). Flash chromatography (MeOH/DCM, 0–3%). Yield: 98 mg (93%, 0.138 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.38 (s, 1H), 7.84 (s, 1H), 7.81 (d, <i>J</i> = 8.3 Hz, 2H), 7.73 (s, 1H), 7.35 (d, <i>J</i> = 8.4 Hz, 2H), 6.41 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.83 (d, <i>J</i> = 8.5 Hz, 1H), 5.39 (s, 2H), 5.34 (dd, <i>J</i> = 11.0, 1.5 Hz, 1H), 5.21 (dd, <i>J</i> = 17.4, 1.5 Hz, 1H), 5.18–5.04 (m, 2H), 4.00 (s, 4H), 3.35 (dd, <i>J</i> = 10.6, 6.5 Hz, 1H), 2.33–2.04 (m, 5H), 1.76 (dd, <i>J</i> = 14.5, 3.1 Hz, 1H), 1.71–1.66 (m, 1H), 1.63–1.59 (m, 1H), 1.57–1.38 (m, 4H), 1.35 (s, 4H), 1.30 (t, <i>J</i> = 7.0 Hz, 6H), 1.18 (s, 3H), 1.16–1.08 (m, 1H), 0.87 (d, <i>J</i> = 7.0 Hz, 3H), 0.72 (d, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 101 MHz): δ 216.5, 165.0, 153.9, 152.9, 150.7, 147.7, 138.6, 138.0, 136.1, 130.3, 128.3, 126.4, 121.0, 119.6, 117.6, 74.6, 71.1, 58.0, 51.7, 46.7, 45.4, 44.8, 44.0, 43.1, 41.9, 36.6, 36.1, 34.4, 30.4, 26.8, 26.4, 24.8, 16.8, 14.6, 13.5, 11.5; HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>40</sub>H<sub>53</sub>N<sub>8</sub>O<sub>4</sub> (M + H<sup>+</sup>), 709.4184; found, 709.4151; HPLC purity at 254 nm: >99.9%</div></div><div id="sec4_2_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 22-[4-(2-((2-Amino-6-(<i>N</i>,<i>N</i>-diethylamino)-9<i>H</i>-purin-9-yl)methyl)phenyl)-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>39</b>)</h4><div class="NLM_p last">A slightly altered General Procedure 1 was applied with the alkyne <b>82</b> (56.6 mg, 0.188 mmol) as the limiting reagent, compound <b>9</b> (96 mg, 0.238 mmol), sodium ascorbate (4.5 mg, 0.023 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (5.7 mg, 0.023 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.5 mL). Flash Chromatography (MeOH/DCM, 0–3%). Yield: 108 mg (80%, 0.150 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.85 (s, 1H), 7.57 (dd, <i>J</i> = 7.5, 1.6 Hz, 1H), 7.48 (s, 1H), 7.33 (m, 2H), 7.15 (dd, <i>J</i> = 7.6, 1.5 Hz, 1H), 6.42 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.83 (d, <i>J</i> = 8.5 Hz, 1H), 5.50 (s, 2H), 5.35 (dd, <i>J</i> = 11.0, 1.4 Hz, 1H), 5.26–5.05 (m, 3H), 4.61 (s, 2H), 3.92 (s, 4H), 3.35 (s, 1H), 2.33–2.05 (m, 6H), 1.76 (m, 1H), 1.72–1.37 (m, 6H), 1.37 (s, 5H), 1.25 (t, <i>J</i> = 7.0 Hz, 7H), 1.17 (s, 3H), 1.13 (dt, <i>J</i> = 13.8, 7.0 Hz, 1H), 0.87 (d, <i>J</i> = 7.0 Hz, 3H), 0.72 (d, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 216.6, 165.1, 159.5, 154.4, 152.9, 147.2, 138.8, 136.6, 134.7, 129.8, 129.2, 129.1, 128.3, 123.6, 117.8, 114.6, 74.7, 71.2, 58.1, 51.8, 45.5, 44.9, 44.8, 44.2, 42.7, 42.0, 36.7, 36.2, 34.5, 30.5, 26.9, 26.5, 25.0, 17.0, 14.8, 13.7, 11.6; HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>40</sub>H<sub>53</sub>N<sub>9</sub>O<sub>4</sub> (M + H<sup>+</sup>), 724.4293; found, 724.4272; HPLC purity at 254 nm: 100%</div></div><div id="sec4_2_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 22-[4-(3-((2-Amino-6-(<i>N</i>,<i>N</i>-diethylamino)-9<i>H</i>-purin-9-yl)methyl)phenyl)-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>40</b>)</h4><div class="NLM_p last">A slightly altered general procedure 1 was applied with the alkyne <b>83</b> (60.7 mg, 0.189 mmol) as the limiting reagent, compound <b>9</b> (98.1 mg, 0.24 mmol), sodium ascorbate (5.2 mg, 0.026 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (5.6 mg, 0.022 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.5 mL). Flash chromatography (MeOH/DCM, 10%). Yield: 132 mg (96%, 0.181 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.84 (s, 1H), 7.79 (d, <i>J</i> = 1.8 Hz, 1H), 7.75 (dt, <i>J</i> = 7.7, 1.4 Hz, 1H), 7.46 (s, 1H), 7.38 (t, <i>J</i> = 7.7 Hz, 1H), 7.21 (dt, <i>J</i> = 7.9, 1.3 Hz, 1H), 6.41 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.83 (d, <i>J</i> = 8.5 Hz, 1H), 5.34 (dd, <i>J</i> = 11.0, 1.5 Hz, 1H), 5.25 (s, 2H), 5.21 (dd, <i>J</i> = 17.4, 1.5 Hz, 1H), 5.18–5.03 (m, 2H), 4.59 (s, 2H), 3.92 (s, 4H), 3.35 (dd, <i>J</i> = 10.7, 6.5 Hz, 1H), 2.31–2.06 (m, 5H), 1.76 (dd, <i>J</i> = 14.5, 3.1 Hz, 1H), 1.72–1.59 (m, 6H), 1.58–1.39 (m, 3H), 1.36 (s, 4H), 1.25 (t, <i>J</i> = 7.0 Hz, 6H), 1.18 (s, 3H), 1.18–1.06 (m, 1H), 0.87 (d, <i>J</i> = 7.0 Hz, 3H), 0.73 (d, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 101 MHz): δ 216.6, 165.2, 159.7, 154.4, 153.0, 148.0, 138.8, 137.4, 136.0, 131.1, 129.6, 127.8, 125.6, 125.3, 121.2, 117.8, 114.7, 74.7, 71.3, 58.2, 51.8, 46.5, 45.6, 44.9, 44.2, 42.7, 42.0, 36.7, 36.2, 34.5, 30.5, 27.0, 26.5, 25.0, 17.0, 14.8, 13.7, 11.6; HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>40</sub>H<sub>53</sub>N<sub>8</sub>O<sub>4</sub> (M + H<sup>+</sup>), 724.4293; found, 724.4311; HPLC purity at 254 nm: 100%</div></div><div id="sec4_2_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 22-[4-(4-((6-(4-Methylpiperazin-1-yl)-9<i>H</i>-purin-9-yl)methyl)phenyl)-1<i>H</i>-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>41</b>)</h4><div class="NLM_p last">General procedure 1 was applied with compound <b>9</b> (81 mg, 0.20 mmol), the alkyne <b>84</b> (68 mg, 0.20 mmol), sodium ascorbate (2.5 mg, 0.02 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (5.0 mg, 0.02 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.5 mL). Flash chromatography (MeOH/CH<sub>2</sub>Cl<sub>2</sub>, 0% → 1% → 2% → 5%). Yield: 70.0 mg (48%, 0.095 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.39 (s, 1H), 7.85 (s, 1H), 7.83 (m, 1H), 7.76 (s, 2H), 7.40 (t, <i>J</i> = 7.7 Hz, 1H), 7.24 (dt, <i>J</i> = 7.7, 1.4 Hz, 1H), 6.41 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.83 (d, <i>J</i> = 8.5 Hz, 1H), 5.41 (s, 2H), 5.33 (dd, <i>J</i> = 11.0, 1.5 Hz, 1H), 5.24–5.04 (m, 3H), 4.35 (s, 4H), 3.36 (d, <i>J</i> = 6.4 Hz, 1H), 2.57 (t, <i>J</i> = 5.1 Hz, 4H), 2.36 (s, 3H), 2.32–2.05 (m, 6H), 1.81–1.58 (m, 4H), 1.57–1.39 (m, 3H), 1.36 (d, <i>J</i> = 2.9 Hz, 3H), 1.33–1.24 (m, 1H), 1.20–1.08 (m, 4H), 0.88 (d, <i>J</i> = 7.0 Hz, 3H), 0.73 (d, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 216.5, 165.0, 152.6, 151.1, 147.6, 138.9, 138.6, 138.2, 138.0, 136.6, 131.1, 129.6, 127.6, 125.7, 125.1, 121.2, 117.6, 74.5, 71.1, 57.9, 55.1, 53.4, 51.6, 46.1, 45.4, 44.7, 44.0, 41.9, 36.5, 36.1, 34.4, 30.3, 26.8, 26.4, 24.8, 16.8, 14.6, 11.5; HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>42</sub>H<sub>56</sub>N<sub>8</sub>O<sub>4</sub> (M + H<sup>+</sup>), 736.4425; found, 736.4295; HPLC purity at 254 nm: 99.2%</div></div><div id="sec4_2_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 22-[4-(4-((6-(4-Methylpiperazin-1-yl)-9<i>H</i>-purin-9-yl)methyl)phenyl)-1<i>H</i>-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>42</b>)</h4><div class="NLM_p last">General procedure 1 was applied with compound <b>9</b> (55 mg, 0.136 mmol), the alkyne <b>85</b> (45.3 mg, 0.136 mmol), sodium ascorbate (5.4 mg, 0.027 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (3.4 mg, 0.014 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.25 mL). Flash chromatography (MeOH/DCM, 2–10%). Yield: 88 mg (88%, 0.120 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.39 (s, 1H), 7.84 (s, 1H), 7.81 (d, <i>J</i> = 8.3 Hz, 2H), 7.74 (s, 1H), 7.34 (d, <i>J</i> = 8.4 Hz, 2H), 6.41 (dd, <i>J</i> = 17.4, 11.0 Hz, 1H), 5.83 (d, <i>J</i> = 8.5 Hz, 1H), 5.40 (s, 2H), 5.34 (dd, <i>J</i> = 11.0, 1.5 Hz, 1H), 5.21 (dd, <i>J</i> = 17.4, 1.5 Hz, 1H), 5.18–5.03 (m, 2H), 4.35 (s, 4H), 3.35 (dd, <i>J</i> = 10.0, 6.5 Hz, 1H), 2.56 (t, <i>J</i> = 5.1 Hz, 4H), 2.35 (s, 3H), 2.32–2.04 (m, 5H), 1.82–1.72 (m, 2H), 1.65 (m, 2H), 1.52 (s, 1H), 1.49–1.38 (m, 3H), 1.37–1.24 (m, 5H), 1.18 (s, 3H), 1.16–1.07 (m, 1H), 0.87 (d, <i>J</i> = 7.0 Hz, 3H), 0.72 (d, <i>J</i> = 7.0 Hz, 3H) (App. 17.A); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 216.5, 165.0, 154.0, 152.7, 151.1, 147.7, 138.6, 138.2, 135.9, 130.4, 128.2, 126.4, 121.0, 119.9, 117.6, 74.5, 71.1, 58.0, 55.2, 51.7, 46.8, 46.2, 45.4, 44.8, 44.0, 41.9, 36.6, 36.1, 34.4, 30.4, 26.8, 26.4, 24.8, 16.8, 14.6, 11.5; HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>41</sub>H<sub>54</sub>N<sub>9</sub>O<sub>4</sub> (M + H<sup>+</sup>), 736.4293; found, 736.4297; HPLC purity at 254 nm: 98.3%</div></div><div id="sec4_2_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 22-[4-(4-((6-(<i>N</i>-(2-Aminoethyl)amino)-9<i>H</i>-purin-9-yl)methyl)phenyl)-1<i>H</i>-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>43</b>)</h4><div class="NLM_p last">General procedure 1 was applied with compound <b>9</b> (60 mg, 0.149 mmol), the alkyne <b>86</b> (43.3 mg, 0.149 mmol), sodium ascorbate (5.9 mg, 0.030 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (3.7 mg, 0.015 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.25 mL). Flash chromatography (NH<sub>3</sub>:MeOH/DCM, 0:5:95 → 0:20:80 → 1/2: 19.5:80). Yield: 57 mg (55%, 0.082 mmol); <sup>1</sup>H NMR (400 MHz, DMSO): δ 8.50 (s, 1H), 8.33 (s, 1H), 8.25 (s, 1H), 7.82 (d, <i>J</i> = 8.2 Hz, 2H), 7.40 (d, <i>J</i> = 8.3 Hz, 2H), 6.12 (dd, <i>J</i> = 17.8, 11.2 Hz, 1H), 5.57 (d, <i>J</i> = 8.3 Hz, 1H), 5.45–5.28 (m, 4H), 5.12 (dd, <i>J</i> = 17.8, 1.8 Hz, 1H), 5.04 (dd, <i>J</i> = 11.2, 1.8 Hz, 1H), 4.56 (s, 1H), 3.62 (s, 3H), 2.90 (d, <i>J</i> = 8.3 Hz, 2H), 2.40 (s, 1H), 2.24–2.00 (m, 4H), 1.61 (q, <i>J</i> = 12.2, 10.8 Hz, 2H), 1.54–1.41 (m, 1H), 1.36 (d, <i>J</i> = 15.9 Hz, 2H), 1.25 (d, <i>J</i> = 12.9 Hz, 2H), 1.22 (s, 3H), 1.07 (s, 3H), 0.99 (td, <i>J</i> = 13.8, 4.4 Hz, 1H), 0.80 (d, <i>J</i> = 6.9 Hz, 3H), 0.63 (d, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (101 MHz, DMSO): δ <sup>13</sup>C NMR (101 MHz, DMSO): δ 216.9, 165.4, 152.4, 145.8, 140.8, 140.7, 136.6, 130.0, 128.1, 125.4, 122.8, 115.3, 72.4, 70.6, 57.0, 51.2, 45.9, 44.8, 44.0, 43.3, 41.4, 36.3, 36.1, 33.9, 29.9, 28.4, 26.4, 24.3, 16.0, 14.1, 11.4; HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>38</sub>H<sub>50</sub>N<sub>9</sub>O<sub>4</sub> (M + H<sup>+</sup>), 696.3980; found, 696.3988; HPLC purity at 254 nm: 96.7%</div></div><div id="sec4_2_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 22-[4-(4-((6-Guanidino-9<i>H</i>-purin-9-yl)methyl)phenyl)-1<i>H</i>-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (<b>44</b>)</h4><div class="NLM_p last">General procedure 1 was applied with compound <b>9</b> (60 mg, 0.149 mmol), the alkyne <b>87</b> (43.5 mg, 0.149 mmol), sodium ascorbate (5.9 mg, 0.030 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (3.7 mg, 0.015 mmol) in degassed <i>t</i>-BuOH/H<sub>2</sub>O (1:1 v/v, 2.25 mL). Flash chromatography (MeOH/DCM, 2–20%). Yield: 55 mg (53%, 0.079 mmol); <sup>1</sup>H NMR (400 MHz, DMSO): δ 8.67 (s, 1H), 8.60 (s, 1H), 8.51 (s, 1H), 8.39 (s, 3H), 7.83 (d, <i>J</i> = 8.3 Hz, 2H), 7.43 (d, <i>J</i> = 8.1 Hz, 2H), 6.12 (dd, <i>J</i> = 17.8, 11.2 Hz, 1H), 5.57 (d, <i>J</i> = 8.3 Hz, 1H), 5.53 (s, 2H), 5.36 (q, <i>J</i> = 17.6 Hz, 2H), 5.11 (dd, <i>J</i> = 17.8, 1.8 Hz, 1H), 5.04 (dd, <i>J</i> = 11.2, 1.7 Hz, 1H), 4.55 (d, <i>J</i> = 6.0 Hz, 1H), 3.41 (t, <i>J</i> = 6.1 Hz, 1H), 2.43–2.36 (m, 1H), 2.23–1.97 (m, 4H), 1.62 (t, <i>J</i> = 12.5 Hz, 2H), 1.53–1.41 (m, 1H), 1.36 (d, <i>J</i> = 16.0 Hz, 2H), 1.31–1.23 (m, 2H), 1.21 (s, 3H), 1.07 (s, 3H), 0.99 (td, <i>J</i> = 13.8, 4.4 Hz, 1H), 0.80 (d, <i>J</i> = 6.9 Hz, 3H), 0.62 (d, <i>J</i> = 6.9 Hz, 3H); <sup>13</sup>C NMR (101 MHz, DMSO): δ 216.9, 165.4, 156.4, 150.7, 145.8, 140.7, 136.0, 130.2, 128.2, 125.5, 122.8, 115.3, 72.4, 70.6, 57.0, 51.2, 48.5, 46.3, 44.8, 44.0, 43.3, 41.4, 36.3, 36.1, 33.9, 30.9, 29.9, 28.4, 26.4, 24.3, 16.0, 14.1, 11.4; HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>37</sub>H<sub>47</sub>N<sub>10</sub>O<sub>4</sub> (M + H<sup>+</sup>), 695.3776; found, 695.3747, HPLC purity at 254 nm: 95.4%</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> In Vitro Susceptibility Assay (MIC) and Minimum Bactericidal Concentration</h3><div class="NLM_p">MRSA USA300 FPR3757<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> was used for susceptibility evaluation of all test compound in combination with Mueller–Hinton (MH) broth. The clinical isolates of MRSA (55508, 52518, and 4828) and MRSE 933010 were obtained via Odense University Hospital (OUH) and Statens Seruminstitut (SSI). Testing was done using a 96-well plate and microbroth serial dilution assay and was conducted in accordance with the guidelines presented by EUCAST<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> (inoculum = 5.0 × 10<sup>5</sup> CFU mL<sup>–1</sup>). One compound was tested per plate, using three single-colony overnight cultures for inoculation and constituted one singular MIC replicate. Each culture was diluted to a concentration of OD<sub>600</sub> = 0.1 before they were diluted an additional 100× and added to each well (100 μL) already containing the serial-diluted antibacterial compound in MH (100 μL) with the final concentration ranging between 0.015 and 16 μg mL<sup>–1</sup>. Plates were covered in aluminium foil and incubated at 37 °C for 20–24 h. MIC was established as the concentration at which no bacterial growth was visible. Inocula were verified by consecutive 10× dilution of the OD<sub>600</sub> = 0.001 bacterial solution in 1× phosphate-buffered saline, followed by plating onto MH/agar plates.</div><div class="NLM_p last">Assessment of MBC was conducted on a completed MIC replicate by plating 10 μL aliquots from the wells downstream of the MIC value, that is, at 2× MIC, 4× MIC, 8× MIC, and 16× MIC. The plates were incubated for 20 h., after which the viable colonies were counted. A bactericidal result is defined as the concentration of antibacterial agent at which a 99.9% reduction of the original standard inoculum is observed.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> MM-GBSA Molecular Model</h3><div class="NLM_p last">The molecular model setup and evaluation were performed using the Maestro program from the Schrödinger suite (version 2019–1) in combination with the X-ray crystal structure of the large ribosomal subunit of <i>Staphylococcus aureus</i> (NTCT 8325) in complex with lefamulin (<b>5</b>) (pdb: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HL7">5HL7</a>).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Initial preprocessing of the full ribosomal subunit was computationally infeasible. To reduce the size of the system, a spherical cut of 30 Å was made (with full residues) around the native ligand, thus fully encompassing the PTC. To verify the reliability of the cut-out PTC model, lefamulin <b>5</b> was redocked with extra precision (XP) Glide (1.0 van der Waals atom scaling), with the result coinciding with the crystalized pose. Glide XP poses were computed for <b>7</b> and <b>35</b> and used as minimized starting points for the prime MM-GBSA model, which is able to grant an approximation of the (solvated) binding mode using the VSGB 2.1 implicit solvent model. An induced fit was not included in the MM-GBSA calculations (no flexibility of proximal residues/nucleotides). Pose visualization was done using VMD 1.9.3.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Cell Viability Assays</h3><div class="NLM_p">The viability of the cells was investigated using the CellTiter-Glo assay measuring cellular ATP levels. Initially, compounds, except SDS, were dissolved in DMSO. Then, compounds were diluted in HBSS buffer (buffered with 10 mM HEPES adjusted to pH 7.4 with NaOH) to a final DMSO concentration <1% for the highest concentrations of <b>35</b>, valnemulin (<b>3</b>), and retapamulin (<b>4</b>). During the experiments, plates were protected from light with aluminium foil. The following concentrations were investigated: 0.011, 0.1, 1.09, 10.9, 35.8, and 108.6 μg mL<sup>–1</sup> for <b>35</b>; 0.01, 0.10, 10.0, 33.0, and 100 μg mL<sup>–1</sup> for valnemulin (<b>3</b>); and 0.1 and 33.0 μg mL<sup>–1</sup> for retapamulin (<b>4</b>). These concentrations were selected to cover a broad concentration range around the IC<sub>50</sub> value (14.9 μg mL<sup>–1</sup>) reported for cytotoxicity of valnemulin (<b>3</b>) in African green monkey kidney epithelial cells (Vero) measured by the MTT assay.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Data in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> show the effect on cell viability of the highest investigated compound concentration.</div><div class="NLM_p">For the CellTiter-Glo assay, the growth medium was aspirated. A total of 50 μL of the test compound was added to the wells and incubated for 3 h at 220 rpm and 37 °C. For measurement of ATP, the CellTiter-Glo reagent (CellTiter-Glo buffer and CellTiter-Glo substrate) was thawed and equilibrated to room temperature and mixed prior to use. The plate was equilibrated for 10 min at room temperature, and 30 μL of CellTiter-Glo 2.0 reagent was added directly to the wells. The plate was mixed on an orbital shaker for 2 min at room temperature. The plate was then incubated at room temperature for 10 min to stabilize the luminescent signal. The viability was assessed by normalizing the luminescence recorded to the luminescence obtained in control cells incubated in HBSS buffer only.</div><div class="NLM_p last">Cellular toxicity of the test compounds was also investigated using an MTT assay. The growth medium was aspirated, and 50 μL of the test compound and SDS (positive control) or HBSS buffer (negative control) was added and the cells were incubated for 3 h at 220 rpm and 37 °C. Then, 30 μL of 1.33 mg mL<sup>–1</sup> MTT (final concentration of 0.5 mg mL<sup>–1</sup>) was added and the cells were incubated for an additional 2 h. To dissolve the formed formazan salt, 200 μL of 10 mM HCl, 50% isobutanol, and 10% SDS were added directly to the well and the cells were incubated overnight at 4 °C. Absorbance was measured at 590 nm.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i51"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01328" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14545" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14545" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01328?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01328</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings for conjugates <b>10</b>–<b>44</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01328/suppl_file/jm0c01328_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Experimental procedures that are not covered in the main text for compounds <b>8</b>–<b>9</b>, <b>48</b>–<b>89</b>, and <b>92</b>–<b>97</b> and <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra and HPLC profiles (254 nm) for conjugates <b>10</b>–<b>44</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01328/suppl_file/jm0c01328_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01328/suppl_file/jm0c01328_si_001.csv">jm0c01328_si_001.csv (5.13 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01328/suppl_file/jm0c01328_si_002.pdf">jm0c01328_si_002.pdf (17.83 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01328" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57816" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57816" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Poul Nielsen</span> - <span class="hlFld-Affiliation affiliation">Department
of Physics, Chemistry and Pharmacy, University
of Southern Denmark, 5230 Odense M, Denmark</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7946-311X" title="Orcid link">http://orcid.org/0000-0001-7946-311X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#fd8d92889193bd8e9988d39996"><span class="__cf_email__" data-cfemail="fa8a958f9694ba899e8fd49e91">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christoffer V. Heidtmann</span> - <span class="hlFld-Affiliation affiliation">Department
of Physics, Chemistry and Pharmacy, University
of Southern Denmark, 5230 Odense M, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Faidra Voukia</span> - <span class="hlFld-Affiliation affiliation">Department
of Physics, Chemistry and Pharmacy, University
of Southern Denmark, 5230 Odense M, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Louise N. Hansen</span> - <span class="hlFld-Affiliation affiliation">Department
of Physics, Chemistry and Pharmacy, University
of Southern Denmark, 5230 Odense M, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stine H. Sørensen</span> - <span class="hlFld-Affiliation affiliation">Department
of Physics, Chemistry and Pharmacy, University
of Southern Denmark, 5230 Odense M, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian Urlund</span> - <span class="hlFld-Affiliation affiliation">Department
of Physics, Chemistry and Pharmacy, University
of Southern Denmark, 5230 Odense M, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Salli Nielsen</span> - <span class="hlFld-Affiliation affiliation">Department
of Physics, Chemistry and Pharmacy, University
of Southern Denmark, 5230 Odense M, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mona Pedersen</span> - <span class="hlFld-Affiliation affiliation">Department
of Physics, Chemistry and Pharmacy, University
of Southern Denmark, 5230 Odense M, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Noor Kelawi</span> - <span class="hlFld-Affiliation affiliation">Department
of Physics, Chemistry and Pharmacy, University
of Southern Denmark, 5230 Odense M, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian N. Andersen</span> - <span class="hlFld-Affiliation affiliation">Department
of Physics, Chemistry and Pharmacy, University
of Southern Denmark, 5230 Odense M, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Pedersen</span> - <span class="hlFld-Affiliation affiliation">Department
of Physics, Chemistry and Pharmacy, University
of Southern Denmark, 5230 Odense M, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Reinholdt</span> - <span class="hlFld-Affiliation affiliation">Department
of Physics, Chemistry and Pharmacy, University
of Southern Denmark, 5230 Odense M, Denmark</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2406-700X" title="Orcid link">http://orcid.org/0000-0003-2406-700X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacob Kongsted</span> - <span class="hlFld-Affiliation affiliation">Department
of Physics, Chemistry and Pharmacy, University
of Southern Denmark, 5230 Odense M, Denmark</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7725-2164" title="Orcid link">http://orcid.org/0000-0002-7725-2164</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carsten U. Nielsen</span> - <span class="hlFld-Affiliation affiliation">Department
of Physics, Chemistry and Pharmacy, University
of Southern Denmark, 5230 Odense M, Denmark</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5776-6865" title="Orcid link">http://orcid.org/0000-0001-5776-6865</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Janne K. Klitgaard</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Biology, Research Unit of Molecular
Microbiology, University of Southern Denmark, 5230 Odense M, Denmark</span>; 
    <span class="hlFld-Affiliation affiliation">Institute
of Clinical Research, Research Unit of Clinical Microbiology, University of Southern Denmark, 5230 Odense M, Denmark</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): A patent application related to compound 35 and derivatives has been filed by University of Southern Denmark with Christoffer Vogsen Heidtmann and Poul Nielsen listed as inventors.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i52">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45176" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45176" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Tina Kronborg and Lone Overgaard Storm for technical assistance with regard to microbiological screening and pleuromutilin conjugate synthesis, respectively. The authors would also like to acknowledge the kind gift of HEK 293 OAT3 cells from professors Maria Karlgren and Per Artursson, Uppsala University.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">MM-GBSA</td><td class="NLM_def"><p class="first last">molecular mechanics generalized Born surface area</p></td></tr><tr><td class="NLM_term">PTC</td><td class="NLM_def"><p class="first last">peptidyl transferase center</p></td></tr><tr><td class="NLM_term">TBAF</td><td class="NLM_def"><p class="first last">tetrabutylammonium fluoride</p></td></tr><tr><td class="NLM_term">PSA</td><td class="NLM_def"><p class="first last">polar surface area</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i54">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34264" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34264" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 41 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neu, H. C.</span></span> <span> </span><span class="NLM_article-title">The Crisis in Antibiotic Resistance</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>257</i></span>,  <span class="NLM_fpage">1064</span>– <span class="NLM_lpage">1073</span>, <span class="refDoi"> DOI: 10.1126/science.257.5073.1064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1126%2Fscience.257.5073.1064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1509257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADyaK38Xls1OhsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1992&pages=1064-1073&author=H.+C.+Neu&title=The+Crisis+in+Antibiotic+Resistance&doi=10.1126%2Fscience.257.5073.1064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The crisis in antibiotic resistance</span></div><div class="casAuthors">Neu, Harold C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">257</span>
        (<span class="NLM_cas:issue">5073</span>),
    <span class="NLM_cas:pages">1064-72</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review with >64 refs.  The synthesis of large nos. of antibiotics over the past three decades has caused complacency about the threat of bacterial resistance.  Bacteria have become resistant to antimicrobial agents as a result of chromosomal changes or the exchange of genetic material via plasmids and transposons.  Streptococcus pneumoniae, Streptococcus pyogenes, and staphylococci, organisms that cause respiratory and cutaneous infections, and members of the Enterobacteriaceae and Pseudomonas families, organisms that cause diarrhea, urinary infection, and sepsis, are now resistant to virtually all of the older antibiotics.  The extensive use of antibiotics in the community and hospitals has fueled this crisis.  Mechanisms such as antibiotic control programs, better hygiene, and synthesis of agents with improved antimicrobial activity need to be adopted in order to limit bacterial resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmntDmhDYAKrVg90H21EOLACvtfcHk0lgc-WyJLmIgLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xls1OhsbY%253D&md5=02b98676a76f669ffde4dbb1f10a3876</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.257.5073.1064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.257.5073.1064%26sid%3Dliteratum%253Aachs%26aulast%3DNeu%26aufirst%3DH.%2BC.%26atitle%3DThe%2520Crisis%2520in%2520Antibiotic%2520Resistance%26jtitle%3DScience%26date%3D1992%26volume%3D257%26spage%3D1064%26epage%3D1073%26doi%3D10.1126%2Fscience.257.5073.1064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martens, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demain, A. L.</span></span> <span> </span><span class="NLM_article-title">The Antibiotic Resistance Crisis, with a Focus on the United States</span>. <i>Jpn. J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">520</span>– <span class="NLM_lpage">526</span>, <span class="refDoi"> DOI: 10.1038/ja.2017.30</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1038%2Fja.2017.30" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=28246379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpslWnsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2017&pages=520-526&author=E.+Martensauthor=A.+L.+Demain&title=The+Antibiotic+Resistance+Crisis%2C+with+a+Focus+on+the+United+States&doi=10.1038%2Fja.2017.30"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The antibiotic resistance crisis, with a focus on the United States</span></div><div class="casAuthors">Martens, Evan; Demain, Arnold L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">520-526</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Beginning with the discovery of penicillin by Alexander Fleming in the late 1920s, antibiotics have revolutionized the field of medicine.  They have saved millions of lives each year, alleviated pain and suffering, and have even been used prophylactically for the prevention of infectious diseases.  However, we have now reached a crisis where many antibiotics are no longer effective against even the simplest infections.  Such infections often result in an increased no. of hospitalizations, more treatment failures, and the persistence of drug-resistant pathogens.  Of particular concern are organisms such as methicillin-resistant Staphylococcus aureus, Clostridium difficile, multidrug and extensively drug-resistant Mycobacterium tuberculosis, Neisseria gonorrhoeae, carbapenem-resistant Enterobacteriaceae, and bacteria that produce extended spectrum β-lactamases such as Escherichia coli.  To make matters worse, there has been a steady decline in the discovery of new and effective antibiotics for a no. of reasons.  These include increased costs, lack of adequate support from the government, poor returns on investment, regulatory hurdles, and pharmaceutical companies that have simply abandoned the antibacterial arena.  Instead, many have chosen to focus on developing drugs that will be used on a chronic basis, which will offer a greater profit and more return on investment.  Therefore, there is now an urgent need to develop new and useful antibiotics to avoid returning to the pre-antibiotic era.  Some potential opportunities for antibiotic discovery include better economic incentives, genome mining, rational metabolic engineering, combinatorial biosynthesis, and further exploration of the earth's biodiversity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0EOgD63Ofl7Vg90H21EOLACvtfcHk0lglY7szeSTr6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpslWnsr0%253D&md5=5ca52ac6d6957a96186e2369ca492dd9</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fja.2017.30&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fja.2017.30%26sid%3Dliteratum%253Aachs%26aulast%3DMartens%26aufirst%3DE.%26aulast%3DDemain%26aufirst%3DA.%2BL.%26atitle%3DThe%2520Antibiotic%2520Resistance%2520Crisis%252C%2520with%2520a%2520Focus%2520on%2520the%2520United%2520States%26jtitle%3DJpn.%2520J.%2520Antibiot.%26date%3D2017%26volume%3D70%26spage%3D520%26epage%3D526%26doi%3D10.1038%2Fja.2017.30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paukner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedl, R.</span></span> <span> </span><span class="NLM_article-title">Pleuromutilins: Potent Drugs for Resistant Bugs-Mode of Action and Resistance</span>. <i>Cold Spring Harbor Perspect. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">a027110</span>, <span class="refDoi"> DOI: 10.1101/cshperspect.a027110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1101%2Fcshperspect.a027110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=27742734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFKms7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=a027110&author=S.+Pauknerauthor=R.+Riedl&title=Pleuromutilins%3A+Potent+Drugs+for+Resistant+Bugs-Mode+of+Action+and+Resistance&doi=10.1101%2Fcshperspect.a027110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Pleuromutilins: potent drugs for resistant bugs-mode of action and resistance</span></div><div class="casAuthors">Paukner, Susanne; Riedl, Rosemarie</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">a027110/1-a027110/16</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Pleuromutilins are antibiotics that selectively inhibit bacterial translation and are semisynthetic derivs. of the naturally occurring tricyclic diterpenoid pleuromutilin, which received its name from the pleuromutilin-producing fungus Pleurotus mutilus.  Tiamulin and valnemulin are two established derivs. in veterinary medicine for oral and i.m. administration.  As these early pleuromutilin drugs were developed at atime when companies focused on major antibacterial classes, such as the β-lactams, and resistance was not regarded as an issue, interest in antibiotic research including pleuromutilins was limited.  Over the last decade or so, there has been a resurgence in interest to develop this class for human use.  This has resulted in a topical deriv., retapamulin, and addnl. derivs. in clin. development.  The most advanced compd. is lefamulin, which is in late-stage development for the i.v. and oral treatment of community-acquired bacterial pneumonia and acute bacterial skin infections.  Overall, pleuromutilins and, in particular, lefamulin are characterized by potent activity against Gram-pos. and fastidious Gram-neg. pathogens as well as against mycoplasmas and intracellular organisms, such as Chlamydia spp. and Legionella pneumophila.  Pleuromutilins are unaffected by resistance to other major antibiotic classes, such as macrolides, fluoroquinolones, tetracyclines, β-lactam antibiotics, and others.  Furthermore, pleuromutilins display very low spontaneous mutation frequencies and slow, stepwise resistance development at sub-MIC in vitro.  The potential for resistance development in clinic is predicted to be slow as confirmed by extremely low resistance rates to this class despite the use of pleuromutilins in veterinary medicine for. 30 years.  Although rare, resistant strains have been identified in human- and livestock-assocd. environments and as with any antibiotic class, require close monitoring as well as prudent use in veterinary medicine.  This review focuses on the structural characteristics, mode of action, antibacterial activity, and resistance development of this potent and novel antibacterial class for systemic use in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNp0PFPUr1RbVg90H21EOLACvtfcHk0lglY7szeSTr6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFKms7jM&md5=9cf381f1b2a3283f2af59ea126070535</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a027110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a027110%26sid%3Dliteratum%253Aachs%26aulast%3DPaukner%26aufirst%3DS.%26aulast%3DRiedl%26aufirst%3DR.%26atitle%3DPleuromutilins%253A%2520Potent%2520Drugs%2520for%2520Resistant%2520Bugs-Mode%2520of%2520Action%2520and%2520Resistance%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2017%26volume%3D7%26spage%3Da027110%26doi%3D10.1101%2Fcshperspect.a027110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kavanagh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hervey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, W. J.</span></span> <span> </span><span class="NLM_article-title">Antibiotic Substances From Basidiomycetes: VIII. Pleurotus Multilus (Fr.) Sacc. and Pleurotus Passeckerianus Pilat</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1951</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">570</span>– <span class="NLM_lpage">574</span>, <span class="refDoi"> DOI: 10.1073/pnas.37.9.570</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1073%2Fpnas.37.9.570" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=16589015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADyaG38XjtlSntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1951&pages=570-574&author=F.+Kavanaghauthor=A.+Herveyauthor=W.+J.+Robbins&title=Antibiotic+Substances+From+Basidiomycetes%3A+VIII.+Pleurotus+Multilus+%28Fr.%29+Sacc.+and+Pleurotus+Passeckerianus+Pilat&doi=10.1073%2Fpnas.37.9.570"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Antibiotic substances from Basidiomyces. VIII. Pleurotus mutilus and Pleurotus passeckerianus</span></div><div class="casAuthors">Kavanagh, Frederick; Hervey, Annette; Robbins, Wm. J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1951</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">570-4</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">cf. C.A. 44, 8423c.  Pleuromutilin (I), an antibacterial substance formed by both P. mutilis and P. passeckerianus was recovered from the fermentation beer by extn. with CHCl3 at pH 5.3, the CHCl3 evapd. at low temp., and the remaining brown gum dissolved in ether which on evapn. yielded white crystals of I.  I was sol. in alc., acetone, CHCl3, and ether; slightly sol. in H2O; and insol. in hexane.  I contains 69.75% C and 9.03% H, has a mol. wt. of 310, m. 166-9° (cor.) without decompn., and [α]D20 ≤ 0.05° (0.2% in 50% EtOH).  The absorption spectrum showed a weak band at 290 mμ (ε = 21.7) and end absorption below 230 mμ.  I was a stable, neutral compd. and sublimed at about 140°.  Crystals were obtained from the fifth funnel of an 8-funnel counter-current distribution of crude gum between 50% H2O-MeOH and a 3:2 mixt. of Et2O-hexane.  I was active mainly against gram-pos. bacteria, showed partial activity against streptococci phage, and was inactive against several fungi species when tested at 0.5 mg./ml.  The activity of I was not reduced after 4 hrs. in broth contg. 5% blood.  I was bacteriostatic for Staphylococcus aureus at 0.25-2 γ/ml. broth and bactericidal at 4 γ/ml.  The LD50 of I for mice (intraperitoneally) was greater than 60 mg./kg.  A single subcutaneous dose of I at 50 mg./kg. protected 63% of the mice, infected with Streptococcus hemolyticus, for 7 days.  I had no effect on growth of sarcoma 180 or Plasmodium gallinaceum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqRlKsz11Vq7Vg90H21EOLACvtfcHk0lhKf_k6C9CzmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG38XjtlSntQ%253D%253D&md5=6e77a9a767c3732146a93cc28e2be781</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1073%2Fpnas.37.9.570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.37.9.570%26sid%3Dliteratum%253Aachs%26aulast%3DKavanagh%26aufirst%3DF.%26aulast%3DHervey%26aufirst%3DA.%26aulast%3DRobbins%26aufirst%3DW.%2BJ.%26atitle%3DAntibiotic%2520Substances%2520From%2520Basidiomycetes%253A%2520VIII.%2520Pleurotus%2520Multilus%2520%2528Fr.%2529%2520Sacc.%2520and%2520Pleurotus%2520Passeckerianus%2520Pilat%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1951%26volume%3D37%26spage%3D570%26epage%3D574%26doi%3D10.1073%2Fpnas.37.9.570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kavanagh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hervey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, W. J.</span></span> <span> </span><span class="NLM_article-title">Antibiotic Substances from Basidiomycetes: IX. Drosophila Subtarata. (Batsch Ex Fr.) Quel</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1952</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1073/pnas.38.7.555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1073%2Fpnas.38.7.555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=16589145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADyaG3sXivFSqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1952&pages=555-560&author=F.+Kavanaghauthor=A.+Herveyauthor=W.+J.+Robbins&title=Antibiotic+Substances+from+Basidiomycetes%3A+IX.+Drosophila+Subtarata.+%28Batsch+Ex+Fr.%29+Quel&doi=10.1073%2Fpnas.38.7.555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Antibiotic substances from basidiomycetes. IX. Drosophila subatrata</span></div><div class="casAuthors">Kavanagh, Frederick; Hervey, Annette; Robbins, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1952</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">555-60</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">cf. C.A. 46, 5662d; following abstr.  Drosophila subatrata produced an activity of 1000 diln. units/ml. for Staphylococcus aureus when grown in shake culture for two weeks on corn steep medium.  Active substances were isolated thus: culture liquid was acidified to pH 3.4, extd. with 0.1 vol. CHCl3 which was then extd. with 0.5 M NaHCO3 to give an aq. ext. (I) contg. 37% of the solids and 20% of the S. aureus activity.  The CHCl3 extn. was evapd. to 1/10 vol. and extd. with an equal vol. of 0.5 M NaHCO3 to give a soln. (II) contg. 25% of the S. aureus activity and 3% of the solids.  The remaining CHCl3 ext. was further extd. with 0.5 M carbonate buffer pH 10 which removed a small amt. of an active substance, drosophilin A (III), isolated by acidifying the buffer soln., extg. with Et2O, and evapg. to yield yellow crystals of III, yield 100 mg. from 31 l. of culture medium.  III dissolved in C6H6, decolorized with C, filtered, and the C6H6 evapd. yielded crystals, which after recrystn. from hexane or dil. aq. alc. m. 118°.  III was also sol. in Me2CO, EtOH, CHCl3, Et2O, and slightly sol. in H2O, showed no basic properties was weakly acidic, gave a color reaction with alc. FeCl3, had absorption peak at 301 mμ, did not ppt. with AgNO3, reduced alk. MnO4-, reacted with alk. AgNO3 with formation of AgCl, did not react with 2, 4-(NO2)2C6H3NHNH2, did not give reactions for α,β-unsatd. ketones, contained 11.70% OCH3, had a mol. wt. 249, and infrared analysis indicated H attached to unsatd. C, a OH group and a CH3 or CH2 group.  The above CHCl3 concentrate after extn. with pH 10 buffer was extd. with 0.5 M Na2CO3 and then by N KOH, the CHCl3 evapd., the solids remaining dissolved in C6H6, and C6H6 evapd. to yield crystals of drosophilin B (IV) which were identical with pleuromutilin.  The II ext. was acidified, the acids taken up in Et2O, the Et2O soln. shaken repeatedly with 0.25 vol. 0.1 N AgNO3, and the yellow ppt. removed each time and kept under H2O.  The combined Ag ppts. were washed with Et2O and H2O, more Et2O added, the Ag compd. decompd. with HCl and the acids were taken up in Et2O.  The substances in Et2O were subjected to counter-current distribution between CHCl3 and 0.5 M phosphate buffer at pH 6.9; most of the solids and antibacterial activity were in the CHCl3 which was distributed again in a 4 funnel system using pH 7.5 buffer.  The purest substance, 4 mg. of drosophilin C (V), was found in the third funnel.  I was acidified, extd. with CHCl3, the CHCl3 shaken with 0.5 vol. pH 6 buffer, and the CHCl3 extd. repeatedly with AgNO3 with removal of the pptd. Ag compd. before using fresh AgNO3.  Counter-current distributions with pH 7 buffer of the CHCl3 soln. yielded drosophilin D (VI), sol. in org. solvents, and pptd. from aq. alc. by AgNO3 as was V.  VI titrated in 20% EtOH as a monobasic acid with pK 4.2 and equiv. wt. 405 and showed ultraviolet spectra characteristic of polyacetylene substances.  The activities of the 4 compds. were measured against 7 organisms and 60 bacteriophages.  The substances were active mainly against gram-pos. bacteria; III was active against staphylophage 8, IV against streptophage 6 and 7; V and VI were inactive against phage.  III and IV were not inactivated by incubation with blood; V was 7/8 inactivated and VI lost 0.5 its activity.  IV was not toxic to mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrexTWmThQB87Vg90H21EOLACvtfcHk0lhKf_k6C9CzmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG3sXivFSqtA%253D%253D&md5=9824a5c8bb8d0c1fdb840a43025d7699</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.38.7.555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.38.7.555%26sid%3Dliteratum%253Aachs%26aulast%3DKavanagh%26aufirst%3DF.%26aulast%3DHervey%26aufirst%3DA.%26aulast%3DRobbins%26aufirst%3DW.%2BJ.%26atitle%3DAntibiotic%2520Substances%2520from%2520Basidiomycetes%253A%2520IX.%2520Drosophila%2520Subtarata.%2520%2528Batsch%2520Ex%2520Fr.%2529%2520Quel%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1952%26volume%3D38%26spage%3D555%26epage%3D560%26doi%3D10.1073%2Fpnas.38.7.555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goethe, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heuer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herzon, S. B.</span></span> <span> </span><span class="NLM_article-title">Antibacterial properties and clinical potential of pleuromutilins</span>. <i>Nat. Prod. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">220</span>– <span class="NLM_lpage">247</span>, <span class="refDoi"> DOI: 10.1039/c8np00042e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1039%2FC8NP00042E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=29979463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht12lsrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2019&pages=220-247&author=O.+Goetheauthor=A.+Heuerauthor=X.+Maauthor=Z.+Wangauthor=S.+B.+Herzon&title=Antibacterial+properties+and+clinical+potential+of+pleuromutilins&doi=10.1039%2Fc8np00042e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Antibacterial properties and clinical potential of pleuromutilins</span></div><div class="casAuthors">Goethe, Olivia; Heuer, Abigail; Ma, Xiaoshen; Wang, Zhixun; Herzon, Seth B.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">220-247</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Covering: up to 2018Pleuromutilins are a clin. validated class of antibiotics derived from the fungal diterpene (+)-pleuromutilin (1).  Pleuromutilins inhibit bacterial protein synthesis by binding to the peptidyl transferase center (PTC) of the ribosome.  In this review we summarize the biosynthesis and recent total syntheses of (+)-pleuromutilin (1).  We review the mode of interaction of pleuromutilins with the bacterial ribosome, which involves binding of the C14 extension and the tricyclic core to the P and A sites of the PTC, resp.  We provide an overview of existing clin. agents, and discuss the three primary modes of bacterial resistance (mutations in ribosomal protein L3, Cfr methylation, and efflux).  Finally we collect structure-activity relationships from publicly available reports, and close with some forward looking statements regarding future development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9TZIovrZMJ7Vg90H21EOLACvtfcHk0lhKf_k6C9CzmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht12lsrnF&md5=ad209d04e0bc1a2fcc73351b1e6cb1e5</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1039%2FC8NP00042E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8NP00042E%26sid%3Dliteratum%253Aachs%26aulast%3DGoethe%26aufirst%3DO.%26aulast%3DHeuer%26aufirst%3DA.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DHerzon%26aufirst%3DS.%2BB.%26atitle%3DAntibacterial%2520properties%2520and%2520clinical%2520potential%2520of%2520pleuromutilins%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2019%26volume%3D36%26spage%3D220%26epage%3D247%26doi%3D10.1039%2Fc8np00042e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drews, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laber, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schütze, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unger, J.</span></span> <span> </span><span class="NLM_article-title">Antimicrobial activities of 81.723 hfu, a new pleuromutilin derivative</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">516</span>, <span class="refDoi"> DOI: 10.1128/aac.7.5.507</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1128%2FAAC.7.5.507" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1170807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADyaE2MXltVygsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1975&pages=507-516&author=J.+Drewsauthor=A.+Georgopoulosauthor=G.+Laberauthor=E.+Sch%C3%BCtzeauthor=J.+Unger&title=Antimicrobial+activities+of+81.723+hfu%2C+a+new+pleuromutilin+derivative&doi=10.1128%2Faac.7.5.507"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Antimicrobial activities of 81.723 hfu, a new pleuromutilin derivative</span></div><div class="casAuthors">Drews, Jurgen; Georgopoulos, Apostolos; Laber, Georg; Schuetze, Eberhard; Unger, Judith</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">507-16</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    </div><div class="casAbstract">The new pleuromutilin deriv. 81.723 hfu (I) [55297-96-6] was extremely active against gram-pos. organisms such as streptococci, staphylococci, and against mycoplasmas.  A no. of Shigella, Klebsiella, and Escherichia coli strains were also found to be quite susceptible to this new agent, whereas other gram-neg. organisms like Pseudomonas aeruginosa, Proteus species, and Alcaligenes faecalis proved to be naturally resistant to 81.723 hfu.  The new compd. acted bacteriostatically.  Bactericidal effects have been obsd. only at concns. which are 100-fold higher than the min. inhibitory concns.  The new antibiotic was well tolerated in all animal species tested so far and has been successfully used in the treatment of exptl. infections with gram-pos. organisms and with mycoplasmas in mice and rats.  Resistance against this new compd. arose gradually in all microorganisms investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0-MNdh6l8B7Vg90H21EOLACvtfcHk0lgtggUEWSFMVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXltVygsLk%253D&md5=7efdc670497e873b0fa01ab272b0d6c5</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1128%2FAAC.7.5.507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.7.5.507%26sid%3Dliteratum%253Aachs%26aulast%3DDrews%26aufirst%3DJ.%26aulast%3DGeorgopoulos%26aufirst%3DA.%26aulast%3DLaber%26aufirst%3DG.%26aulast%3DSch%25C3%25BCtze%26aufirst%3DE.%26aulast%3DUnger%26aufirst%3DJ.%26atitle%3DAntimicrobial%2520activities%2520of%252081.723%2520hfu%252C%2520a%2520new%2520pleuromutilin%2520derivative%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1975%26volume%3D7%26spage%3D507%26epage%3D516%26doi%3D10.1128%2Faac.7.5.507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burch, D. G. S.</span>; <span class="NLM_string-name">Ripley, P. H.</span>; <span class="NLM_string-name">Zeisl, E.</span></span>. <span> </span><span class="NLM_article-title">Veterinary Use of a Pleuromutilin Derivative</span>. <span class="NLM_patent">WO 1998001127 A1</span>, <span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=D.+G.+S.+Burch&author=P.+H.+Ripley&author=E.+Zeisl&title=Veterinary+Use+of+a+Pleuromutilin+Derivative"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurch%26aufirst%3DD.%2BG.%2BS.%26atitle%3DVeterinary%2520Use%2520of%2520a%2520Pleuromutilin%2520Derivative%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritsche, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sader, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, J. E.</span></span> <span> </span><span class="NLM_article-title">Activity of Retapamulin (SB-275833), a Novel Pleuromutilin, against Selected Resistant Gram-Positive Cocci</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">2583</span>– <span class="NLM_lpage">2586</span>, <span class="refDoi"> DOI: 10.1128/aac.01432-05</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1128%2FAAC.01432-05" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=16801451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvVWrtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=2583-2586&author=R.+N.+Jonesauthor=T.+R.+Fritscheauthor=H.+S.+Saderauthor=J.+E.+Ross&title=Activity+of+Retapamulin+%28SB-275833%29%2C+a+Novel+Pleuromutilin%2C+against+Selected+Resistant+Gram-Positive+Cocci&doi=10.1128%2Faac.01432-05"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant Gram-positive cocci</span></div><div class="casAuthors">Jones, Ronald N.; Fritsche, Thomas R.; Sader, Helio S.; Ross, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2583-2586</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Retapamulin (SB-275833), the first pleuromutilin to be developed for human topical use, was tested against a selected population of staphylococci and β-hemolytic streptococci.  The MIC90 results for retapamulin were 0.12 μg/mL for Staphylococcus aureus and ≤0.03 μg/mL for Streptococcus pyogenes; no cross-resistance was obsd. for organism subsets resistant to oxacillin, erythromycin, or mupirocin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1DMTvarj5ALVg90H21EOLACvtfcHk0lgtggUEWSFMVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvVWrtL0%253D&md5=48b91d3b2458757e9d898a573d6d4faa</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1128%2FAAC.01432-05&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01432-05%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DR.%2BN.%26aulast%3DFritsche%26aufirst%3DT.%2BR.%26aulast%3DSader%26aufirst%3DH.%2BS.%26aulast%3DRoss%26aufirst%3DJ.%2BE.%26atitle%3DActivity%2520of%2520Retapamulin%2520%2528SB-275833%2529%252C%2520a%2520Novel%2520Pleuromutilin%252C%2520against%2520Selected%2520Resistant%2520Gram-Positive%2520Cocci%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D2583%26epage%3D2586%26doi%3D10.1128%2Faac.01432-05" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paukner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golparian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unemo, M.</span></span> <span> </span><span class="NLM_article-title"><i>In Vitro</i> Activity of the Novel Pleuromutilin Lefamulin (BC-3781) and Effect of Efflux Pump Inactivation on Multidrug-Resistant and Extensively Drug-Resistant Neisseria Gonorrhoeae</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">e01497</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1128/aac.01497-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1128%2FAAC.01497-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=28893785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpvVWltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=e01497-17&author=S.+Jacobssonauthor=S.+Pauknerauthor=D.+Golparianauthor=J.+S.+Jensenauthor=M.+Unemo&title=In+Vitro+Activity+of+the+Novel+Pleuromutilin+Lefamulin+%28BC-3781%29+and+Effect+of+Efflux+Pump+Inactivation+on+Multidrug-Resistant+and+Extensively+Drug-Resistant+Neisseria+Gonorrhoeae&doi=10.1128%2Faac.01497-17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro activity of the novel pleuromutilin lefamulin (BC-3781) and effect of efflux pump inactivation on multidrug-resistant and extensively drug-resistant Neisseria gonorrhoeae</span></div><div class="casAuthors">Jacobsson, Susanne; Paukner, Susanne; Golparian, Daniel; Jensen, Joergen S.; Unemo, Magnus</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e01497-17/1-e01497-17/5</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We evaluated the activity of the novel semisynthetic pleuromutilin lefamulin, inhibiting protein synthesis and growth, and the effect of efflux pump inactivation on clin. gonococcal isolates and ref. strains (n = 251), including numerous multidrug-resistant and extensively drug-resistant isolates.  Lefamulin showed potent activity against all gonococcal isolates, and no significant cross-resistance to other antimicrobials was identified.  Further studies of lefamulin are warranted, including in vitro selection and mechanisms of resistance, pharmacokinetics/pharmacodynamics, optimal dosing, and performance in randomized controlled trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-Bjo6DyCsE7Vg90H21EOLACvtfcHk0lg5UBYwwbpuyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpvVWltrg%253D&md5=130dca9f45a6f5d73eef0ba209bee763</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1128%2FAAC.01497-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01497-17%26sid%3Dliteratum%253Aachs%26aulast%3DJacobsson%26aufirst%3DS.%26aulast%3DPaukner%26aufirst%3DS.%26aulast%3DGolparian%26aufirst%3DD.%26aulast%3DJensen%26aufirst%3DJ.%2BS.%26aulast%3DUnemo%26aufirst%3DM.%26atitle%3DIn%2520Vitro%2520Activity%2520of%2520the%2520Novel%2520Pleuromutilin%2520Lefamulin%2520%2528BC-3781%2529%2520and%2520Effect%2520of%2520Efflux%2520Pump%2520Inactivation%2520on%2520Multidrug-Resistant%2520and%2520Extensively%2520Drug-Resistant%2520Neisseria%2520Gonorrhoeae%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26spage%3De01497%26epage%3D17%26doi%3D10.1128%2Faac.01497-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sader, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biedenbach, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paukner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivezic-Schoenfeld, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. N.</span></span> <span> </span><span class="NLM_article-title">Antimicrobial Activity of the Investigational Pleuromutilin Compound BC-3781 Tested Against Gram-positive Organisms Commonly Associated with Acute Bacterial Skin and Skin Structure Infections</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1619</span>– <span class="NLM_lpage">1623</span>, <span class="refDoi"> DOI: 10.1128/aac.05789-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1128%2FAAC.05789-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=22232289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsVKltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=1619-1623&author=H.+S.+Saderauthor=D.+J.+Biedenbachauthor=S.+Pauknerauthor=Z.+Ivezic-Schoenfeldauthor=R.+N.+Jones&title=Antimicrobial+Activity+of+the+Investigational+Pleuromutilin+Compound+BC-3781+Tested+Against+Gram-positive+Organisms+Commonly+Associated+with+Acute+Bacterial+Skin+and+Skin+Structure+Infections&doi=10.1128%2Faac.05789-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Antimicrobial activity of the investigational pleuromutilin compound BC-3781 tested against Gram-positive organisms commonly associated with acute bacterial skin and skin structure infections</span></div><div class="casAuthors">Sader, Helio S.; Biedenbach, Douglas J.; Paukner, Susanne; Ivezic-Schoenfeld, Zrinka; Jones, Ronald N.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1619-1623</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">BC-3781 is a novel semisynthetic pleuromutilin antimicrobial agent developed as an i.v. and oral therapy for acute bacterial skin and skin structure infections (ABSSSI) and respiratory tract infections (RTI).  BC-3781 and comparator agents were tested by the broth microdilution method against 1893 clin. Gram-pos. organisms predominantly causing ABSSSI.  BC-3781 exhibited potent activity against methicillin-resistant Staphylococcus aureus (MIC50/90, 0.12/0.25 μg/mL), coagulase-neg. staphylococci (MIC50/90, 0.06/0.12 μg/mL), β-hemolytic streptococci (MIC50/90, 0.03/0.06 μg/mL), viridans group streptococci (MIC50/90, 0.12/0.5 μg/mL), and Enterococcus faecium (including vancomycin-nonsusceptible strains) (MIC50/90, 0.12/2 μg/mL).  Compared with other antibiotics in use for the treatment of ABSSSI, BC-3781 displayed the lowest MICs and only a minimal potential for cross-resistance with other antimicrobial classes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO9JRQ8KYR6rVg90H21EOLACvtfcHk0lg5UBYwwbpuyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsVKltb8%253D&md5=a476df25c60954a24ab5348d1bda783e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1128%2FAAC.05789-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.05789-11%26sid%3Dliteratum%253Aachs%26aulast%3DSader%26aufirst%3DH.%2BS.%26aulast%3DBiedenbach%26aufirst%3DD.%2BJ.%26aulast%3DPaukner%26aufirst%3DS.%26aulast%3DIvezic-Schoenfeld%26aufirst%3DZ.%26aulast%3DJones%26aufirst%3DR.%2BN.%26atitle%3DAntimicrobial%2520Activity%2520of%2520the%2520Investigational%2520Pleuromutilin%2520Compound%2520BC-3781%2520Tested%2520Against%2520Gram-positive%2520Organisms%2520Commonly%2520Associated%2520with%2520Acute%2520Bacterial%2520Skin%2520and%2520Skin%2520Structure%2520Infections%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D1619%26epage%3D1623%26doi%3D10.1128%2Faac.05789-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paukner, S. C. C.</span>, <span class="NLM_string-name">Ivezic-Schoenfeld, Z.</span>, <span class="NLM_string-name">Kosowska-Shick, K.</span></span>. <span> </span><span class="NLM_article-title">Single- and Multistep Resistance Selection with the Pleuromutilin Antibiotic BC-3781</span>.  <i>In 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)</i>: <span class="NLM_publisher-loc">San Francisco</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=S.+C.+C.+Paukner&author=Z.+Ivezic-Schoenfeld&author=K.+Kosowska-Shick&title=Single-+and+Multistep+Resistance+Selection+with+the+Pleuromutilin+Antibiotic+BC-3781"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DPaukner%26aufirst%3DS.%2BC.%2BC.%26atitle%3DSingle-%2520and%2520Multistep%2520Resistance%2520Selection%2520with%2520the%2520Pleuromutilin%2520Antibiotic%2520BC-3781%26jtitle%3DIn%252052nd%2520Interscience%2520Conference%2520on%2520Antimicrobial%2520Agents%2520and%2520Chemotherapy%2520%2528ICAAC%2529%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vester, B.</span></span> <span> </span><span class="NLM_article-title">The Pleuromutilin Drugs Tiamulin and Valnemulin Bind to the RNA at the Peptidyl Transferase Centre on the Ribosome</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1091</span>– <span class="NLM_lpage">1099</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2958.2001.02595.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1046%2Fj.1365-2958.2001.02595.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=11555289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntlGhsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=1091-1099&author=S.+M.+Poulsenauthor=M.+Karlssonauthor=L.+B.+Johanssonauthor=B.+Vester&title=The+Pleuromutilin+Drugs+Tiamulin+and+Valnemulin+Bind+to+the+RNA+at+the+Peptidyl+Transferase+Centre+on+the+Ribosome&doi=10.1046%2Fj.1365-2958.2001.02595.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The pleuromutilin drugs tiamulin and valnemulin bind to the RNA at the peptidyl transferase centre on the ribosome</span></div><div class="casAuthors">Poulsen, Susan M.; Karlsson, Marit; Johansson, Lena B.; Vester, Birte</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1091-1099</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The pleuromutilin antibiotic derivs., tiamulin and valnemulin, inhibit protein synthesis by binding to the 50S ribosomal subunit of bacteria.  The action and binding site of tiamulin and valnemulin was further characterized on Escherichia coli ribosomes.  It was revealed that these drugs are strong inhibitors of peptidyl transferase and interact with domain V of 23S RNA, giving clear chem. footprints at nucleotides A2058-9, U2506 and U2584-5.  Most of these nucleotides are highly conserved phylogenetically and functionally important, and all of them are at or near the peptidyl transferase center and have been assocd. with binding of several antibiotics.  Competitive footprinting shows that tiamulin and valnemulin can bind concurrently with the macrolide erythromycin but compete with the macrolide carbomycin, which is a peptidyl transferase inhibitor.  We infer from these and previous results that tiamulin and valnemulin interact with the rRNA in the peptidyl transferase slot on the ribosomes in which they prevent the correct positioning of the CCA-ends of tRNAs for peptide transfer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo23jaXaFOT-LVg90H21EOLACvtfcHk0ljx4dySTOGTZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntlGhsLw%253D&md5=63aa6dbc5ed8f2353eb391ed35ddb37a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2958.2001.02595.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2958.2001.02595.x%26sid%3Dliteratum%253Aachs%26aulast%3DPoulsen%26aufirst%3DS.%2BM.%26aulast%3DKarlsson%26aufirst%3DM.%26aulast%3DJohansson%26aufirst%3DL.%2BB.%26aulast%3DVester%26aufirst%3DB.%26atitle%3DThe%2520Pleuromutilin%2520Drugs%2520Tiamulin%2520and%2520Valnemulin%2520Bind%2520to%2520the%2520RNA%2520at%2520the%2520Peptidyl%2520Transferase%2520Centre%2520on%2520the%2520Ribosome%26jtitle%3DMol.%2520Microbiol.%26date%3D2001%26volume%3D41%26spage%3D1091%26epage%3D1099%26doi%3D10.1046%2Fj.1365-2958.2001.02595.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dreier, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vester, B.</span></span> <span> </span><span class="NLM_article-title">A Click Chemistry Approach to Pleuromutilin Derivatives. Part 3: Extended Footprinting Analysis and Excellent MRSA Inhibition for a Derivative with an Adenine Phenyl Side Chain</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1043</span>– <span class="NLM_lpage">1046</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.01.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1016%2Fj.bmcl.2014.01.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=24486133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Cqurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1043-1046&author=I.+Dreierauthor=L.+H.+Hansenauthor=P.+Nielsenauthor=B.+Vester&title=A+Click+Chemistry+Approach+to+Pleuromutilin+Derivatives.+Part+3%3A+Extended+Footprinting+Analysis+and+Excellent+MRSA+Inhibition+for+a+Derivative+with+an+Adenine+Phenyl+Side+Chain&doi=10.1016%2Fj.bmcl.2014.01.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A click chemistry approach to pleuromutilin derivatives. Part 3: Extended footprinting analysis and excellent MRSA inhibition for a derivative with an adenine phenyl side chain</span></div><div class="casAuthors">Dreier, Ida; Hansen, Lykke H.; Nielsen, Poul; Vester, Birte</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1043-1046</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Five promising pleuromutilin derivs. from our former studies, all contg. adenine on various linkers, were supplemented with two new compds.  The binding to Escherichia coli ribosomes was verified by extensive chem. footprinting anal.  The ability to inhibit bacterial growth was investigated on two Staphylococcus aureus strains and compared to the pleuromutilin drugs tiamulin and valnemulin.  Three of the compds. show an effect similar to tiamulin and one compd. shows an excellent effect similar to valnemulin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql1fKotZzpebVg90H21EOLACvtfcHk0ljx4dySTOGTZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Cqurs%253D&md5=06423d6334834068e05d6ef91378f1f7</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.01.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.01.019%26sid%3Dliteratum%253Aachs%26aulast%3DDreier%26aufirst%3DI.%26aulast%3DHansen%26aufirst%3DL.%2BH.%26aulast%3DNielsen%26aufirst%3DP.%26aulast%3DVester%26aufirst%3DB.%26atitle%3DA%2520Click%2520Chemistry%2520Approach%2520to%2520Pleuromutilin%2520Derivatives.%2520Part%25203%253A%2520Extended%2520Footprinting%2520Analysis%2520and%2520Excellent%2520MRSA%2520Inhibition%2520for%2520a%2520Derivative%2520with%2520an%2520Adenine%2520Phenyl%2520Side%2520Chain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D1043%26epage%3D1046%26doi%3D10.1016%2Fj.bmcl.2014.01.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Long, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakobsen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vester, B.</span></span> <span> </span><span class="NLM_article-title">Interaction of Pleuromutilin Derivatives with the Ribosomal Peptidyl Transferase Center</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1458</span>– <span class="NLM_lpage">1462</span>, <span class="refDoi"> DOI: 10.1128/aac.50.4.1458-1462.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1128%2FAAC.50.4.1458-1462.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=16569865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFOrsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=1458-1462&author=K.+S.+Longauthor=L.+H.+Hansenauthor=L.+Jakobsenauthor=B.+Vester&title=Interaction+of+Pleuromutilin+Derivatives+with+the+Ribosomal+Peptidyl+Transferase+Center&doi=10.1128%2Faac.50.4.1458-1462.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of pleuromutilin derivatives with the ribosomal peptidyl transferase center</span></div><div class="casAuthors">Long, Katherine S.; Hansen, Lykke H.; Jakobsen, Lene; Vester, Birte</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1458-1462</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Tiamulin is a pleuromutilin antibiotic that is used in veterinary medicine.  The recently published crystal structure of a tiamulin-50S ribosomal subunit complex provides detailed information about how this drug targets the peptidyl transferase center of the ribosome.  To promote rational design of pleuromutilin-based drugs, the binding of the antibiotic pleuromutilin and three semisynthetic derivs. with different side chain extensions has been investigated using chem. footprinting.  The nucleotides A2058, A2059, G2505, and U2506 are affected in all of the footprints, suggesting that the drugs are similarly anchored in the binding pocket by the common tricyclic mutilin core.  However, varying effects are obsd. at U2584 and U2585, indicating that the side chain extensions adopt distinct conformations within the cavity and thereby affect the rRNA conformation differently.  An Escherichia coli L3 mutant strain is resistant to tiamulin and pleuromutilin, but not valnemulin, implying that valnemulin is better able to withstand an altered rRNA binding surface around the mutilin core.  This is likely due to addnl. interactions made between the valnemulin side chain extension and the rRNA binding site.  The data suggest that pleuromutilin drugs with enhanced antimicrobial activity may be obtained by maximizing the no. of interactions between the side chain moiety and the peptidyl transferase cavity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0EDXbWyeDp7Vg90H21EOLACvtfcHk0ljx4dySTOGTZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFOrsL0%253D&md5=b5d81c9e5074fb5e910bee8bb73a76e4</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FAAC.50.4.1458-1462.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.50.4.1458-1462.2006%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DK.%2BS.%26aulast%3DHansen%26aufirst%3DL.%2BH.%26aulast%3DJakobsen%26aufirst%3DL.%26aulast%3DVester%26aufirst%3DB.%26atitle%3DInteraction%2520of%2520Pleuromutilin%2520Derivatives%2520with%2520the%2520Ribosomal%2520Peptidyl%2520Transferase%2520Center%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D1458%26epage%3D1462%26doi%3D10.1128%2Faac.50.4.1458-1462.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schlünzen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyetan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fucini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yonath, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harms, J. M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Peptide Bond Formation by Pleuromutilins: the Structure of the 50S Ribosomal Subunit From Deinococcus Radiodurans in Complex with Tiamulin</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1287</span>– <span class="NLM_lpage">1294</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.2004.04346.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1111%2Fj.1365-2958.2004.04346.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=15554968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOlsr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2004&pages=1287-1294&author=F.+Schl%C3%BCnzenauthor=E.+Pyetanauthor=P.+Fuciniauthor=A.+Yonathauthor=J.+M.+Harms&title=Inhibition+of+Peptide+Bond+Formation+by+Pleuromutilins%3A+the+Structure+of+the+50S+Ribosomal+Subunit+From+Deinococcus+Radiodurans+in+Complex+with+Tiamulin&doi=10.1111%2Fj.1365-2958.2004.04346.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of peptide bond formation by pleuromutilins: The structure of the 50S ribosomal subunit from Deinococcus radiodurans in complex with tiamulin</span></div><div class="casAuthors">Schluenzen, Frank; Pyetan, Erez; Fucini, Paola; Yonath, Ada; Harms, Joerg M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1287-1294</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Tiamulin, a prominent member of the pleuromutilin class of antibiotics, is a potent inhibitor of protein synthesis in bacteria.  Up to now the effect of pleuromutilins on the ribosome has not been detd. on a mol. level.  The 3.5 Å structure of the 50S ribosomal subunit from Deinococcus radiodurans in complex with tiamulin provides for the first time a detailed picture of its interactions with the 23S rRNA, thus explaining the mol. mechanism of the antimicrobial activity of the pleuromutilin class of antibiotics.  Our results show that tiamulin is located within the peptidyl transferase center (PTC) of the 50S ribosomal subunit with its tricyclic mutilin core positioned in a tight pocket at the A-tRNA binding site.  Also, the extension, which protrudes from its mutilin core, partially overlaps with the P-tRNA binding site.  Thereby, tiamulin directly inhibits peptide bond formation.  Comparison of the tiamulin binding site with other PTC targeting drugs, like chloramphenicol, clindamycin and streptogramins, may facilitate the design of modified or hybridized drugs that extend the applicability of this class of antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2D1Idh-v-kLVg90H21EOLACvtfcHk0li0Shtj_xLh5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOlsr3I&md5=9c1cff85ea16f04813897b2778077237</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2004.04346.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2004.04346.x%26sid%3Dliteratum%253Aachs%26aulast%3DSchl%25C3%25BCnzen%26aufirst%3DF.%26aulast%3DPyetan%26aufirst%3DE.%26aulast%3DFucini%26aufirst%3DP.%26aulast%3DYonath%26aufirst%3DA.%26aulast%3DHarms%26aufirst%3DJ.%2BM.%26atitle%3DInhibition%2520of%2520Peptide%2520Bond%2520Formation%2520by%2520Pleuromutilins%253A%2520the%2520Structure%2520of%2520the%252050S%2520Ribosomal%2520Subunit%2520From%2520Deinococcus%2520Radiodurans%2520in%2520Complex%2520with%2520Tiamulin%26jtitle%3DMol.%2520Microbiol.%26date%3D2004%26volume%3D54%26spage%3D1287%26epage%3D1294%26doi%3D10.1111%2Fj.1365-2958.2004.04346.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eyal, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matzov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krupkin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paukner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedl, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozenberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bashan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yonath, A.</span></span> <span> </span><span class="NLM_article-title">A Novel Pleuromutilin Antibacterial Compound, its Binding Mode and Selectivity Mechanism</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">39004</span>, <span class="refDoi"> DOI: 10.1038/srep39004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1038%2Fsrep39004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=27958389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFGjtrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=39004&author=Z.+Eyalauthor=D.+Matzovauthor=M.+Krupkinauthor=S.+Pauknerauthor=R.+Riedlauthor=H.+Rozenbergauthor=E.+Zimmermanauthor=A.+Bashanauthor=A.+Yonath&title=A+Novel+Pleuromutilin+Antibacterial+Compound%2C+its+Binding+Mode+and+Selectivity+Mechanism&doi=10.1038%2Fsrep39004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A novel pleuromutilin antibacterial compound, its binding mode and selectivity mechanism</span></div><div class="casAuthors">Eyal, Zohar; Matzov, Donna; Krupkin, Miri; Paukner, Susanne; Riedl, Rosemarie; Rozenberg, Haim; Zimmerman, Ella; Bashan, Anat; Yonath, Ada</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">39004</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The increasing appearance of pathogenic bacteria with antibiotic resistance is a global threat.  Consequently, clin. available potent antibiotics that are active against multidrug resistant pathogens are becoming exceedingly scarce.  Ribosomes are a main target for antibiotics, and hence are an objective for novel drug development.  Lefamulin, a semi-synthetic pleuromutilin compd. highly active against multi-resistant pathogens, is a promising antibiotic currently in phase III trials for the treatment of community-acquired bacterial pneumonia in adults.  The crystal structure of the Staphylococcus aureus large ribosomal subunit in complex with lefamulin reveals its protein synthesis inhibition mechanism and the rationale for its potency.  In addn., anal. of the bacterial and eukaryotes ribosome structures around the pleuromutilin binding pocket has elucidated the key for the drug's selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcIIQ8ddZpi7Vg90H21EOLACvtfcHk0li0Shtj_xLh5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFGjtrrN&md5=232d92ed0c8207372496fa91527ce231</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fsrep39004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep39004%26sid%3Dliteratum%253Aachs%26aulast%3DEyal%26aufirst%3DZ.%26aulast%3DMatzov%26aufirst%3DD.%26aulast%3DKrupkin%26aufirst%3DM.%26aulast%3DPaukner%26aufirst%3DS.%26aulast%3DRiedl%26aufirst%3DR.%26aulast%3DRozenberg%26aufirst%3DH.%26aulast%3DZimmerman%26aufirst%3DE.%26aulast%3DBashan%26aufirst%3DA.%26aulast%3DYonath%26aufirst%3DA.%26atitle%3DA%2520Novel%2520Pleuromutilin%2520Antibacterial%2520Compound%252C%2520its%2520Binding%2520Mode%2520and%2520Selectivity%2520Mechanism%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D39004%26doi%3D10.1038%2Fsrep39004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eyal, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matzov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krupkin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wekselman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paukner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozenberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bashan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yonath, A.</span></span> <span> </span><span class="NLM_article-title">Structural Insights into Species-specific Features of the Ribosome from the Pathogen Staphylococcus Aureus</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">E5805</span>– <span class="NLM_lpage">E5814</span>, <span class="refDoi"> DOI: 10.1073/pnas.1517952112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1073%2Fpnas.1517952112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=26464510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1CntrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=E5805-E5814&author=Z.+Eyalauthor=D.+Matzovauthor=M.+Krupkinauthor=I.+Wekselmanauthor=S.+Pauknerauthor=E.+Zimmermanauthor=H.+Rozenbergauthor=A.+Bashanauthor=A.+Yonath&title=Structural+Insights+into+Species-specific+Features+of+the+Ribosome+from+the+Pathogen+Staphylococcus+Aureus&doi=10.1073%2Fpnas.1517952112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into species-specific features of the ribosome from the pathogen Staphylococcus aureus</span></div><div class="casAuthors">Eyal, Zohar; Matzov, Donna; Krupkin, Miri; Wekselman, Itai; Paukner, Susanne; Zimmerman, Ella; Rozenberg, Haim; Bashan, Anat; Yonath, Ada</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">E5805-E5814</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The emergence of bacterial multidrug resistance to antibiotics threatens to cause regression to the preantibiotic era.  Here, the authors present the crystal structure of the large ribosomal subunit from Staphylococcus aureus, a versatile Gram-pos. aggressive pathogen, and its complexes with the known antibiotics linezolid and telithromycin, as well as with a new, highly potent pleuromutilin deriv., BC-3205.  These crystal structures shed light on specific structural motifs of the S. aureus ribosome and the binding modes of the aforementioned antibiotics.  Moreover, by analyzing the ribosome structure and comparing it with those of nonpathogenic bacterial models, we identified some unique internal and peripheral structural motifs that may be potential candidates for improving known antibiotics and for use in the design of selective antibiotic drugs against S. aureus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5OmCRBYsxp7Vg90H21EOLACvtfcHk0li0Shtj_xLh5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1CntrrM&md5=f79d8db740a04ec15e7127aad824a499</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1517952112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1517952112%26sid%3Dliteratum%253Aachs%26aulast%3DEyal%26aufirst%3DZ.%26aulast%3DMatzov%26aufirst%3DD.%26aulast%3DKrupkin%26aufirst%3DM.%26aulast%3DWekselman%26aufirst%3DI.%26aulast%3DPaukner%26aufirst%3DS.%26aulast%3DZimmerman%26aufirst%3DE.%26aulast%3DRozenberg%26aufirst%3DH.%26aulast%3DBashan%26aufirst%3DA.%26aulast%3DYonath%26aufirst%3DA.%26atitle%3DStructural%2520Insights%2520into%2520Species-specific%2520Features%2520of%2520the%2520Ribosome%2520from%2520the%2520Pathogen%2520Staphylococcus%2520Aureus%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2015%26volume%3D112%26spage%3DE5805%26epage%3DE5814%26doi%3D10.1073%2Fpnas.1517952112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dreier, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Søndergaard, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasmussen, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">List, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kongsted, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vester, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, P.</span></span> <span> </span><span class="NLM_article-title">A Click Chemistry Approach to Pleuromutilin Derivatives, Part 2: Conjugates with Acyclic Nucleosides and their Ribosomal Binding and Antibacterial Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">2067</span>– <span class="NLM_lpage">2077</span>, <span class="refDoi"> DOI: 10.1021/jm201266b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201266b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Ohtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2067-2077&author=I.+Dreierauthor=S.+Kumarauthor=H.+S%C3%B8ndergaardauthor=M.+L.+Rasmussenauthor=L.+H.+Hansenauthor=N.+H.+Listauthor=J.+Kongstedauthor=B.+Vesterauthor=P.+Nielsen&title=A+Click+Chemistry+Approach+to+Pleuromutilin+Derivatives%2C+Part+2%3A+Conjugates+with+Acyclic+Nucleosides+and+their+Ribosomal+Binding+and+Antibacterial+Activity&doi=10.1021%2Fjm201266b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A Click Chemistry Approach to Pleuromutilin Derivatives, Part 2: Conjugates with Acyclic Nucleosides and Their Ribosomal Binding and Antibacterial Activity</span></div><div class="casAuthors">Dreier, Ida; Kumar, Surender; Soendergaard, Helle; Rasmussen, Maria Louise; Hansen, Lykke Haastrup; List, Nanna Holmgaard; Kongsted, Jacob; Vester, Birte; Nielsen, Poul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2067-2077</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pleuromutilin is an antibiotic that binds to bacterial ribosomes and thereby inhibit protein synthesis.  A new series of semisynthetic pleuromutilin derivs. were synthesized by a click chem. strategy.  Pleuromutilin was conjugated by different linkers to a nucleobase, nucleoside, or Ph group, as a side-chain extension at the C22 position of pleuromutilin.  The linkers were designed on the basis of the best linker from our first series of pleuromutilin derivs. following either conformational restriction or an isosteric methylene to oxygen exchange.  The binding of the new compds. to the Escherichia coli ribosome was investigated by mol. modeling and chem. footprinting of nucleotide U2506, and it was found that all the derivs. bind to the specific site and most of them better than pleuromutilin itself.  The effect of the side-chain extension was also explored by chem. footprinting of nucleotide U2585, and the results showed that all the compds. interact with this position to varying degrees.  Derivs. with a conformational restriction of the linker generally had a higher affinity than derivs. with an isosteric exchange of one of the carbons in the linker with a hydrophilic oxygen.  A growth inhibition assay with three different bacterial strains showed significant activity of several of the new compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0isS_bIe9x7Vg90H21EOLACvtfcHk0lgbjRcVUq02SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Ohtbs%253D&md5=ab32757d2e0c662ba7b3a5a034effa5f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm201266b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201266b%26sid%3Dliteratum%253Aachs%26aulast%3DDreier%26aufirst%3DI.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DS%25C3%25B8ndergaard%26aufirst%3DH.%26aulast%3DRasmussen%26aufirst%3DM.%2BL.%26aulast%3DHansen%26aufirst%3DL.%2BH.%26aulast%3DList%26aufirst%3DN.%2BH.%26aulast%3DKongsted%26aufirst%3DJ.%26aulast%3DVester%26aufirst%3DB.%26aulast%3DNielsen%26aufirst%3DP.%26atitle%3DA%2520Click%2520Chemistry%2520Approach%2520to%2520Pleuromutilin%2520Derivatives%252C%2520Part%25202%253A%2520Conjugates%2520with%2520Acyclic%2520Nucleosides%2520and%2520their%2520Ribosomal%2520Binding%2520and%2520Antibacterial%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2067%26epage%3D2077%26doi%3D10.1021%2Fjm201266b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madden, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choudhry, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gontarek, R. R.</span></span> <span> </span><span class="NLM_article-title">Biochemical Characterization of the Interactions of the Novel Pleuromutilin Derivative Retapamulin with Bacterial Ribosomes</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3875</span>– <span class="NLM_lpage">3881</span>, <span class="refDoi"> DOI: 10.1128/aac.00184-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1128%2FAAC.00184-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=16940066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOkt7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=3875-3881&author=K.+Yanauthor=L.+Maddenauthor=A.+E.+Choudhryauthor=C.+S.+Voigtauthor=R.+A.+Copelandauthor=R.+R.+Gontarek&title=Biochemical+Characterization+of+the+Interactions+of+the+Novel+Pleuromutilin+Derivative+Retapamulin+with+Bacterial+Ribosomes&doi=10.1128%2Faac.00184-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical characterization of the interactions of the novel pleuromutilin derivative retapamulin with bacterial ribosomes</span></div><div class="casAuthors">Yan, Kang; Madden, Lenore; Choudhry, Anthony E.; Voigt, Christine S.; Copeland, Robert A.; Gontarek, Richard R.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3875-3881</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Retapamulin is a semisynthetic pleuromutilin deriv. being developed as a topical antibiotic for treating bacterial infections of the skin.  It is potent in vitro against susceptible and multidrug-resistant organisms commonly assocd. with bacterial skin infections.  The authors report detailed mode of action studies demonstrating that retapamulin binds to the bacterial ribosome with high affinity, inhibits ribosomal peptidyl transferase activity, and partially inhibits the binding of the initiator tRNA substrate to the ribosomal P-site.  Taken together, these data distinguish the mode of action of retapamulin from that of other classes of antibiotics.  This unique mode of action may explain the lack of clin. relevant, target-specific cross-resistance of retapamulin with antibacterials in current use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXbpd6E__e-rVg90H21EOLACvtfcHk0lhkAT8n45R0iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOkt7bE&md5=59aa9270f04fa0844ac7cc8cc819a849</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1128%2FAAC.00184-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00184-06%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DK.%26aulast%3DMadden%26aufirst%3DL.%26aulast%3DChoudhry%26aufirst%3DA.%2BE.%26aulast%3DVoigt%26aufirst%3DC.%2BS.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DGontarek%26aufirst%3DR.%2BR.%26atitle%3DBiochemical%2520Characterization%2520of%2520the%2520Interactions%2520of%2520the%2520Novel%2520Pleuromutilin%2520Derivative%2520Retapamulin%2520with%2520Bacterial%2520Ribosomes%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D3875%26epage%3D3881%26doi%3D10.1128%2Faac.00184-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Long, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poehlsgaard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobbie, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Böttger, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vester, B.</span></span> <span> </span><span class="NLM_article-title">Single 23S rRNA mutations at the ribosomal peptidyl transferase centre confer resistance to valnemulin and other antibiotics inMycobacterium smegmatisby perturbation of the drug binding pocket</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1218</span>– <span class="NLM_lpage">1227</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.2009.06596.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1111%2Fj.1365-2958.2009.06596.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=19154331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjslSlt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2009&pages=1218-1227&author=K.+S.+Longauthor=J.+Poehlsgaardauthor=L.+H.+Hansenauthor=S.+N.+Hobbieauthor=E.+C.+B%C3%B6ttgerauthor=B.+Vester&title=Single+23S+rRNA+mutations+at+the+ribosomal+peptidyl+transferase+centre+confer+resistance+to+valnemulin+and+other+antibiotics+inMycobacterium+smegmatisby+perturbation+of+the+drug+binding+pocket&doi=10.1111%2Fj.1365-2958.2009.06596.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Single 23S rRNA mutations at the ribosomal peptidyl transferase centre confer resistance to valnemulin and other antibiotics in Mycobacterium smegmatis by perturbation of the drug binding pocket</span></div><div class="casAuthors">Long, Katherine S.; Poehlsgaard, Jacob; Hansen, Lykke H.; Hobbie, Sven N.; Bottger, Erik C.; Vester, Birte</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1218-1227</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Tiamulin and valnemulin target the peptidyl transferase center (PTC) on the bacterial ribosome.  They are used in veterinary medicine to treat infections caused by a variety of bacterial pathogens, including the intestinal spirochetes Brachyspira spp.  Mutations in ribosomal protein L3 and 23S rRNA have previously been assocd. with tiamulin resistance in Brachyspira spp. isolates, but as multiple mutations were isolated together, the roles of the individual mutations are unclear.  In this work, individual 23S rRNA mutations assocd. with pleuromutilin resistance at positions 2055, 2447, 2504 and 2572 (Escherichia coli numbering) are introduced into a Mycobacterium smegmatis strain with a single rRNA operon.  The single mutations each confer a significant and similar degree of valnemulin resistance and those at 2447 and 2504 also confer cross-resistance to other antibiotics that bind to the PTC in M. smegmatis.  Antibiotic footprinting expts. on mutant ribosomes show that the introduced mutations cause structural perturbations at the PTC and reduced binding of pleuromutilin antibiotics.  This work underscores the fact that mutations at nucleotides distant from the pleuromutilin binding site can confer the same level of valnemulin resistance as those at nucleotides abutting the bound drug, and suggests that the former function indirectly by altering local structure and flexibility at the drug binding pocket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjJappF9TBlrVg90H21EOLACvtfcHk0lhkAT8n45R0iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjslSlt7g%253D&md5=2c6ee80f703c3514d3d0696bc82f26ed</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2009.06596.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2009.06596.x%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DK.%2BS.%26aulast%3DPoehlsgaard%26aufirst%3DJ.%26aulast%3DHansen%26aufirst%3DL.%2BH.%26aulast%3DHobbie%26aufirst%3DS.%2BN.%26aulast%3DB%25C3%25B6ttger%26aufirst%3DE.%2BC.%26aulast%3DVester%26aufirst%3DB.%26atitle%3DSingle%252023S%2520rRNA%2520mutations%2520at%2520the%2520ribosomal%2520peptidyl%2520transferase%2520centre%2520confer%2520resistance%2520to%2520valnemulin%2520and%2520other%2520antibiotics%2520inMycobacterium%2520smegmatisby%2520perturbation%2520of%2520the%2520drug%2520binding%2520pocket%26jtitle%3DMol.%2520Microbiol.%26date%3D2009%26volume%3D71%26spage%3D1218%26epage%3D1227%26doi%3D10.1111%2Fj.1365-2958.2009.06596.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hodgin, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogenauer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgin, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Högenauer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoegenauer, G.</span></span> <span> </span><span class="NLM_article-title">The Mode of Action of Pleuromutilin Derivatives. Effect on Cell-Free Polypeptide Synthesis</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1974</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">527</span>– <span class="NLM_lpage">533</span>, <span class="refDoi"> DOI: 10.1111/j.1432-1033.1974.tb03721.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1111%2Fj.1432-1033.1974.tb03721.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=4611767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADyaE2MXjvFShuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1974&pages=527-533&author=L.+A.+Hodginauthor=G.+Hogenauerauthor=L.+A.+Hodginauthor=G.+H%C3%B6genauerauthor=G.+Hoegenauer&title=The+Mode+of+Action+of+Pleuromutilin+Derivatives.+Effect+on+Cell-Free+Polypeptide+Synthesis&doi=10.1111%2Fj.1432-1033.1974.tb03721.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Mode of action of pleuromutilin derivatives.  Effect on cell-free polypeptide synthesis</span></div><div class="casAuthors">Hodgin, Louise A.; Hoegenauer, Gregor</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">527-33</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">The pleuromutilin (I) deriv. 14-deoxy-14-[[(2-diethylaminoethyl)thio]acetoxy]mutilin-HCl (I) [42301-75-7] interfered strongly with cell-free poly(U)-directed polyphenylalanine [25191-15-5] synthesis in an ext. from Escherichia coli.  II was unable to inhibit the assembly of initiation complexes and did not significantly influence Phe-tRNA attachment to the ribosomal A-site catalyzed by elongation factor T.  It reduced the puromycin release of formylmethionine from initiator tRNA bound to the P-site, however, indicating that either the peptidyl transferase was affected or the binding of puromycin was abolished.  The influence of II on protein synthesis by E. coli polysomes was less pronounced than the inhibition of polyphenylalanine synthesis.  The opposite effect was reported for chloramphenicol.  The formation of formylmethionylalanine [15183-28-5] coded for by R-17 phage RNA was also impeded by II.  The binding of Ala-tRNA to the A-site was affected in this reaction.  II apparently requires an occupied P-site in order to prevent binding of aminoacyl-tRNA to the A-site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfmH7vEbxNGrVg90H21EOLACvtfcHk0lhkAT8n45R0iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXjvFShuw%253D%253D&md5=a5dea25b9abef36caccc3f8c07e372bd</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1974.tb03721.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1974.tb03721.x%26sid%3Dliteratum%253Aachs%26aulast%3DHodgin%26aufirst%3DL.%2BA.%26aulast%3DHogenauer%26aufirst%3DG.%26aulast%3DHodgin%26aufirst%3DL.%2BA.%26aulast%3DH%25C3%25B6genauer%26aufirst%3DG.%26aulast%3DHoegenauer%26aufirst%3DG.%26atitle%3DThe%2520Mode%2520of%2520Action%2520of%2520Pleuromutilin%2520Derivatives.%2520Effect%2520on%2520Cell-Free%2520Polypeptide%2520Synthesis%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1974%26volume%3D47%26spage%3D527%26epage%3D533%26doi%3D10.1111%2Fj.1432-1033.1974.tb03721.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Högenauer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruf, C.</span></span> <span> </span><span class="NLM_article-title">Ribosomal Binding Region for the Antibiotic Tiamulin: Stoichiometry, Subunit Location, and Affinity for Various Analogs</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">260</span>– <span class="NLM_lpage">265</span>, <span class="refDoi"> DOI: 10.1128/aac.19.2.260</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1128%2FAAC.19.2.260" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=6751216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A280%3ADyaL3s%252FitFWlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1981&pages=260-265&author=G.+H%C3%B6genauerauthor=C.+Ruf&title=Ribosomal+Binding+Region+for+the+Antibiotic+Tiamulin%3A+Stoichiometry%2C+Subunit+Location%2C+and+Affinity+for+Various+Analogs&doi=10.1128%2Faac.19.2.260"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Ribosomal binding region for the antibiotic tiamulin: stoichiometry, subunit location, and affinity for various analogs</span></div><div class="casAuthors">Hogenauer G; Ruf C</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial agents and chemotherapy</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">260-5</span>
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    </div><div class="casAbstract">Equilibrium dialysis experiments with a highly purified preparation of labeled tiamulin, a semisynthetic derivative of the antibiotic pleuromutilin, and Escherichia coli ribosomes allowed the determination of two binding sites for the drug.  The binding reaction showed a cooperative effect.  Of the two subunits, the 50S particle was able to bind the antibiotic in a 1:1 stoichiometry.  Hence, the 50S subunit contributed predominantly to the binding energy which held the antibiotic to the ribosomes.  The 30S subunit, showing no strong affinity for the drug, may be needed for the generation of the second binding site in the 70S particle.  If depleted of ammonium ions, 70S ribosomes lost their binding capacity for the antibiotic.  The attachment sites for tiamulin could be restored by heating the ribosomes to 40 degrees C in the presence of either ammonium ions or the antibiotic.  Other pleuromutilin derivatives displaced labeled tiamulin from its ribosomal binding sites.  By quantifying this competition, the relative affinity of various pleuromutilin derivatives for E. coli ribosomes was determined.  The binding correlated with the minimal inhibitory concentrations of these compounds against E. coli.  When compared with the minimal inhibitory concentrations of these compounds against E. coli.  When compared with the minimal inhibitory concentrations against E. coli.  When compared with the minimal inhibitory concentrations against Staphylococcus aureus, the correlation was less strict, but the same trend prevailed.  These results suggest that the antibacterial activities of various pleuromutilin derivatives on a given test organism are mainly determined by the strength of binding to the ribosomes within the bacterial cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSXcTTs-omSE0odMGTatQ7LfW6udTcc2ea4nb_PfWn-tLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3s%252FitFWlug%253D%253D&md5=ac4edcdca65db5c9ed3e5fce09287046</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1128%2FAAC.19.2.260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.19.2.260%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25B6genauer%26aufirst%3DG.%26aulast%3DRuf%26aufirst%3DC.%26atitle%3DRibosomal%2520Binding%2520Region%2520for%2520the%2520Antibiotic%2520Tiamulin%253A%2520Stoichiometry%252C%2520Subunit%2520Location%252C%2520and%2520Affinity%2520for%2520Various%2520Analogs%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1981%26volume%3D19%26spage%3D260%26epage%3D265%26doi%3D10.1128%2Faac.19.2.260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dornhelm, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Högenauer, G.</span></span> <span> </span><span class="NLM_article-title">The Effects of Tiamulin, a Semisynthetic Pleuromutilin Derivative, on Bacterial Polypeptide Chain Initiation</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">465</span>– <span class="NLM_lpage">473</span>, <span class="refDoi"> DOI: 10.1111/j.1432-1033.1978.tb12699.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1111%2Fj.1432-1033.1978.tb12699.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=365525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADyaE1MXms1Grtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1978&pages=465-473&author=P.+Dornhelmauthor=G.+H%C3%B6genauer&title=The+Effects+of+Tiamulin%2C+a+Semisynthetic+Pleuromutilin+Derivative%2C+on+Bacterial+Polypeptide+Chain+Initiation&doi=10.1111%2Fj.1432-1033.1978.tb12699.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of tiamulin, a semisynthetic pleuromutilin derivative, on bacterial polypeptide chain initiation</span></div><div class="casAuthors">Dornhelm, Peter; Hoegenauer, Gregor</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">465-73</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">Tiamulin (I)  [55297-95-5], a water-sol. and highly effective semisynthetic deriv. of pleuromutilin led to the formation of physiolog. inactive polypeptide chain initiation complexes which readily decompd. and did not enter the phase of peptide chain elongation.  Once elongation began it continued even in the presence of I as was shown by measuring the formation of N-acetylphenylalanine-poly(phenylalanine).  The formation of abortive initiation complexes was obsd. regardless of whether AcPhe-tRNA of fMet-tRNA was used as an initiator or whether artificial messengers or a natural messenger, like R17 bacteriophage RNA, was used.  When this drug was acting on whole cells, it led to the disappearance of polysomes.  The only structures which could be detected were of the monosome size.  Therefore, polysomes seem to elongate the polypeptide chains in whole cells in the presence of this antibiotic, but since effective reinitiation is blocked, the polysome pool of the cell soon becomes depleted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_mj68-cgi2rVg90H21EOLACvtfcHk0lhyeR78pH9KaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXms1Grtw%253D%253D&md5=82b5285c1ffcb795194b8155ee6de2ae</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1978.tb12699.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1978.tb12699.x%26sid%3Dliteratum%253Aachs%26aulast%3DDornhelm%26aufirst%3DP.%26aulast%3DH%25C3%25B6genauer%26aufirst%3DG.%26atitle%3DThe%2520Effects%2520of%2520Tiamulin%252C%2520a%2520Semisynthetic%2520Pleuromutilin%2520Derivative%252C%2520on%2520Bacterial%2520Polypeptide%2520Chain%2520Initiation%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1978%26volume%3D91%26spage%3D465%26epage%3D473%26doi%3D10.1111%2Fj.1432-1033.1978.tb12699.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span> </span><span class="NLM_article-title">Discontinuation of Altargo 10 mg/g ointment
(Retapamulin)</span>. <a href="https://gskpro.com/en-mt/updates/2018/july/discontinuation_of_altargo/" class="extLink">https://gskpro.com/en-mt/updates/2018/july/discontinuation_of_altargo/</a> (accessed March 30, 2020).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Discontinuation+of+Altargo+10+mg%2Fg+ointment%0A%28Retapamulin%29.+https%3A%2F%2Fgskpro.com%2Fen-mt%2Fupdates%2F2018%2Fjuly%2Fdiscontinuation_of_altargo%2F+%28accessed+March+30%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DDiscontinuation%2520of%2520Altargo%252010%2520mg%252Fg%2520ointment%250A%2528Retapamulin%2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biedenbach, D. J.</span>; <span class="NLM_string-name">Jones, R. N.</span>; <span class="NLM_string-name">Ivezic-Schoenfeld, Z.</span>; <span class="NLM_string-name">Paukner, S.</span>; <span class="NLM_string-name">Novak, R.</span></span>. <span> </span><span class="NLM_article-title">In Vitro Antibacterial Spectrum of BC-7013, a Novel Pleuromutilin Derivative for Topical Use in Humans</span>.  <i>In 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)</i>: <span class="NLM_publisher-loc">San Francisco, CA</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=D.+J.+Biedenbach&author=R.+N.+Jones&author=Z.+Ivezic-Schoenfeld&author=S.+Paukner&author=R.+Novak&title=In+Vitro+Antibacterial+Spectrum+of+BC-7013%2C+a+Novel+Pleuromutilin+Derivative+for+Topical+Use+in+Humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DBiedenbach%26aufirst%3DD.%2BJ.%26atitle%3DIn%2520Vitro%2520Antibacterial%2520Spectrum%2520of%2520BC-7013%252C%2520a%2520Novel%2520Pleuromutilin%2520Derivative%2520for%2520Topical%2520Use%2520in%2520Humans%26jtitle%3DIn%252049th%2520Interscience%2520Conference%2520on%2520Antimicrobial%2520Agents%2520and%2520Chemotherapy%2520%2528ICAAC%2529%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thirring, K.</span>; <span class="NLM_string-name">Ascher, G.</span>; <span class="NLM_string-name">Paukner, S.</span>; <span class="NLM_string-name">Heilmayer, W.</span>; <span class="NLM_string-name">Novak, R.</span></span>. <span> </span><span class="NLM_article-title">Mutilin Derivatives and their use as Pharmaceutical</span>. <span class="NLM_patent">WO 2007079515 A1</span>, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=K.+Thirring&author=G.+Ascher&author=S.+Paukner&author=W.+Heilmayer&author=R.+Novak&title=Mutilin+Derivatives+and+their+use+as+Pharmaceutical"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DThirring%26aufirst%3DK.%26atitle%3DMutilin%2520Derivatives%2520and%2520their%2520use%2520as%2520Pharmaceutical%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thirring, K.</span>; <span class="NLM_string-name">Heilmayer, W.</span></span>. <span> </span><span class="NLM_article-title">Pleuromutilin Derivatives and their use as Antimicrobials</span>. <span class="NLM_patent">WO 2009009812 A1</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=K.+Thirring&author=W.+Heilmayer&title=Pleuromutilin+Derivatives+and+their+use+as+Antimicrobials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DThirring%26aufirst%3DK.%26atitle%3DPleuromutilin%2520Derivatives%2520and%2520their%2520use%2520as%2520Antimicrobials%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thirring, K.</span>; <span class="NLM_string-name">Heilmayer, W.</span></span>. <span> </span><span class="NLM_article-title">Pleuromutilin Derivatives</span>. <span class="NLM_patent">EP 2176211 B1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=K.+Thirring&author=W.+Heilmayer&title=Pleuromutilin+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DThirring%26aufirst%3DK.%26atitle%3DPleuromutilin%2520Derivatives%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diep, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carleton, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mongodin, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sensabaugh, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perdreau-Remington, F.</span></span> <span> </span><span class="NLM_article-title">Complete Genome Sequence of USA300, an Epidemic Clone of Community-acquired Meticillin-Resistant Staphylococcus Aureus</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>367</i></span>,  <span class="NLM_fpage">731</span>– <span class="NLM_lpage">739</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(06)68231-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1016%2Fs0140-6736%2806%2968231-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=16517273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVejsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2006&pages=731-739&author=B.+A.+Diepauthor=S.+R.+Gillauthor=R.+F.+Changauthor=T.+H.+Phanauthor=J.+H.+Chenauthor=M.+G.+Davidsonauthor=F.+Linauthor=J.+Linauthor=H.+A.+Carletonauthor=E.+F.+Mongodinauthor=G.+F.+Sensabaughauthor=F.+Perdreau-Remington&title=Complete+Genome+Sequence+of+USA300%2C+an+Epidemic+Clone+of+Community-acquired+Meticillin-Resistant+Staphylococcus+Aureus&doi=10.1016%2Fs0140-6736%2806%2968231-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus</span></div><div class="casAuthors">Diep, Binh An; Gill, Steven R.; Chang, Richard F.; Phan, Tiffany HaiVan; Chen, Jason H.; Davidson, Matthew G.; Lin, Felice; Lin, Jessica; Carleton, Heather A.; Mongodin, Emmanuel F.; Sensabaugh, George F.; Perdreau-Remington, Francoise</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">9512</span>),
    <span class="NLM_cas:pages">731-739</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">USA300, a clone of meticillin-resistant Staphylococcus aureus, is a major source of community-acquired infections in the USA, Canada, and Europe.  The aim was to sequence its genome and compare it with those of other strains of S. aureus to try to identify genes responsible for its distinctive epidemiol. and virulence properties.  The genome sequence of FPR3757, a multidrug resistant USA300 strain, was ascertained by random shotgun sequencing, then compared with the sequences of 10 other staphylococcal strains.  Compared with closely related S. aureus, almost all of the unique genes in USA300 are clustered in novel allotypes of mobile genetic elements.  Some of the unique genes are involved in pathogenesis, including Panton-Valentine leucocidin and mol. variants of enterotoxin Q and K. The most striking feature of the USA300 genome is the horizontal acquisition of a novel mobile genetic element that encodes an arginine deiminase pathway and an oligopeptide permease system that could contribute to growth and survival of USA300.  This element, termed arginine catabolic mobile element (ACME), was not detected in other S. aureus strains.  A high prevalence of ACME was noted in S. epidermidis, suggesting not only that ACME transfers into USA300 from S. epidermidis, but also that this element confers a selective advantage to this ubiquitous commensal of the human skin.  USA300 has acquired mobile genetic elements that encode resistance and virulence determinants that could enhance fitness and pathogenicity.  The genome and e plasmid sequences are deposited in GenBank/EMBL/DDBJ under accession nos. CP000255-CP000258.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojfR14TSWS7bVg90H21EOLACvtfcHk0lhkbEmdzbCaMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVejsr4%253D&md5=61ce2595af508a0253ff48c1908df09d</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fs0140-6736%2806%2968231-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0140-6736%252806%252968231-7%26sid%3Dliteratum%253Aachs%26aulast%3DDiep%26aufirst%3DB.%2BA.%26aulast%3DGill%26aufirst%3DS.%2BR.%26aulast%3DChang%26aufirst%3DR.%2BF.%26aulast%3DPhan%26aufirst%3DT.%2BH.%26aulast%3DChen%26aufirst%3DJ.%2BH.%26aulast%3DDavidson%26aufirst%3DM.%2BG.%26aulast%3DLin%26aufirst%3DF.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DCarleton%26aufirst%3DH.%2BA.%26aulast%3DMongodin%26aufirst%3DE.%2BF.%26aulast%3DSensabaugh%26aufirst%3DG.%2BF.%26aulast%3DPerdreau-Remington%26aufirst%3DF.%26atitle%3DComplete%2520Genome%2520Sequence%2520of%2520USA300%252C%2520an%2520Epidemic%2520Clone%2520of%2520Community-acquired%2520Meticillin-Resistant%2520Staphylococcus%2520Aureus%26jtitle%3DLancet%26date%3D2006%26volume%3D367%26spage%3D731%26epage%3D739%26doi%3D10.1016%2Fs0140-6736%2806%2968231-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McDougal, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fosheim, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulens, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limbago, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearer, J. E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summers, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, J. B.</span></span> <span> </span><span class="NLM_article-title">Emergence of Resistance Among USA300 Methicillin-Resistant Staphylococcus Aureus Isolates Causing Invasive Disease in the United States</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">3804</span>– <span class="NLM_lpage">3811</span>, <span class="refDoi"> DOI: 10.1128/aac.00351-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1128%2FAAC.00351-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=20585117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht12ktLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=3804-3811&author=L.+K.+McDougalauthor=G.+E.+Fosheimauthor=A.+Nicholsonauthor=S.+N.+Bulensauthor=B.+M.+Limbagoauthor=J.+E.+S.+Shearerauthor=A.+O.+Summersauthor=J.+B.+Patel&title=Emergence+of+Resistance+Among+USA300+Methicillin-Resistant+Staphylococcus+Aureus+Isolates+Causing+Invasive+Disease+in+the+United+States&doi=10.1128%2Faac.00351-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Emergence of resistance among USA300 methicillin-resistant Staphylococcus aureus isolates causing invasive disease in the United States</span></div><div class="casAuthors">McDougal, Linda K.; Fosheim, Gregory E.; Nicholson, Anisley; Bulens, Sandra N.; Limbago, Brandi M.; Shearer, Julia E. S.; Summers, Anne O.; Patel, Jean B.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3804-3811</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">USA300 methicillin-resistant Staphylococcus aureus (MRSA) isolates are usually resistant only to oxacillin, erythromycin, and, increasingly, levofloxacin.  Of these, oxacillin and levofloxacin resistances are chromosomally encoded.  Plasmid-mediated clindamycin, mupirocin, and/or tetracycline resistance has been obsd. among USA300 isolates, but these descriptions were limited to specific patient populations or isolated occurrences.  The authors examd. the antimicrobial susceptibilities of invasive MRSA isolates from a national surveillance population to identify USA300 isolates with unusual, possibly emerging, plasmid-mediated antimicrobial resistance.  DNA from these isolates was assayed for the presence of resistance determinants and the presence of a pSK41-like conjugative plasmid.  Of 823 USA300 isolates, 72 (9%) were tetracycline resistant; 69 of these were doxycycline susceptible and tetK pos., and 3 were doxycycline resistant and tetM pos.  Fifty-one (6.2%) isolates were clindamycin resistant and ermC pos.; 22 (2.7%) isolates were high-level mupirocin resistant (mupA pos.); 5 (0.6%) isolates were trimethoprim-sulfamethoxazole (TMP-SMZ) resistant, of which 4 were dfrA pos.; and 7 (0.9%) isolates were gentamicin resistant and aac6'-aph2'' pos.  Isolates with pSK41-like plasmids (n = 24) were pos. for mupA (n = 19), dfrA (n = 6), aac6'-aph2'' (n = 6), tetM (n = 2), and ermC (n = 8); 20 pSK41-pos. isolates were pos. for two or more resistance genes.  Conjugative transfer of resistance was demonstrated between four gentamicin- and mupirocin-resistant and three gentamicin- and TMP-SMZ-resistant USA300 isolates; transconjugants harbored a single pSK41-like plasmid, which was PCR pos. for aac6'-aph2'' and either mupA and/or dfrA.  USA300 and USA100 isolates from the same state with identical resistance profiles contained pSK41-like plasmids with indistinguishable restriction and Southern blot profiles, suggesting horizontal plasmid transfer between USA100 and USA300 isolates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol7LRee8we8bVg90H21EOLACvtfcHk0lg_Pny0xLz0tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht12ktLzN&md5=41b38673ecc1425f8ba20c5579a2f89a</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1128%2FAAC.00351-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00351-10%26sid%3Dliteratum%253Aachs%26aulast%3DMcDougal%26aufirst%3DL.%2BK.%26aulast%3DFosheim%26aufirst%3DG.%2BE.%26aulast%3DNicholson%26aufirst%3DA.%26aulast%3DBulens%26aufirst%3DS.%2BN.%26aulast%3DLimbago%26aufirst%3DB.%2BM.%26aulast%3DShearer%26aufirst%3DJ.%2BE.%2BS.%26aulast%3DSummers%26aufirst%3DA.%2BO.%26aulast%3DPatel%26aufirst%3DJ.%2BB.%26atitle%3DEmergence%2520of%2520Resistance%2520Among%2520USA300%2520Methicillin-Resistant%2520Staphylococcus%2520Aureus%2520Isolates%2520Causing%2520Invasive%2520Disease%2520in%2520the%2520United%2520States%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D3804%26epage%3D3811%26doi%3D10.1128%2Faac.00351-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takadama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakaminami, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoshi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, N.</span></span> <span> </span><span class="NLM_article-title">Dissemination of Panton-Valentine Leukocidin–positive Methicillin-resistant Staphylococcus Aureus USA300 Clone in Multiple Hospitals in Tokyo</span>. <i>Japan. Clin. Microbiol. Infect.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1211.e1</span>– <span class="NLM_lpage">1211.e7</span>, <span class="refDoi"> DOI: 10.1016/j.cmi.2018.02.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1016%2Fj.cmi.2018.02.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=1211.e1-1211.e7&author=S.+Takadamaauthor=H.+Nakaminamiauthor=A.+Satoauthor=M.+Shoshiauthor=T.+Fujiiauthor=N.+Noguchi&title=Dissemination+of+Panton-Valentine+Leukocidin%E2%80%93positive+Methicillin-resistant+Staphylococcus+Aureus+USA300+Clone+in+Multiple+Hospitals+in+Tokyo&doi=10.1016%2Fj.cmi.2018.02.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.cmi.2018.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmi.2018.02.012%26sid%3Dliteratum%253Aachs%26aulast%3DTakadama%26aufirst%3DS.%26aulast%3DNakaminami%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DShoshi%26aufirst%3DM.%26aulast%3DFujii%26aufirst%3DT.%26aulast%3DNoguchi%26aufirst%3DN.%26atitle%3DDissemination%2520of%2520Panton-Valentine%2520Leukocidin%25E2%2580%2593positive%2520Methicillin-resistant%2520Staphylococcus%2520Aureus%2520USA300%2520Clone%2520in%2520Multiple%2520Hospitals%2520in%2520Tokyo%26jtitle%3DJapan.%2520Clin.%2520Microbiol.%2520Infect.%26date%3D2018%26volume%3D24%26spage%3D1211.e1%26epage%3D1211.e7%26doi%3D10.1016%2Fj.cmi.2018.02.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lolk, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pøhlsgaard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jepsen, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffansen, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparving, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vester, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, P.</span></span> <span> </span><span class="NLM_article-title">A Click Chemistry Approach to Pleuromutilin Conjugates with Nucleosides or Acyclic Nucleoside Derivatives and Their Binding to the Bacterial Ribosome</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">4957</span>– <span class="NLM_lpage">4967</span>, <span class="refDoi"> DOI: 10.1021/jm800261u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800261u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptl2hsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4957-4967&author=L.+Lolkauthor=J.+P%C3%B8hlsgaardauthor=A.+S.+Jepsenauthor=L.+H.+Hansenauthor=H.+Nielsenauthor=S.+I.+Steffansenauthor=L.+Sparvingauthor=A.+B.+Nielsenauthor=B.+Vesterauthor=P.+Nielsen&title=A+Click+Chemistry+Approach+to+Pleuromutilin+Conjugates+with+Nucleosides+or+Acyclic+Nucleoside+Derivatives+and+Their+Binding+to+the+Bacterial+Ribosome&doi=10.1021%2Fjm800261u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A Click Chemistry Approach to Pleuromutilin Conjugates with Nucleosides or Acyclic Nucleoside Derivatives and Their Binding to the Bacterial Ribosome</span></div><div class="casAuthors">Lolk, Line; Pohlsgaard, Jacob; Jepsen, Anne Sofie; Hansen, Lykke H.; Nielsen, Henrik; Steffansen, Signe I.; Sparving, Laura; Nielsen, Annette B.; Vester, Birte; Nielsen, Poul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4957-4967</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pleuromutilin and its derivs. are antibacterial drugs that inhibit protein synthesis in bacteria by binding to ribosomes.  To promote rational design of pleuromutilin based drugs, 19 pleuromutilin conjugates with different nucleoside fragments as side chain extensions were synthesized by a click chem. protocol.  Binding was assessed by chem. footprinting of nucleotide U2506 in 23S rRNA, and all conjugates bind to varying degree reflecting their binding affinity to the peptidyl transferase center.  The side chain extensions also show various protections at position U2585.  Docking studies of the conjugates with the highest affinities support the conclusion that despite the various conjugations, the pleuromutilin skeleton binds in the same binding pocket.  The conjugated triazole moiety is well accommodated, and the nucleobases are placed in different pockets in the 50S ribosomal subunit.  The deriv. showing the highest affinity and a significantly better binding than pleuromutilin itself contains an adenine-9-ylpropylene triazole conjugate to pleuromutilin C-22.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVooKVD0xfHrVg90H21EOLACvtfcHk0lg_Pny0xLz0tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptl2hsbY%253D&md5=3ba75a24fa6268f2ae3f9d02440ad92d</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm800261u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800261u%26sid%3Dliteratum%253Aachs%26aulast%3DLolk%26aufirst%3DL.%26aulast%3DP%25C3%25B8hlsgaard%26aufirst%3DJ.%26aulast%3DJepsen%26aufirst%3DA.%2BS.%26aulast%3DHansen%26aufirst%3DL.%2BH.%26aulast%3DNielsen%26aufirst%3DH.%26aulast%3DSteffansen%26aufirst%3DS.%2BI.%26aulast%3DSparving%26aufirst%3DL.%26aulast%3DNielsen%26aufirst%3DA.%2BB.%26aulast%3DVester%26aufirst%3DB.%26aulast%3DNielsen%26aufirst%3DP.%26atitle%3DA%2520Click%2520Chemistry%2520Approach%2520to%2520Pleuromutilin%2520Conjugates%2520with%2520Nucleosides%2520or%2520Acyclic%2520Nucleoside%2520Derivatives%2520and%2520Their%2520Binding%2520to%2520the%2520Bacterial%2520Ribosome%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4957%26epage%3D4967%26doi%3D10.1021%2Fjm800261u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span> <span> </span><span class="NLM_article-title">Mulin Acetate Comprising Substituted Squaric Acid, and Application Thereof</span>. <span class="NLM_patent">CN 103204787 A</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+Chen&title=Mulin+Acetate+Comprising+Substituted+Squaric+Acid%2C+and+Application+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26atitle%3DMulin%2520Acetate%2520Comprising%2520Substituted%2520Squaric%2520Acid%252C%2520and%2520Application%2520Thereof%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Česnek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holý, A. n.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masojídková, M.</span></span> <span> </span><span class="NLM_article-title">6-Guanidinopurine Nucleosides and Their Analogues</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2985</span>– <span class="NLM_lpage">2996</span>, <span class="refDoi"> DOI: 10.1016/s0040-4020(02)00186-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1016%2FS0040-4020%2802%2900186-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Cnu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=2985-2996&author=M.+%C4%8Cesnekauthor=A.+n.+Hol%C3%BDauthor=M.+Masoj%C3%ADdkov%C3%A1&title=6-Guanidinopurine+Nucleosides+and+Their+Analogues&doi=10.1016%2Fs0040-4020%2802%2900186-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">6-Guanidinopurine nucleosides and their analogues</span></div><div class="casAuthors">Cesnek, Michal; Holy, Antonin; Masojidkova, Milena</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2985-2996</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A general synthetic approach to 6-guanidinopurines, their ribonucleosides, 2-deoxyribonucleosides, acyclic nucleoside analogs and acyclic nucleoside phosphonates was developed.  The approach consists of reaction of the 6-chloropurine derivs. with guanidine soln. in DMF under DABCO catalysis.  This method was used to synthesize 6-guanidinopurine and 2-amino-6-guanidinopurine derivs.  Acyclic nucleosides and acyclic nucleoside phosphonates were also obtained by alkylation of the 6-guanidinopurine bases.  None of tested derivs. showed any noticeable cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ-hBRoZqlIrVg90H21EOLACvtfcHk0lgFFioPy06NgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Cnu7w%253D&md5=f77eeb21f1a0f1d5b7127c23b5874963</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2802%2900186-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252802%252900186-2%26sid%3Dliteratum%253Aachs%26aulast%3D%25C4%258Cesnek%26aufirst%3DM.%26aulast%3DHol%25C3%25BD%26aufirst%3DA.%2Bn.%26aulast%3DMasoj%25C3%25ADdkov%25C3%25A1%26aufirst%3DM.%26atitle%3D6-Guanidinopurine%2520Nucleosides%2520and%2520Their%2520Analogues%26jtitle%3DTetrahedron%26date%3D2002%26volume%3D58%26spage%3D2985%26epage%3D2996%26doi%3D10.1016%2Fs0040-4020%2802%2900186-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saá, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varela-Fernández, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varela, J.</span></span> <span> </span><span class="NLM_article-title">Formation of Indoles, Dihydroisoquinolines, and Dihydroquinolines by Ruthenium-Catalyzed Heterocyclizations</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">3285</span>– <span class="NLM_lpage">3295</span>, <span class="refDoi"> DOI: 10.1055/s-0032-1316539</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1055%2Fs-0032-1316539" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt12nsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2012&pages=3285-3295&author=C.+Sa%C3%A1author=A.+Varela-Fern%C3%A1ndezauthor=J.+Varela&title=Formation+of+Indoles%2C+Dihydroisoquinolines%2C+and+Dihydroquinolines+by+Ruthenium-Catalyzed+Heterocyclizations&doi=10.1055%2Fs-0032-1316539"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Formation of indoles, dihydroisoquinolines, and dihydroquinolines by ruthenium-catalyzed heterocyclizations</span></div><div class="casAuthors">Varela-Fernandez, Alejandro; Varela, Jesus A.; Saa, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3285-3295</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Indoles, dihydroisoquinolines, and dihydroquinolines were efficiently prepd. by ruthenium-catalyzed heterocyclizations of arom. homo- and bis-homopropargyl amines/amides in the presence of an amine/ammonium base-acid pair.  E.g., in presence of CpRuCl(PPh3)2, heterocyclization of 2-CH≡CC6H4NH2 gave 84% indole.  These regioselective 5-endo and 6-endo cyclizations most probably occur by nucleophilic trapping of key ruthenium-vinylidene intermediates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojaah-DPYj9LVg90H21EOLACvtfcHk0lgFFioPy06NgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt12nsg%253D%253D&md5=238d8eec5947409940c64543643608d8</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1055%2Fs-0032-1316539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0032-1316539%26sid%3Dliteratum%253Aachs%26aulast%3DSa%25C3%25A1%26aufirst%3DC.%26aulast%3DVarela-Fern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DVarela%26aufirst%3DJ.%26atitle%3DFormation%2520of%2520Indoles%252C%2520Dihydroisoquinolines%252C%2520and%2520Dihydroquinolines%2520by%2520Ruthenium-Catalyzed%2520Heterocyclizations%26jtitle%3DSynthesis%26date%3D2012%26volume%3D44%26spage%3D3285%26epage%3D3295%26doi%3D10.1055%2Fs-0032-1316539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pankey, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabath, L. D.</span></span> <span> </span><span class="NLM_article-title">Clinical Relevance of Bacteriostatic versus Bactericidal Mechanisms of Action in the Treatment of Gram-Positive Bacterial Infections</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">864</span>– <span class="NLM_lpage">870</span>, <span class="refDoi"> DOI: 10.1086/381972</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1086%2F381972" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=14999632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtlCksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2004&pages=864-870&author=G.+A.+Pankeyauthor=L.+D.+Sabath&title=Clinical+Relevance+of+Bacteriostatic+versus+Bactericidal+Mechanisms+of+Action+in+the+Treatment+of+Gram-Positive+Bacterial+Infections&doi=10.1086%2F381972"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of gram-positive bacterial infections</span></div><div class="casAuthors">Pankey, G. A.; Sabath, L. D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">864-870</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">A review.  The distinction between bactericidal and bacteriostatic agents appears to be clear according to the in vitro definition, but this only applies under strict lab. conditions and is inconsistent for a particular agent against all bacteria.  The distinction is more arbitrary when agents are categorized in clin. situations.  The supposed superiority of bactericidal agents over bacteriostatic agents is of little relevance when treating the vast majority of infections with gram-pos. bacteria, particularly in patients with uncomplicated infections and noncompromised immune systems.  Bacteriostatic agents (e.g., chloramphenicol, clindamycin, and linezolid) were effectively used for treatment of endocarditis, meningitis, and osteomyelitis-indications that are often considered to require bactericidal activity.  Although bacteriostatic/bactericidal data may provide valuable information on the potential action of antibacterial agents in vitro, it is necessary to combine this information with pharmacokinetic and pharmacodynamic data to provide more meaningful prediction of efficacy in vivo.  The ultimate guide to treatment of any infection must be clin. outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_xAGW1Cri1rVg90H21EOLACvtfcHk0lg4BvOj97PCqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtlCksrc%253D&md5=4847394218daaf4fa66c1fce9e21f543</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1086%2F381972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F381972%26sid%3Dliteratum%253Aachs%26aulast%3DPankey%26aufirst%3DG.%2BA.%26aulast%3DSabath%26aufirst%3DL.%2BD.%26atitle%3DClinical%2520Relevance%2520of%2520Bacteriostatic%2520versus%2520Bactericidal%2520Mechanisms%2520of%2520Action%2520in%2520the%2520Treatment%2520of%2520Gram-Positive%2520Bacterial%2520Infections%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2004%26volume%3D38%26spage%3D864%26epage%3D870%26doi%3D10.1086%2F381972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siricilla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitachi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eslamimehr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemieux, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meibohm, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurosu, M.</span></span> <span> </span><span class="NLM_article-title">A New Combination of a Pleuromutilin Derivative and Doxycycline for Treatment of Multidrug-ResistantAcinetobacter baumannii</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2869</span>– <span class="NLM_lpage">2878</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01805</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01805" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkt1OiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2869-2878&author=S.+Siricillaauthor=K.+Mitachiauthor=J.+Yangauthor=S.+Eslamimehrauthor=M.+R.+Lemieuxauthor=B.+Meibohmauthor=Y.+Jiauthor=M.+Kurosu&title=A+New+Combination+of+a+Pleuromutilin+Derivative+and+Doxycycline+for+Treatment+of+Multidrug-ResistantAcinetobacter+baumannii&doi=10.1021%2Facs.jmedchem.6b01805"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A New Combination of a Pleuromutilin Derivative and Doxycycline for Treatment of Multidrug-Resistant Acinetobacter baumannii</span></div><div class="casAuthors">Siricilla, Shajila; Mitachi, Katsuhiko; Yang, Junshu; Eslamimehr, Shakiba; Lemieux, Maddie R.; Meibohm, Bernd; Ji, Yinduo; Kurosu, Michio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2869-2878</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Multidrug-resistant (MDR) Acinetobacter baumannii is one of the most difficult Gram-neg. bacteria to treat and eradicate.  In a cell-based screening of pleuromutilin derivs. against a drug sensitive A. baumannii strain (ATCC 19606), new mols. (2-4) exhibit bacteriostatic activity with 3.13 μg/mL concn. and 1 shows bactericidal activity with an MBC of 6.25 μg/mL.  The pleuromutilin deriv. 1 displays strong synergistic effects with doxycycline in a wide range of concns.  A 35/1 ratio of 1 and doxycycline (1-Dox35/1) kills drug susceptible A. baumannii with the MBC of 2.0 μg/mL and MDR A. baumannii (ATCC BAA-1800) with the MBC range of 3.13-8.0 μg/mL.  In vitro bactericidal activity of 1-Dox35/1 against A. baumannii is superior to that of clin. drugs such as tobramycin, tigecycline, and colistin (polymyxin E).  The efficacy of 1-Dox35/1 is evaluated in a mouse septicemia model; treatment of the infected C57BL/6 mice with 1-Dox35/1 protects from lethal infection of A. baumannii with an ED50 value of <2.0 mg/kg (a single-dose).  The frequency of resistance to 1-Dox35/1 is less than 1x10-10 for A. baumannii (at the 8xMIC concn.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzh89uMW0I9rVg90H21EOLACvtfcHk0lg4BvOj97PCqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkt1OiurY%253D&md5=5ec9df79c19e630e453e6a8d68174421</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01805%26sid%3Dliteratum%253Aachs%26aulast%3DSiricilla%26aufirst%3DS.%26aulast%3DMitachi%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DEslamimehr%26aufirst%3DS.%26aulast%3DLemieux%26aufirst%3DM.%2BR.%26aulast%3DMeibohm%26aufirst%3DB.%26aulast%3DJi%26aufirst%3DY.%26aulast%3DKurosu%26aufirst%3DM.%26atitle%3DA%2520New%2520Combination%2520of%2520a%2520Pleuromutilin%2520Derivative%2520and%2520Doxycycline%2520for%2520Treatment%2520of%2520Multidrug-ResistantAcinetobacter%2520baumannii%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2869%26epage%3D2878%26doi%3D10.1021%2Facs.jmedchem.6b01805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zamaraeva, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabirov, R. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeno, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando-Akatsuka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bessonova, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, Y.</span></span> <span> </span><span class="NLM_article-title">Cells Die with Increased Cytosolic Atp During Apoptosis: A Bioluminescence Study with Intracellular Luciferase</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1390</span>– <span class="NLM_lpage">1397</span>, <span class="refDoi"> DOI: 10.1038/sj.cdd.4401661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1038%2Fsj.cdd.4401661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=15905877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtV2kt7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=1390-1397&author=M.+V.+Zamaraevaauthor=R.+Z.+Sabirovauthor=E.+Maenoauthor=Y.+Ando-Akatsukaauthor=S.+V.+Bessonovaauthor=Y.+Okada&title=Cells+Die+with+Increased+Cytosolic+Atp+During+Apoptosis%3A+A+Bioluminescence+Study+with+Intracellular+Luciferase&doi=10.1038%2Fsj.cdd.4401661"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Cells die with increased cytosolic ATP during apoptosis: a bioluminescence study with intracellular luciferase</span></div><div class="casAuthors">Zamaraeva, M. V.; Sabirov, R. Z.; Maeno, E.; Ando-Akatsuka, Y.; Bessonova, S. V.; Okada, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1390-1397</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Apoptosis is a distinct form of cell death, which requires energy.  Here, we made real-time continuous measurements of the cytosolic ATP level throughout the apoptotic process in intact HeLa, PC12 and U937 cells transfected with the firefly luciferase gene.  Apoptotic stimuli (staurosporine (STS), tumor necrosis factor α (TNFα), etoposide) induced significant elevation of the cytosolic ATP level.  The cytosolic ATP level remained at a higher level than in the control for up to 6 h during which activation of caspase-3 and internucleosomal DNA fragmentation took place.  When the STS-induced ATP response was abolished by glucose deprivation-induced inhibition of glycolysis, both caspase activation and DNA laddering were completely inhibited.  Annexin V-binding induced by STS or TNFα was largely suppressed by glycolysis inhibition.  Thus, it is suggested that the cells die with increased cytosolic ATP, and elevation of cytosolic ATP level is a requisite to the apoptotic cell death process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHa_hTXp-IT7Vg90H21EOLACvtfcHk0lg4BvOj97PCqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtV2kt7zJ&md5=8a9259b700c52bffa561b9255cfb2133</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4401661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4401661%26sid%3Dliteratum%253Aachs%26aulast%3DZamaraeva%26aufirst%3DM.%2BV.%26aulast%3DSabirov%26aufirst%3DR.%2BZ.%26aulast%3DMaeno%26aufirst%3DE.%26aulast%3DAndo-Akatsuka%26aufirst%3DY.%26aulast%3DBessonova%26aufirst%3DS.%2BV.%26aulast%3DOkada%26aufirst%3DY.%26atitle%3DCells%2520Die%2520with%2520Increased%2520Cytosolic%2520Atp%2520During%2520Apoptosis%253A%2520A%2520Bioluminescence%2520Study%2520with%2520Intracellular%2520Luciferase%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2005%26volume%3D12%26spage%3D1390%26epage%3D1397%26doi%3D10.1038%2Fsj.cdd.4401661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antonescu, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlgren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoff, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergström, C. A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhoff, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artursson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffansen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, C. U.</span></span> <span> </span><span class="NLM_article-title">Acamprosate Is a Substrate of the Human Organic Anion Transporter (Oat) 1 without Oat3 Inhibitory Properties: Implications for Renal Acamprosate Secretion and Drug-Drug Interactions</span>. <i>Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">390</span>, <span class="refDoi"> DOI: 10.3390/pharmaceutics12040390</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.3390%2Fpharmaceutics12040390" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitlGgur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=390&author=I.+E.+Antonescuauthor=M.+Karlgrenauthor=M.+L.+Pedersenauthor=I.+Simoffauthor=C.+A.+S.+Bergstr%C3%B6mauthor=S.+Neuhoffauthor=P.+Arturssonauthor=B.+Steffansenauthor=C.+U.+Nielsen&title=Acamprosate+Is+a+Substrate+of+the+Human+Organic+Anion+Transporter+%28Oat%29+1+without+Oat3+Inhibitory+Properties%3A+Implications+for+Renal+Acamprosate+Secretion+and+Drug-Drug+Interactions&doi=10.3390%2Fpharmaceutics12040390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Acamprosate is a substrate of the human organic anion transporter (OAT) 1 without OAT3 inhibitory properties: implications for renal acamprosate secretion and drug-drug interactions</span></div><div class="casAuthors">Antonescu, Irina E.; Karlgren, Maria; Pedersen, Maria L.; Simoff, Ivailo; Bergstrom, Christel A. S.; Neuhoff, Sibylle; Artursson, Per; Steffansen, Bente; Nielsen, Carsten Uhd</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutics</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">390</span>CODEN:
                <span class="NLM_cas:coden">PHARK5</span>;
        ISSN:<span class="NLM_cas:issn">1999-4923</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Acamprosate is an anionic drug substance widely used in treating symptoms of alc. withdrawal.  It was recently shown that oral acamprosate absorption is likely due to paracellular transport.  In contrast, little is known about the eliminating mechanism clearing acamprosate from the blood in the kidneys, despite the fact that studies have shown renal secretion of acamprosate.  The hypothesis of the present study was therefore that renal org. anion transporters (OATs) facilitate the renal excretion of acamprosate in humans.  The aim of the present study was to establish and apply OAT1 (gene product of SLC22A6) and OAT3 (gene product of SLC22A8) expressing cell lines to investigate whether acamprosate is a substrate or inhibitor of OAT1 and/or OAT3.  The studies were performed in HEK293-Flp-In cells stably transfected with SLC22A6 or SLC22A8.  Protein and functional data showed that the established cell lines are useful for studyingOAT1- andOAT3-mediated transport in bi-lab. studies.  Acamprosate inhibited OAT1-mediated p-aminohippuric acid (PAH) uptake but did not inhibit substrate uptake via OAT3 expressing cells, neither when applied concomitantly nor after a 3 h preincubation with acamprosate.  The uptake of PAH via OAT1 was inhibited in a competitive manner by acamprosate and cellular uptake studies showed that acamprosate is a substrate for OAT1 with a Km-value of approx. 700 μM.  Probenecid inhibited OAT1-mediated acamprosate uptake with a Ki-value of approx. 13 μM, which may translate into an estd. clin. significant DDI index.  In conclusion, acamprosate was identified as a substrate of OAT1 but not OAT3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpngES3ZI8InbVg90H21EOLACvtfcHk0lhDpSbakjbt9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitlGgur3O&md5=9128be10a15607b6ca51f8ae991dcbba</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3390%2Fpharmaceutics12040390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fpharmaceutics12040390%26sid%3Dliteratum%253Aachs%26aulast%3DAntonescu%26aufirst%3DI.%2BE.%26aulast%3DKarlgren%26aufirst%3DM.%26aulast%3DPedersen%26aufirst%3DM.%2BL.%26aulast%3DSimoff%26aufirst%3DI.%26aulast%3DBergstr%25C3%25B6m%26aufirst%3DC.%2BA.%2BS.%26aulast%3DNeuhoff%26aufirst%3DS.%26aulast%3DArtursson%26aufirst%3DP.%26aulast%3DSteffansen%26aufirst%3DB.%26aulast%3DNielsen%26aufirst%3DC.%2BU.%26atitle%3DAcamprosate%2520Is%2520a%2520Substrate%2520of%2520the%2520Human%2520Organic%2520Anion%2520Transporter%2520%2528Oat%2529%25201%2520without%2520Oat3%2520Inhibitory%2520Properties%253A%2520Implications%2520for%2520Renal%2520Acamprosate%2520Secretion%2520and%2520Drug-Drug%2520Interactions%26jtitle%3DPharmaceutics%26date%3D2020%26volume%3D12%26spage%3D390%26doi%3D10.3390%2Fpharmaceutics12040390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wiegand, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, R. E. W.</span></span> <span> </span><span class="NLM_article-title">Agar and Broth Dilution Methods to Determine the Minimal Inhibitory Concentration (MIC) of Antimicrobial Substances</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">175</span>, <span class="refDoi"> DOI: 10.1038/nprot.2007.521</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1038%2Fnprot.2007.521" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=18274517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvVyls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=163-175&author=I.+Wiegandauthor=K.+Hilpertauthor=R.+E.+W.+Hancock&title=Agar+and+Broth+Dilution+Methods+to+Determine+the+Minimal+Inhibitory+Concentration+%28MIC%29+of+Antimicrobial+Substances&doi=10.1038%2Fnprot.2007.521"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances</span></div><div class="casAuthors">Wiegand, Irith; Hilpert, Kai; Hancock, Robert E. W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">163-175</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The aim of broth and agar diln. methods is to det. the lowest concn. of the assayed antimicrobial agent (minimal inhibitory concn., MIC) that, under defined test conditions, inhibits the visible growth of the bacterium being investigated.  MIC values are used to det. susceptibilities of bacteria to drugs and also to evaluate the activity of new antimicrobial agents.  Agar diln. involves the incorporation of different concns. of the antimicrobial substance into a nutrient agar medium followed by the application of a standardized no. of cells to the surface of the agar plate.  For broth diln., often detd. in 96-well microtiter plate format, bacteria are inoculated into a liq. growth medium in the presence of different concns. of an antimicrobial agent.  Growth is assessed after incubation for a defined period of time (16-20 h) and the MIC value is read.  This protocol applies only to aerobic bacteria and can be completed in 3 d.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd1uwvRDLPQ7Vg90H21EOLACvtfcHk0lhDpSbakjbt9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvVyls78%253D&md5=a235d207868342de52085d4100062471</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2007.521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2007.521%26sid%3Dliteratum%253Aachs%26aulast%3DWiegand%26aufirst%3DI.%26aulast%3DHilpert%26aufirst%3DK.%26aulast%3DHancock%26aufirst%3DR.%2BE.%2BW.%26atitle%3DAgar%2520and%2520Broth%2520Dilution%2520Methods%2520to%2520Determine%2520the%2520Minimal%2520Inhibitory%2520Concentration%2520%2528MIC%2529%2520of%2520Antimicrobial%2520Substances%26jtitle%3DNat.%2520Protoc.%26date%3D2008%26volume%3D3%26spage%3D163%26epage%3D175%26doi%3D10.1038%2Fnprot.2007.521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/medium/jm0c01328_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01328&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/medium/jm0c01328_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of clinically approved and relevant pleuromutilins conjugates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01328&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/medium/jm0c01328_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Pleuromutilin mode of binding and actions. Tricyclic mutilin core: red circle; C14 substituent: blue ellipse. (A) Inhibition of tRNA association and peptide bond formation. (B) Inhibition of initiation complex formation by sterical hindrance.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01328&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/medium/jm0c01328_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of the lead (compound <b>7</b><a onclick="showRef(event, 'ref14 ref19'); return false;" href="javascript:void(0);" class="ref ref14 ref19">(14,19)</a>) and the benzyl adaption thereof.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01328&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/medium/jm0c01328_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01328&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) mesyl-Cl, DCM, Et<sub>3</sub>N, 0 °C → rt.; (b) NaN<sub>3</sub>, acetone/H<sub>2</sub>O, 70 °C; (c) CuSO<sub>4</sub>·5H<sub>2</sub>O, sodium ascorbate, <i>t</i>-BuOH/H<sub>2</sub>O (1:1, v/v), 110 °C MW.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/medium/jm0c01328_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01328&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) trimethylsilylacetylene, Pd(PPh<sub>3</sub>)<sub>4</sub>, CuI, anh. piperidine 50 °C (<b>48</b>, <b>49</b>) or anh. Et<sub>3</sub>N at rt. (<b>50</b>). (b) DBU, PBr<sub>3</sub>, DCM, 0 °C → rt.; (c) tetrabutylammonium fluoride (TBAF), THF, rt. (<b>51</b>) or K<sub>2</sub>CO<sub>3</sub>, MeOH, rt. (<b>52</b>); (d) anh. THF, 55 °C, diethylamine (<b>57</b>, <b>58</b>) or 1-methylpiperazine (<b>59</b>, <b>60</b>) followed by K<sub>2</sub>CO<sub>3</sub>, MeOH, rt. (<b>57</b>, <b>59</b>); (e) appropriate boronic acid, Pd(OAc)<sub>2</sub>, PPh<sub>3</sub>, K<sub>3</sub>PO<sub>4</sub>, toluene 80 °C (<b>61</b>) or Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, THF/H<sub>2</sub>O (2:1, v/v) (<b>62</b>–<b>65</b>) followed by K<sub>2</sub>CO<sub>3</sub>, MeOH/DCM 2:1 (v/v), rt. (<b>61</b>–<b>65</b>)<sub>;</sub> (f) NaBH<sub>4</sub>, MeOH, 0 °C → rt. (<b>66</b>) or diethylamine, NaBH<sub>4</sub>, MeOH, 0 °C followed by K<sub>2</sub>CO<sub>3</sub>, MeOH/DCM 2:1 (v/v), rt. (<b>67</b>); (g) appropriate nucleobase (B) or chloropurine, K<sub>2</sub>CO<sub>3</sub>, DMF, rt. (<b>68</b>–<b>72</b>, <b>74</b>, <b>77</b>, <b>78</b>) or NaH, DMF, rt. (<b>73</b>, <b>76</b>) followed by tetrabutylammonium fluoride (TBAF), THF, rt. (<b>69</b>, <b>70</b>, <b>75, 78</b>); (h) appropriate amino species, anh. EtOH, 75 °C (<b>79</b>–<b>86</b>) or i) guanidine·HCl, NaH, MeCN/DMF (2:1, v/v), rt. (ii) 1,4-diazabicyclo[2.2.2]octane (DABCO), rt. (<b>87</b>).</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/medium/jm0c01328_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01328&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) K-phthalimide, DMF, rt.; (b) H<sub>2</sub>N–NH<sub>2</sub>·H<sub>2</sub>O 50–60% w/w, EtOH, 78 °C; (c) trimethylsilylacetylene, Pd(PPh<sub>3</sub>)<sub>4</sub>, CuI, anh. piperidine 80 °C; (d) K<sub>2</sub>CO<sub>3</sub>, MeOH, rt.; (e) (i) 1 M LiAlH<sub>4</sub> in THF, THF, −10 °C → rt. (ii) H<sub>2</sub>O, NaOH (sat.).</p></p></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/medium/jm0c01328_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. 2D pharmacophore fingerprints of adenine–phenyltriazolo–pleuromutilin conjugates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01328&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/medium/jm0c01328_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) 3D superimposition of the lead <b>7</b> and <b>35</b> in the full PTC binding pocket (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HL7">5HL7</a>). (B) Top view of superimposition with nucleotides C2090, A2089, and G2088 removed to grant a better overview of the potential hydrogen bonding between <b>35</b> and C2469 (<i>S. aureus</i> accession numbers).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01328&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/medium/jm0c01328_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of compound <b>35</b>, valnemulin (<b>3</b>), retapamulin (<b>4</b>), and SDS on cell viability. Cell viability was assessed via the CellTiter-Glo 2.0 assay. ATP was measured in cells treated for 3 h with either 10 mM HEPES in HBSS buffer (control) or different concentrations of antibacterials (μg/mL). (A) Fully differentiated Caco-2 cells, (B) undifferentiated Caco-2 cells, (C) PC-3 cells, (D) HEK-293 OAT3 cells, (E) MDCK I cells, and (F) MTT assay in undifferentiated Caco-2 cells. Fit obtained via GraphPad Prism 7.01. Each bar depicts the mean ± SD of replicates in 3 cell containing wells from one cell passage.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01328/20201218/images/large/jm0c01328_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01328&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i54">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02111" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02111" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 41 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neu, H. C.</span></span> <span> </span><span class="NLM_article-title">The Crisis in Antibiotic Resistance</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>257</i></span>,  <span class="NLM_fpage">1064</span>– <span class="NLM_lpage">1073</span>, <span class="refDoi"> DOI: 10.1126/science.257.5073.1064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1126%2Fscience.257.5073.1064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1509257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADyaK38Xls1OhsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1992&pages=1064-1073&author=H.+C.+Neu&title=The+Crisis+in+Antibiotic+Resistance&doi=10.1126%2Fscience.257.5073.1064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The crisis in antibiotic resistance</span></div><div class="casAuthors">Neu, Harold C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">257</span>
        (<span class="NLM_cas:issue">5073</span>),
    <span class="NLM_cas:pages">1064-72</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review with >64 refs.  The synthesis of large nos. of antibiotics over the past three decades has caused complacency about the threat of bacterial resistance.  Bacteria have become resistant to antimicrobial agents as a result of chromosomal changes or the exchange of genetic material via plasmids and transposons.  Streptococcus pneumoniae, Streptococcus pyogenes, and staphylococci, organisms that cause respiratory and cutaneous infections, and members of the Enterobacteriaceae and Pseudomonas families, organisms that cause diarrhea, urinary infection, and sepsis, are now resistant to virtually all of the older antibiotics.  The extensive use of antibiotics in the community and hospitals has fueled this crisis.  Mechanisms such as antibiotic control programs, better hygiene, and synthesis of agents with improved antimicrobial activity need to be adopted in order to limit bacterial resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmntDmhDYAKrVg90H21EOLACvtfcHk0lgCU4za9HMojQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xls1OhsbY%253D&md5=02b98676a76f669ffde4dbb1f10a3876</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.257.5073.1064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.257.5073.1064%26sid%3Dliteratum%253Aachs%26aulast%3DNeu%26aufirst%3DH.%2BC.%26atitle%3DThe%2520Crisis%2520in%2520Antibiotic%2520Resistance%26jtitle%3DScience%26date%3D1992%26volume%3D257%26spage%3D1064%26epage%3D1073%26doi%3D10.1126%2Fscience.257.5073.1064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martens, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demain, A. L.</span></span> <span> </span><span class="NLM_article-title">The Antibiotic Resistance Crisis, with a Focus on the United States</span>. <i>Jpn. J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">520</span>– <span class="NLM_lpage">526</span>, <span class="refDoi"> DOI: 10.1038/ja.2017.30</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1038%2Fja.2017.30" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=28246379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpslWnsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2017&pages=520-526&author=E.+Martensauthor=A.+L.+Demain&title=The+Antibiotic+Resistance+Crisis%2C+with+a+Focus+on+the+United+States&doi=10.1038%2Fja.2017.30"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The antibiotic resistance crisis, with a focus on the United States</span></div><div class="casAuthors">Martens, Evan; Demain, Arnold L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">520-526</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Beginning with the discovery of penicillin by Alexander Fleming in the late 1920s, antibiotics have revolutionized the field of medicine.  They have saved millions of lives each year, alleviated pain and suffering, and have even been used prophylactically for the prevention of infectious diseases.  However, we have now reached a crisis where many antibiotics are no longer effective against even the simplest infections.  Such infections often result in an increased no. of hospitalizations, more treatment failures, and the persistence of drug-resistant pathogens.  Of particular concern are organisms such as methicillin-resistant Staphylococcus aureus, Clostridium difficile, multidrug and extensively drug-resistant Mycobacterium tuberculosis, Neisseria gonorrhoeae, carbapenem-resistant Enterobacteriaceae, and bacteria that produce extended spectrum β-lactamases such as Escherichia coli.  To make matters worse, there has been a steady decline in the discovery of new and effective antibiotics for a no. of reasons.  These include increased costs, lack of adequate support from the government, poor returns on investment, regulatory hurdles, and pharmaceutical companies that have simply abandoned the antibacterial arena.  Instead, many have chosen to focus on developing drugs that will be used on a chronic basis, which will offer a greater profit and more return on investment.  Therefore, there is now an urgent need to develop new and useful antibiotics to avoid returning to the pre-antibiotic era.  Some potential opportunities for antibiotic discovery include better economic incentives, genome mining, rational metabolic engineering, combinatorial biosynthesis, and further exploration of the earth's biodiversity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0EOgD63Ofl7Vg90H21EOLACvtfcHk0lifaTExX8E8mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpslWnsr0%253D&md5=5ca52ac6d6957a96186e2369ca492dd9</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fja.2017.30&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fja.2017.30%26sid%3Dliteratum%253Aachs%26aulast%3DMartens%26aufirst%3DE.%26aulast%3DDemain%26aufirst%3DA.%2BL.%26atitle%3DThe%2520Antibiotic%2520Resistance%2520Crisis%252C%2520with%2520a%2520Focus%2520on%2520the%2520United%2520States%26jtitle%3DJpn.%2520J.%2520Antibiot.%26date%3D2017%26volume%3D70%26spage%3D520%26epage%3D526%26doi%3D10.1038%2Fja.2017.30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paukner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedl, R.</span></span> <span> </span><span class="NLM_article-title">Pleuromutilins: Potent Drugs for Resistant Bugs-Mode of Action and Resistance</span>. <i>Cold Spring Harbor Perspect. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">a027110</span>, <span class="refDoi"> DOI: 10.1101/cshperspect.a027110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1101%2Fcshperspect.a027110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=27742734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFKms7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=a027110&author=S.+Pauknerauthor=R.+Riedl&title=Pleuromutilins%3A+Potent+Drugs+for+Resistant+Bugs-Mode+of+Action+and+Resistance&doi=10.1101%2Fcshperspect.a027110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Pleuromutilins: potent drugs for resistant bugs-mode of action and resistance</span></div><div class="casAuthors">Paukner, Susanne; Riedl, Rosemarie</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">a027110/1-a027110/16</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Pleuromutilins are antibiotics that selectively inhibit bacterial translation and are semisynthetic derivs. of the naturally occurring tricyclic diterpenoid pleuromutilin, which received its name from the pleuromutilin-producing fungus Pleurotus mutilus.  Tiamulin and valnemulin are two established derivs. in veterinary medicine for oral and i.m. administration.  As these early pleuromutilin drugs were developed at atime when companies focused on major antibacterial classes, such as the β-lactams, and resistance was not regarded as an issue, interest in antibiotic research including pleuromutilins was limited.  Over the last decade or so, there has been a resurgence in interest to develop this class for human use.  This has resulted in a topical deriv., retapamulin, and addnl. derivs. in clin. development.  The most advanced compd. is lefamulin, which is in late-stage development for the i.v. and oral treatment of community-acquired bacterial pneumonia and acute bacterial skin infections.  Overall, pleuromutilins and, in particular, lefamulin are characterized by potent activity against Gram-pos. and fastidious Gram-neg. pathogens as well as against mycoplasmas and intracellular organisms, such as Chlamydia spp. and Legionella pneumophila.  Pleuromutilins are unaffected by resistance to other major antibiotic classes, such as macrolides, fluoroquinolones, tetracyclines, β-lactam antibiotics, and others.  Furthermore, pleuromutilins display very low spontaneous mutation frequencies and slow, stepwise resistance development at sub-MIC in vitro.  The potential for resistance development in clinic is predicted to be slow as confirmed by extremely low resistance rates to this class despite the use of pleuromutilins in veterinary medicine for. 30 years.  Although rare, resistant strains have been identified in human- and livestock-assocd. environments and as with any antibiotic class, require close monitoring as well as prudent use in veterinary medicine.  This review focuses on the structural characteristics, mode of action, antibacterial activity, and resistance development of this potent and novel antibacterial class for systemic use in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNp0PFPUr1RbVg90H21EOLACvtfcHk0lifaTExX8E8mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFKms7jM&md5=9cf381f1b2a3283f2af59ea126070535</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a027110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a027110%26sid%3Dliteratum%253Aachs%26aulast%3DPaukner%26aufirst%3DS.%26aulast%3DRiedl%26aufirst%3DR.%26atitle%3DPleuromutilins%253A%2520Potent%2520Drugs%2520for%2520Resistant%2520Bugs-Mode%2520of%2520Action%2520and%2520Resistance%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2017%26volume%3D7%26spage%3Da027110%26doi%3D10.1101%2Fcshperspect.a027110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kavanagh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hervey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, W. J.</span></span> <span> </span><span class="NLM_article-title">Antibiotic Substances From Basidiomycetes: VIII. Pleurotus Multilus (Fr.) Sacc. and Pleurotus Passeckerianus Pilat</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1951</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">570</span>– <span class="NLM_lpage">574</span>, <span class="refDoi"> DOI: 10.1073/pnas.37.9.570</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1073%2Fpnas.37.9.570" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=16589015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADyaG38XjtlSntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1951&pages=570-574&author=F.+Kavanaghauthor=A.+Herveyauthor=W.+J.+Robbins&title=Antibiotic+Substances+From+Basidiomycetes%3A+VIII.+Pleurotus+Multilus+%28Fr.%29+Sacc.+and+Pleurotus+Passeckerianus+Pilat&doi=10.1073%2Fpnas.37.9.570"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Antibiotic substances from Basidiomyces. VIII. Pleurotus mutilus and Pleurotus passeckerianus</span></div><div class="casAuthors">Kavanagh, Frederick; Hervey, Annette; Robbins, Wm. J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1951</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">570-4</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">cf. C.A. 44, 8423c.  Pleuromutilin (I), an antibacterial substance formed by both P. mutilis and P. passeckerianus was recovered from the fermentation beer by extn. with CHCl3 at pH 5.3, the CHCl3 evapd. at low temp., and the remaining brown gum dissolved in ether which on evapn. yielded white crystals of I.  I was sol. in alc., acetone, CHCl3, and ether; slightly sol. in H2O; and insol. in hexane.  I contains 69.75% C and 9.03% H, has a mol. wt. of 310, m. 166-9° (cor.) without decompn., and [α]D20 ≤ 0.05° (0.2% in 50% EtOH).  The absorption spectrum showed a weak band at 290 mμ (ε = 21.7) and end absorption below 230 mμ.  I was a stable, neutral compd. and sublimed at about 140°.  Crystals were obtained from the fifth funnel of an 8-funnel counter-current distribution of crude gum between 50% H2O-MeOH and a 3:2 mixt. of Et2O-hexane.  I was active mainly against gram-pos. bacteria, showed partial activity against streptococci phage, and was inactive against several fungi species when tested at 0.5 mg./ml.  The activity of I was not reduced after 4 hrs. in broth contg. 5% blood.  I was bacteriostatic for Staphylococcus aureus at 0.25-2 γ/ml. broth and bactericidal at 4 γ/ml.  The LD50 of I for mice (intraperitoneally) was greater than 60 mg./kg.  A single subcutaneous dose of I at 50 mg./kg. protected 63% of the mice, infected with Streptococcus hemolyticus, for 7 days.  I had no effect on growth of sarcoma 180 or Plasmodium gallinaceum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqRlKsz11Vq7Vg90H21EOLACvtfcHk0lg9l8PnAm2iWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG38XjtlSntQ%253D%253D&md5=6e77a9a767c3732146a93cc28e2be781</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1073%2Fpnas.37.9.570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.37.9.570%26sid%3Dliteratum%253Aachs%26aulast%3DKavanagh%26aufirst%3DF.%26aulast%3DHervey%26aufirst%3DA.%26aulast%3DRobbins%26aufirst%3DW.%2BJ.%26atitle%3DAntibiotic%2520Substances%2520From%2520Basidiomycetes%253A%2520VIII.%2520Pleurotus%2520Multilus%2520%2528Fr.%2529%2520Sacc.%2520and%2520Pleurotus%2520Passeckerianus%2520Pilat%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1951%26volume%3D37%26spage%3D570%26epage%3D574%26doi%3D10.1073%2Fpnas.37.9.570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kavanagh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hervey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, W. J.</span></span> <span> </span><span class="NLM_article-title">Antibiotic Substances from Basidiomycetes: IX. Drosophila Subtarata. (Batsch Ex Fr.) Quel</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1952</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1073/pnas.38.7.555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1073%2Fpnas.38.7.555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=16589145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADyaG3sXivFSqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1952&pages=555-560&author=F.+Kavanaghauthor=A.+Herveyauthor=W.+J.+Robbins&title=Antibiotic+Substances+from+Basidiomycetes%3A+IX.+Drosophila+Subtarata.+%28Batsch+Ex+Fr.%29+Quel&doi=10.1073%2Fpnas.38.7.555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Antibiotic substances from basidiomycetes. IX. Drosophila subatrata</span></div><div class="casAuthors">Kavanagh, Frederick; Hervey, Annette; Robbins, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1952</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">555-60</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">cf. C.A. 46, 5662d; following abstr.  Drosophila subatrata produced an activity of 1000 diln. units/ml. for Staphylococcus aureus when grown in shake culture for two weeks on corn steep medium.  Active substances were isolated thus: culture liquid was acidified to pH 3.4, extd. with 0.1 vol. CHCl3 which was then extd. with 0.5 M NaHCO3 to give an aq. ext. (I) contg. 37% of the solids and 20% of the S. aureus activity.  The CHCl3 extn. was evapd. to 1/10 vol. and extd. with an equal vol. of 0.5 M NaHCO3 to give a soln. (II) contg. 25% of the S. aureus activity and 3% of the solids.  The remaining CHCl3 ext. was further extd. with 0.5 M carbonate buffer pH 10 which removed a small amt. of an active substance, drosophilin A (III), isolated by acidifying the buffer soln., extg. with Et2O, and evapg. to yield yellow crystals of III, yield 100 mg. from 31 l. of culture medium.  III dissolved in C6H6, decolorized with C, filtered, and the C6H6 evapd. yielded crystals, which after recrystn. from hexane or dil. aq. alc. m. 118°.  III was also sol. in Me2CO, EtOH, CHCl3, Et2O, and slightly sol. in H2O, showed no basic properties was weakly acidic, gave a color reaction with alc. FeCl3, had absorption peak at 301 mμ, did not ppt. with AgNO3, reduced alk. MnO4-, reacted with alk. AgNO3 with formation of AgCl, did not react with 2, 4-(NO2)2C6H3NHNH2, did not give reactions for α,β-unsatd. ketones, contained 11.70% OCH3, had a mol. wt. 249, and infrared analysis indicated H attached to unsatd. C, a OH group and a CH3 or CH2 group.  The above CHCl3 concentrate after extn. with pH 10 buffer was extd. with 0.5 M Na2CO3 and then by N KOH, the CHCl3 evapd., the solids remaining dissolved in C6H6, and C6H6 evapd. to yield crystals of drosophilin B (IV) which were identical with pleuromutilin.  The II ext. was acidified, the acids taken up in Et2O, the Et2O soln. shaken repeatedly with 0.25 vol. 0.1 N AgNO3, and the yellow ppt. removed each time and kept under H2O.  The combined Ag ppts. were washed with Et2O and H2O, more Et2O added, the Ag compd. decompd. with HCl and the acids were taken up in Et2O.  The substances in Et2O were subjected to counter-current distribution between CHCl3 and 0.5 M phosphate buffer at pH 6.9; most of the solids and antibacterial activity were in the CHCl3 which was distributed again in a 4 funnel system using pH 7.5 buffer.  The purest substance, 4 mg. of drosophilin C (V), was found in the third funnel.  I was acidified, extd. with CHCl3, the CHCl3 shaken with 0.5 vol. pH 6 buffer, and the CHCl3 extd. repeatedly with AgNO3 with removal of the pptd. Ag compd. before using fresh AgNO3.  Counter-current distributions with pH 7 buffer of the CHCl3 soln. yielded drosophilin D (VI), sol. in org. solvents, and pptd. from aq. alc. by AgNO3 as was V.  VI titrated in 20% EtOH as a monobasic acid with pK 4.2 and equiv. wt. 405 and showed ultraviolet spectra characteristic of polyacetylene substances.  The activities of the 4 compds. were measured against 7 organisms and 60 bacteriophages.  The substances were active mainly against gram-pos. bacteria; III was active against staphylophage 8, IV against streptophage 6 and 7; V and VI were inactive against phage.  III and IV were not inactivated by incubation with blood; V was 7/8 inactivated and VI lost 0.5 its activity.  IV was not toxic to mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrexTWmThQB87Vg90H21EOLACvtfcHk0lg9l8PnAm2iWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG3sXivFSqtA%253D%253D&md5=9824a5c8bb8d0c1fdb840a43025d7699</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.38.7.555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.38.7.555%26sid%3Dliteratum%253Aachs%26aulast%3DKavanagh%26aufirst%3DF.%26aulast%3DHervey%26aufirst%3DA.%26aulast%3DRobbins%26aufirst%3DW.%2BJ.%26atitle%3DAntibiotic%2520Substances%2520from%2520Basidiomycetes%253A%2520IX.%2520Drosophila%2520Subtarata.%2520%2528Batsch%2520Ex%2520Fr.%2529%2520Quel%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1952%26volume%3D38%26spage%3D555%26epage%3D560%26doi%3D10.1073%2Fpnas.38.7.555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goethe, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heuer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herzon, S. B.</span></span> <span> </span><span class="NLM_article-title">Antibacterial properties and clinical potential of pleuromutilins</span>. <i>Nat. Prod. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">220</span>– <span class="NLM_lpage">247</span>, <span class="refDoi"> DOI: 10.1039/c8np00042e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1039%2FC8NP00042E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=29979463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht12lsrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2019&pages=220-247&author=O.+Goetheauthor=A.+Heuerauthor=X.+Maauthor=Z.+Wangauthor=S.+B.+Herzon&title=Antibacterial+properties+and+clinical+potential+of+pleuromutilins&doi=10.1039%2Fc8np00042e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Antibacterial properties and clinical potential of pleuromutilins</span></div><div class="casAuthors">Goethe, Olivia; Heuer, Abigail; Ma, Xiaoshen; Wang, Zhixun; Herzon, Seth B.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">220-247</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Covering: up to 2018Pleuromutilins are a clin. validated class of antibiotics derived from the fungal diterpene (+)-pleuromutilin (1).  Pleuromutilins inhibit bacterial protein synthesis by binding to the peptidyl transferase center (PTC) of the ribosome.  In this review we summarize the biosynthesis and recent total syntheses of (+)-pleuromutilin (1).  We review the mode of interaction of pleuromutilins with the bacterial ribosome, which involves binding of the C14 extension and the tricyclic core to the P and A sites of the PTC, resp.  We provide an overview of existing clin. agents, and discuss the three primary modes of bacterial resistance (mutations in ribosomal protein L3, Cfr methylation, and efflux).  Finally we collect structure-activity relationships from publicly available reports, and close with some forward looking statements regarding future development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9TZIovrZMJ7Vg90H21EOLACvtfcHk0lg9l8PnAm2iWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht12lsrnF&md5=ad209d04e0bc1a2fcc73351b1e6cb1e5</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1039%2FC8NP00042E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8NP00042E%26sid%3Dliteratum%253Aachs%26aulast%3DGoethe%26aufirst%3DO.%26aulast%3DHeuer%26aufirst%3DA.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DHerzon%26aufirst%3DS.%2BB.%26atitle%3DAntibacterial%2520properties%2520and%2520clinical%2520potential%2520of%2520pleuromutilins%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2019%26volume%3D36%26spage%3D220%26epage%3D247%26doi%3D10.1039%2Fc8np00042e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drews, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laber, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schütze, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unger, J.</span></span> <span> </span><span class="NLM_article-title">Antimicrobial activities of 81.723 hfu, a new pleuromutilin derivative</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">516</span>, <span class="refDoi"> DOI: 10.1128/aac.7.5.507</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1128%2FAAC.7.5.507" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1170807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADyaE2MXltVygsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1975&pages=507-516&author=J.+Drewsauthor=A.+Georgopoulosauthor=G.+Laberauthor=E.+Sch%C3%BCtzeauthor=J.+Unger&title=Antimicrobial+activities+of+81.723+hfu%2C+a+new+pleuromutilin+derivative&doi=10.1128%2Faac.7.5.507"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Antimicrobial activities of 81.723 hfu, a new pleuromutilin derivative</span></div><div class="casAuthors">Drews, Jurgen; Georgopoulos, Apostolos; Laber, Georg; Schuetze, Eberhard; Unger, Judith</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">507-16</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    </div><div class="casAbstract">The new pleuromutilin deriv. 81.723 hfu (I) [55297-96-6] was extremely active against gram-pos. organisms such as streptococci, staphylococci, and against mycoplasmas.  A no. of Shigella, Klebsiella, and Escherichia coli strains were also found to be quite susceptible to this new agent, whereas other gram-neg. organisms like Pseudomonas aeruginosa, Proteus species, and Alcaligenes faecalis proved to be naturally resistant to 81.723 hfu.  The new compd. acted bacteriostatically.  Bactericidal effects have been obsd. only at concns. which are 100-fold higher than the min. inhibitory concns.  The new antibiotic was well tolerated in all animal species tested so far and has been successfully used in the treatment of exptl. infections with gram-pos. organisms and with mycoplasmas in mice and rats.  Resistance against this new compd. arose gradually in all microorganisms investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0-MNdh6l8B7Vg90H21EOLACvtfcHk0lgfmMCTTBTS4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXltVygsLk%253D&md5=7efdc670497e873b0fa01ab272b0d6c5</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1128%2FAAC.7.5.507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.7.5.507%26sid%3Dliteratum%253Aachs%26aulast%3DDrews%26aufirst%3DJ.%26aulast%3DGeorgopoulos%26aufirst%3DA.%26aulast%3DLaber%26aufirst%3DG.%26aulast%3DSch%25C3%25BCtze%26aufirst%3DE.%26aulast%3DUnger%26aufirst%3DJ.%26atitle%3DAntimicrobial%2520activities%2520of%252081.723%2520hfu%252C%2520a%2520new%2520pleuromutilin%2520derivative%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1975%26volume%3D7%26spage%3D507%26epage%3D516%26doi%3D10.1128%2Faac.7.5.507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burch, D. G. S.</span>; <span class="NLM_string-name">Ripley, P. H.</span>; <span class="NLM_string-name">Zeisl, E.</span></span>. <span> </span><span class="NLM_article-title">Veterinary Use of a Pleuromutilin Derivative</span>. <span class="NLM_patent">WO 1998001127 A1</span>, <span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=D.+G.+S.+Burch&author=P.+H.+Ripley&author=E.+Zeisl&title=Veterinary+Use+of+a+Pleuromutilin+Derivative"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurch%26aufirst%3DD.%2BG.%2BS.%26atitle%3DVeterinary%2520Use%2520of%2520a%2520Pleuromutilin%2520Derivative%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritsche, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sader, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, J. E.</span></span> <span> </span><span class="NLM_article-title">Activity of Retapamulin (SB-275833), a Novel Pleuromutilin, against Selected Resistant Gram-Positive Cocci</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">2583</span>– <span class="NLM_lpage">2586</span>, <span class="refDoi"> DOI: 10.1128/aac.01432-05</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1128%2FAAC.01432-05" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=16801451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvVWrtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=2583-2586&author=R.+N.+Jonesauthor=T.+R.+Fritscheauthor=H.+S.+Saderauthor=J.+E.+Ross&title=Activity+of+Retapamulin+%28SB-275833%29%2C+a+Novel+Pleuromutilin%2C+against+Selected+Resistant+Gram-Positive+Cocci&doi=10.1128%2Faac.01432-05"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant Gram-positive cocci</span></div><div class="casAuthors">Jones, Ronald N.; Fritsche, Thomas R.; Sader, Helio S.; Ross, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2583-2586</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Retapamulin (SB-275833), the first pleuromutilin to be developed for human topical use, was tested against a selected population of staphylococci and β-hemolytic streptococci.  The MIC90 results for retapamulin were 0.12 μg/mL for Staphylococcus aureus and ≤0.03 μg/mL for Streptococcus pyogenes; no cross-resistance was obsd. for organism subsets resistant to oxacillin, erythromycin, or mupirocin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1DMTvarj5ALVg90H21EOLACvtfcHk0lgfmMCTTBTS4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvVWrtL0%253D&md5=48b91d3b2458757e9d898a573d6d4faa</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1128%2FAAC.01432-05&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01432-05%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DR.%2BN.%26aulast%3DFritsche%26aufirst%3DT.%2BR.%26aulast%3DSader%26aufirst%3DH.%2BS.%26aulast%3DRoss%26aufirst%3DJ.%2BE.%26atitle%3DActivity%2520of%2520Retapamulin%2520%2528SB-275833%2529%252C%2520a%2520Novel%2520Pleuromutilin%252C%2520against%2520Selected%2520Resistant%2520Gram-Positive%2520Cocci%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D2583%26epage%3D2586%26doi%3D10.1128%2Faac.01432-05" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paukner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golparian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unemo, M.</span></span> <span> </span><span class="NLM_article-title"><i>In Vitro</i> Activity of the Novel Pleuromutilin Lefamulin (BC-3781) and Effect of Efflux Pump Inactivation on Multidrug-Resistant and Extensively Drug-Resistant Neisseria Gonorrhoeae</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">e01497</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1128/aac.01497-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1128%2FAAC.01497-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=28893785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpvVWltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=e01497-17&author=S.+Jacobssonauthor=S.+Pauknerauthor=D.+Golparianauthor=J.+S.+Jensenauthor=M.+Unemo&title=In+Vitro+Activity+of+the+Novel+Pleuromutilin+Lefamulin+%28BC-3781%29+and+Effect+of+Efflux+Pump+Inactivation+on+Multidrug-Resistant+and+Extensively+Drug-Resistant+Neisseria+Gonorrhoeae&doi=10.1128%2Faac.01497-17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro activity of the novel pleuromutilin lefamulin (BC-3781) and effect of efflux pump inactivation on multidrug-resistant and extensively drug-resistant Neisseria gonorrhoeae</span></div><div class="casAuthors">Jacobsson, Susanne; Paukner, Susanne; Golparian, Daniel; Jensen, Joergen S.; Unemo, Magnus</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e01497-17/1-e01497-17/5</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We evaluated the activity of the novel semisynthetic pleuromutilin lefamulin, inhibiting protein synthesis and growth, and the effect of efflux pump inactivation on clin. gonococcal isolates and ref. strains (n = 251), including numerous multidrug-resistant and extensively drug-resistant isolates.  Lefamulin showed potent activity against all gonococcal isolates, and no significant cross-resistance to other antimicrobials was identified.  Further studies of lefamulin are warranted, including in vitro selection and mechanisms of resistance, pharmacokinetics/pharmacodynamics, optimal dosing, and performance in randomized controlled trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-Bjo6DyCsE7Vg90H21EOLACvtfcHk0lhlBYfW_aXSOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpvVWltrg%253D&md5=130dca9f45a6f5d73eef0ba209bee763</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1128%2FAAC.01497-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01497-17%26sid%3Dliteratum%253Aachs%26aulast%3DJacobsson%26aufirst%3DS.%26aulast%3DPaukner%26aufirst%3DS.%26aulast%3DGolparian%26aufirst%3DD.%26aulast%3DJensen%26aufirst%3DJ.%2BS.%26aulast%3DUnemo%26aufirst%3DM.%26atitle%3DIn%2520Vitro%2520Activity%2520of%2520the%2520Novel%2520Pleuromutilin%2520Lefamulin%2520%2528BC-3781%2529%2520and%2520Effect%2520of%2520Efflux%2520Pump%2520Inactivation%2520on%2520Multidrug-Resistant%2520and%2520Extensively%2520Drug-Resistant%2520Neisseria%2520Gonorrhoeae%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26spage%3De01497%26epage%3D17%26doi%3D10.1128%2Faac.01497-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sader, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biedenbach, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paukner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivezic-Schoenfeld, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. N.</span></span> <span> </span><span class="NLM_article-title">Antimicrobial Activity of the Investigational Pleuromutilin Compound BC-3781 Tested Against Gram-positive Organisms Commonly Associated with Acute Bacterial Skin and Skin Structure Infections</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1619</span>– <span class="NLM_lpage">1623</span>, <span class="refDoi"> DOI: 10.1128/aac.05789-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1128%2FAAC.05789-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=22232289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsVKltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=1619-1623&author=H.+S.+Saderauthor=D.+J.+Biedenbachauthor=S.+Pauknerauthor=Z.+Ivezic-Schoenfeldauthor=R.+N.+Jones&title=Antimicrobial+Activity+of+the+Investigational+Pleuromutilin+Compound+BC-3781+Tested+Against+Gram-positive+Organisms+Commonly+Associated+with+Acute+Bacterial+Skin+and+Skin+Structure+Infections&doi=10.1128%2Faac.05789-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Antimicrobial activity of the investigational pleuromutilin compound BC-3781 tested against Gram-positive organisms commonly associated with acute bacterial skin and skin structure infections</span></div><div class="casAuthors">Sader, Helio S.; Biedenbach, Douglas J.; Paukner, Susanne; Ivezic-Schoenfeld, Zrinka; Jones, Ronald N.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1619-1623</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">BC-3781 is a novel semisynthetic pleuromutilin antimicrobial agent developed as an i.v. and oral therapy for acute bacterial skin and skin structure infections (ABSSSI) and respiratory tract infections (RTI).  BC-3781 and comparator agents were tested by the broth microdilution method against 1893 clin. Gram-pos. organisms predominantly causing ABSSSI.  BC-3781 exhibited potent activity against methicillin-resistant Staphylococcus aureus (MIC50/90, 0.12/0.25 μg/mL), coagulase-neg. staphylococci (MIC50/90, 0.06/0.12 μg/mL), β-hemolytic streptococci (MIC50/90, 0.03/0.06 μg/mL), viridans group streptococci (MIC50/90, 0.12/0.5 μg/mL), and Enterococcus faecium (including vancomycin-nonsusceptible strains) (MIC50/90, 0.12/2 μg/mL).  Compared with other antibiotics in use for the treatment of ABSSSI, BC-3781 displayed the lowest MICs and only a minimal potential for cross-resistance with other antimicrobial classes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO9JRQ8KYR6rVg90H21EOLACvtfcHk0lhlBYfW_aXSOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsVKltb8%253D&md5=a476df25c60954a24ab5348d1bda783e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1128%2FAAC.05789-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.05789-11%26sid%3Dliteratum%253Aachs%26aulast%3DSader%26aufirst%3DH.%2BS.%26aulast%3DBiedenbach%26aufirst%3DD.%2BJ.%26aulast%3DPaukner%26aufirst%3DS.%26aulast%3DIvezic-Schoenfeld%26aufirst%3DZ.%26aulast%3DJones%26aufirst%3DR.%2BN.%26atitle%3DAntimicrobial%2520Activity%2520of%2520the%2520Investigational%2520Pleuromutilin%2520Compound%2520BC-3781%2520Tested%2520Against%2520Gram-positive%2520Organisms%2520Commonly%2520Associated%2520with%2520Acute%2520Bacterial%2520Skin%2520and%2520Skin%2520Structure%2520Infections%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D1619%26epage%3D1623%26doi%3D10.1128%2Faac.05789-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paukner, S. C. C.</span>, <span class="NLM_string-name">Ivezic-Schoenfeld, Z.</span>, <span class="NLM_string-name">Kosowska-Shick, K.</span></span>. <span> </span><span class="NLM_article-title">Single- and Multistep Resistance Selection with the Pleuromutilin Antibiotic BC-3781</span>.  <i>In 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)</i>: <span class="NLM_publisher-loc">San Francisco</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=S.+C.+C.+Paukner&author=Z.+Ivezic-Schoenfeld&author=K.+Kosowska-Shick&title=Single-+and+Multistep+Resistance+Selection+with+the+Pleuromutilin+Antibiotic+BC-3781"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DPaukner%26aufirst%3DS.%2BC.%2BC.%26atitle%3DSingle-%2520and%2520Multistep%2520Resistance%2520Selection%2520with%2520the%2520Pleuromutilin%2520Antibiotic%2520BC-3781%26jtitle%3DIn%252052nd%2520Interscience%2520Conference%2520on%2520Antimicrobial%2520Agents%2520and%2520Chemotherapy%2520%2528ICAAC%2529%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vester, B.</span></span> <span> </span><span class="NLM_article-title">The Pleuromutilin Drugs Tiamulin and Valnemulin Bind to the RNA at the Peptidyl Transferase Centre on the Ribosome</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1091</span>– <span class="NLM_lpage">1099</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2958.2001.02595.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1046%2Fj.1365-2958.2001.02595.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=11555289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntlGhsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=1091-1099&author=S.+M.+Poulsenauthor=M.+Karlssonauthor=L.+B.+Johanssonauthor=B.+Vester&title=The+Pleuromutilin+Drugs+Tiamulin+and+Valnemulin+Bind+to+the+RNA+at+the+Peptidyl+Transferase+Centre+on+the+Ribosome&doi=10.1046%2Fj.1365-2958.2001.02595.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The pleuromutilin drugs tiamulin and valnemulin bind to the RNA at the peptidyl transferase centre on the ribosome</span></div><div class="casAuthors">Poulsen, Susan M.; Karlsson, Marit; Johansson, Lena B.; Vester, Birte</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1091-1099</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The pleuromutilin antibiotic derivs., tiamulin and valnemulin, inhibit protein synthesis by binding to the 50S ribosomal subunit of bacteria.  The action and binding site of tiamulin and valnemulin was further characterized on Escherichia coli ribosomes.  It was revealed that these drugs are strong inhibitors of peptidyl transferase and interact with domain V of 23S RNA, giving clear chem. footprints at nucleotides A2058-9, U2506 and U2584-5.  Most of these nucleotides are highly conserved phylogenetically and functionally important, and all of them are at or near the peptidyl transferase center and have been assocd. with binding of several antibiotics.  Competitive footprinting shows that tiamulin and valnemulin can bind concurrently with the macrolide erythromycin but compete with the macrolide carbomycin, which is a peptidyl transferase inhibitor.  We infer from these and previous results that tiamulin and valnemulin interact with the rRNA in the peptidyl transferase slot on the ribosomes in which they prevent the correct positioning of the CCA-ends of tRNAs for peptide transfer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo23jaXaFOT-LVg90H21EOLACvtfcHk0lhlBYfW_aXSOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntlGhsLw%253D&md5=63aa6dbc5ed8f2353eb391ed35ddb37a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2958.2001.02595.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2958.2001.02595.x%26sid%3Dliteratum%253Aachs%26aulast%3DPoulsen%26aufirst%3DS.%2BM.%26aulast%3DKarlsson%26aufirst%3DM.%26aulast%3DJohansson%26aufirst%3DL.%2BB.%26aulast%3DVester%26aufirst%3DB.%26atitle%3DThe%2520Pleuromutilin%2520Drugs%2520Tiamulin%2520and%2520Valnemulin%2520Bind%2520to%2520the%2520RNA%2520at%2520the%2520Peptidyl%2520Transferase%2520Centre%2520on%2520the%2520Ribosome%26jtitle%3DMol.%2520Microbiol.%26date%3D2001%26volume%3D41%26spage%3D1091%26epage%3D1099%26doi%3D10.1046%2Fj.1365-2958.2001.02595.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dreier, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vester, B.</span></span> <span> </span><span class="NLM_article-title">A Click Chemistry Approach to Pleuromutilin Derivatives. Part 3: Extended Footprinting Analysis and Excellent MRSA Inhibition for a Derivative with an Adenine Phenyl Side Chain</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1043</span>– <span class="NLM_lpage">1046</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.01.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1016%2Fj.bmcl.2014.01.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=24486133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Cqurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1043-1046&author=I.+Dreierauthor=L.+H.+Hansenauthor=P.+Nielsenauthor=B.+Vester&title=A+Click+Chemistry+Approach+to+Pleuromutilin+Derivatives.+Part+3%3A+Extended+Footprinting+Analysis+and+Excellent+MRSA+Inhibition+for+a+Derivative+with+an+Adenine+Phenyl+Side+Chain&doi=10.1016%2Fj.bmcl.2014.01.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A click chemistry approach to pleuromutilin derivatives. Part 3: Extended footprinting analysis and excellent MRSA inhibition for a derivative with an adenine phenyl side chain</span></div><div class="casAuthors">Dreier, Ida; Hansen, Lykke H.; Nielsen, Poul; Vester, Birte</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1043-1046</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Five promising pleuromutilin derivs. from our former studies, all contg. adenine on various linkers, were supplemented with two new compds.  The binding to Escherichia coli ribosomes was verified by extensive chem. footprinting anal.  The ability to inhibit bacterial growth was investigated on two Staphylococcus aureus strains and compared to the pleuromutilin drugs tiamulin and valnemulin.  Three of the compds. show an effect similar to tiamulin and one compd. shows an excellent effect similar to valnemulin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql1fKotZzpebVg90H21EOLACvtfcHk0lgfcxi8SWQw0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Cqurs%253D&md5=06423d6334834068e05d6ef91378f1f7</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.01.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.01.019%26sid%3Dliteratum%253Aachs%26aulast%3DDreier%26aufirst%3DI.%26aulast%3DHansen%26aufirst%3DL.%2BH.%26aulast%3DNielsen%26aufirst%3DP.%26aulast%3DVester%26aufirst%3DB.%26atitle%3DA%2520Click%2520Chemistry%2520Approach%2520to%2520Pleuromutilin%2520Derivatives.%2520Part%25203%253A%2520Extended%2520Footprinting%2520Analysis%2520and%2520Excellent%2520MRSA%2520Inhibition%2520for%2520a%2520Derivative%2520with%2520an%2520Adenine%2520Phenyl%2520Side%2520Chain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D1043%26epage%3D1046%26doi%3D10.1016%2Fj.bmcl.2014.01.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Long, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakobsen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vester, B.</span></span> <span> </span><span class="NLM_article-title">Interaction of Pleuromutilin Derivatives with the Ribosomal Peptidyl Transferase Center</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1458</span>– <span class="NLM_lpage">1462</span>, <span class="refDoi"> DOI: 10.1128/aac.50.4.1458-1462.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1128%2FAAC.50.4.1458-1462.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=16569865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFOrsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=1458-1462&author=K.+S.+Longauthor=L.+H.+Hansenauthor=L.+Jakobsenauthor=B.+Vester&title=Interaction+of+Pleuromutilin+Derivatives+with+the+Ribosomal+Peptidyl+Transferase+Center&doi=10.1128%2Faac.50.4.1458-1462.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of pleuromutilin derivatives with the ribosomal peptidyl transferase center</span></div><div class="casAuthors">Long, Katherine S.; Hansen, Lykke H.; Jakobsen, Lene; Vester, Birte</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1458-1462</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Tiamulin is a pleuromutilin antibiotic that is used in veterinary medicine.  The recently published crystal structure of a tiamulin-50S ribosomal subunit complex provides detailed information about how this drug targets the peptidyl transferase center of the ribosome.  To promote rational design of pleuromutilin-based drugs, the binding of the antibiotic pleuromutilin and three semisynthetic derivs. with different side chain extensions has been investigated using chem. footprinting.  The nucleotides A2058, A2059, G2505, and U2506 are affected in all of the footprints, suggesting that the drugs are similarly anchored in the binding pocket by the common tricyclic mutilin core.  However, varying effects are obsd. at U2584 and U2585, indicating that the side chain extensions adopt distinct conformations within the cavity and thereby affect the rRNA conformation differently.  An Escherichia coli L3 mutant strain is resistant to tiamulin and pleuromutilin, but not valnemulin, implying that valnemulin is better able to withstand an altered rRNA binding surface around the mutilin core.  This is likely due to addnl. interactions made between the valnemulin side chain extension and the rRNA binding site.  The data suggest that pleuromutilin drugs with enhanced antimicrobial activity may be obtained by maximizing the no. of interactions between the side chain moiety and the peptidyl transferase cavity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0EDXbWyeDp7Vg90H21EOLACvtfcHk0lgfcxi8SWQw0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFOrsL0%253D&md5=b5d81c9e5074fb5e910bee8bb73a76e4</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FAAC.50.4.1458-1462.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.50.4.1458-1462.2006%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DK.%2BS.%26aulast%3DHansen%26aufirst%3DL.%2BH.%26aulast%3DJakobsen%26aufirst%3DL.%26aulast%3DVester%26aufirst%3DB.%26atitle%3DInteraction%2520of%2520Pleuromutilin%2520Derivatives%2520with%2520the%2520Ribosomal%2520Peptidyl%2520Transferase%2520Center%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D1458%26epage%3D1462%26doi%3D10.1128%2Faac.50.4.1458-1462.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schlünzen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyetan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fucini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yonath, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harms, J. M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Peptide Bond Formation by Pleuromutilins: the Structure of the 50S Ribosomal Subunit From Deinococcus Radiodurans in Complex with Tiamulin</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1287</span>– <span class="NLM_lpage">1294</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.2004.04346.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1111%2Fj.1365-2958.2004.04346.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=15554968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOlsr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2004&pages=1287-1294&author=F.+Schl%C3%BCnzenauthor=E.+Pyetanauthor=P.+Fuciniauthor=A.+Yonathauthor=J.+M.+Harms&title=Inhibition+of+Peptide+Bond+Formation+by+Pleuromutilins%3A+the+Structure+of+the+50S+Ribosomal+Subunit+From+Deinococcus+Radiodurans+in+Complex+with+Tiamulin&doi=10.1111%2Fj.1365-2958.2004.04346.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of peptide bond formation by pleuromutilins: The structure of the 50S ribosomal subunit from Deinococcus radiodurans in complex with tiamulin</span></div><div class="casAuthors">Schluenzen, Frank; Pyetan, Erez; Fucini, Paola; Yonath, Ada; Harms, Joerg M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1287-1294</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Tiamulin, a prominent member of the pleuromutilin class of antibiotics, is a potent inhibitor of protein synthesis in bacteria.  Up to now the effect of pleuromutilins on the ribosome has not been detd. on a mol. level.  The 3.5 Å structure of the 50S ribosomal subunit from Deinococcus radiodurans in complex with tiamulin provides for the first time a detailed picture of its interactions with the 23S rRNA, thus explaining the mol. mechanism of the antimicrobial activity of the pleuromutilin class of antibiotics.  Our results show that tiamulin is located within the peptidyl transferase center (PTC) of the 50S ribosomal subunit with its tricyclic mutilin core positioned in a tight pocket at the A-tRNA binding site.  Also, the extension, which protrudes from its mutilin core, partially overlaps with the P-tRNA binding site.  Thereby, tiamulin directly inhibits peptide bond formation.  Comparison of the tiamulin binding site with other PTC targeting drugs, like chloramphenicol, clindamycin and streptogramins, may facilitate the design of modified or hybridized drugs that extend the applicability of this class of antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2D1Idh-v-kLVg90H21EOLACvtfcHk0lg_SoqGaVWLzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOlsr3I&md5=9c1cff85ea16f04813897b2778077237</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2004.04346.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2004.04346.x%26sid%3Dliteratum%253Aachs%26aulast%3DSchl%25C3%25BCnzen%26aufirst%3DF.%26aulast%3DPyetan%26aufirst%3DE.%26aulast%3DFucini%26aufirst%3DP.%26aulast%3DYonath%26aufirst%3DA.%26aulast%3DHarms%26aufirst%3DJ.%2BM.%26atitle%3DInhibition%2520of%2520Peptide%2520Bond%2520Formation%2520by%2520Pleuromutilins%253A%2520the%2520Structure%2520of%2520the%252050S%2520Ribosomal%2520Subunit%2520From%2520Deinococcus%2520Radiodurans%2520in%2520Complex%2520with%2520Tiamulin%26jtitle%3DMol.%2520Microbiol.%26date%3D2004%26volume%3D54%26spage%3D1287%26epage%3D1294%26doi%3D10.1111%2Fj.1365-2958.2004.04346.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eyal, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matzov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krupkin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paukner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedl, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozenberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bashan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yonath, A.</span></span> <span> </span><span class="NLM_article-title">A Novel Pleuromutilin Antibacterial Compound, its Binding Mode and Selectivity Mechanism</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">39004</span>, <span class="refDoi"> DOI: 10.1038/srep39004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1038%2Fsrep39004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=27958389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFGjtrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=39004&author=Z.+Eyalauthor=D.+Matzovauthor=M.+Krupkinauthor=S.+Pauknerauthor=R.+Riedlauthor=H.+Rozenbergauthor=E.+Zimmermanauthor=A.+Bashanauthor=A.+Yonath&title=A+Novel+Pleuromutilin+Antibacterial+Compound%2C+its+Binding+Mode+and+Selectivity+Mechanism&doi=10.1038%2Fsrep39004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A novel pleuromutilin antibacterial compound, its binding mode and selectivity mechanism</span></div><div class="casAuthors">Eyal, Zohar; Matzov, Donna; Krupkin, Miri; Paukner, Susanne; Riedl, Rosemarie; Rozenberg, Haim; Zimmerman, Ella; Bashan, Anat; Yonath, Ada</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">39004</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The increasing appearance of pathogenic bacteria with antibiotic resistance is a global threat.  Consequently, clin. available potent antibiotics that are active against multidrug resistant pathogens are becoming exceedingly scarce.  Ribosomes are a main target for antibiotics, and hence are an objective for novel drug development.  Lefamulin, a semi-synthetic pleuromutilin compd. highly active against multi-resistant pathogens, is a promising antibiotic currently in phase III trials for the treatment of community-acquired bacterial pneumonia in adults.  The crystal structure of the Staphylococcus aureus large ribosomal subunit in complex with lefamulin reveals its protein synthesis inhibition mechanism and the rationale for its potency.  In addn., anal. of the bacterial and eukaryotes ribosome structures around the pleuromutilin binding pocket has elucidated the key for the drug's selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcIIQ8ddZpi7Vg90H21EOLACvtfcHk0lg_SoqGaVWLzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFGjtrrN&md5=232d92ed0c8207372496fa91527ce231</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fsrep39004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep39004%26sid%3Dliteratum%253Aachs%26aulast%3DEyal%26aufirst%3DZ.%26aulast%3DMatzov%26aufirst%3DD.%26aulast%3DKrupkin%26aufirst%3DM.%26aulast%3DPaukner%26aufirst%3DS.%26aulast%3DRiedl%26aufirst%3DR.%26aulast%3DRozenberg%26aufirst%3DH.%26aulast%3DZimmerman%26aufirst%3DE.%26aulast%3DBashan%26aufirst%3DA.%26aulast%3DYonath%26aufirst%3DA.%26atitle%3DA%2520Novel%2520Pleuromutilin%2520Antibacterial%2520Compound%252C%2520its%2520Binding%2520Mode%2520and%2520Selectivity%2520Mechanism%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D39004%26doi%3D10.1038%2Fsrep39004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eyal, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matzov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krupkin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wekselman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paukner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozenberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bashan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yonath, A.</span></span> <span> </span><span class="NLM_article-title">Structural Insights into Species-specific Features of the Ribosome from the Pathogen Staphylococcus Aureus</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">E5805</span>– <span class="NLM_lpage">E5814</span>, <span class="refDoi"> DOI: 10.1073/pnas.1517952112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1073%2Fpnas.1517952112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=26464510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1CntrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=E5805-E5814&author=Z.+Eyalauthor=D.+Matzovauthor=M.+Krupkinauthor=I.+Wekselmanauthor=S.+Pauknerauthor=E.+Zimmermanauthor=H.+Rozenbergauthor=A.+Bashanauthor=A.+Yonath&title=Structural+Insights+into+Species-specific+Features+of+the+Ribosome+from+the+Pathogen+Staphylococcus+Aureus&doi=10.1073%2Fpnas.1517952112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into species-specific features of the ribosome from the pathogen Staphylococcus aureus</span></div><div class="casAuthors">Eyal, Zohar; Matzov, Donna; Krupkin, Miri; Wekselman, Itai; Paukner, Susanne; Zimmerman, Ella; Rozenberg, Haim; Bashan, Anat; Yonath, Ada</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">E5805-E5814</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The emergence of bacterial multidrug resistance to antibiotics threatens to cause regression to the preantibiotic era.  Here, the authors present the crystal structure of the large ribosomal subunit from Staphylococcus aureus, a versatile Gram-pos. aggressive pathogen, and its complexes with the known antibiotics linezolid and telithromycin, as well as with a new, highly potent pleuromutilin deriv., BC-3205.  These crystal structures shed light on specific structural motifs of the S. aureus ribosome and the binding modes of the aforementioned antibiotics.  Moreover, by analyzing the ribosome structure and comparing it with those of nonpathogenic bacterial models, we identified some unique internal and peripheral structural motifs that may be potential candidates for improving known antibiotics and for use in the design of selective antibiotic drugs against S. aureus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5OmCRBYsxp7Vg90H21EOLACvtfcHk0lhIRkbVVpj6lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1CntrrM&md5=f79d8db740a04ec15e7127aad824a499</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1517952112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1517952112%26sid%3Dliteratum%253Aachs%26aulast%3DEyal%26aufirst%3DZ.%26aulast%3DMatzov%26aufirst%3DD.%26aulast%3DKrupkin%26aufirst%3DM.%26aulast%3DWekselman%26aufirst%3DI.%26aulast%3DPaukner%26aufirst%3DS.%26aulast%3DZimmerman%26aufirst%3DE.%26aulast%3DRozenberg%26aufirst%3DH.%26aulast%3DBashan%26aufirst%3DA.%26aulast%3DYonath%26aufirst%3DA.%26atitle%3DStructural%2520Insights%2520into%2520Species-specific%2520Features%2520of%2520the%2520Ribosome%2520from%2520the%2520Pathogen%2520Staphylococcus%2520Aureus%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2015%26volume%3D112%26spage%3DE5805%26epage%3DE5814%26doi%3D10.1073%2Fpnas.1517952112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dreier, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Søndergaard, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasmussen, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">List, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kongsted, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vester, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, P.</span></span> <span> </span><span class="NLM_article-title">A Click Chemistry Approach to Pleuromutilin Derivatives, Part 2: Conjugates with Acyclic Nucleosides and their Ribosomal Binding and Antibacterial Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">2067</span>– <span class="NLM_lpage">2077</span>, <span class="refDoi"> DOI: 10.1021/jm201266b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201266b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Ohtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2067-2077&author=I.+Dreierauthor=S.+Kumarauthor=H.+S%C3%B8ndergaardauthor=M.+L.+Rasmussenauthor=L.+H.+Hansenauthor=N.+H.+Listauthor=J.+Kongstedauthor=B.+Vesterauthor=P.+Nielsen&title=A+Click+Chemistry+Approach+to+Pleuromutilin+Derivatives%2C+Part+2%3A+Conjugates+with+Acyclic+Nucleosides+and+their+Ribosomal+Binding+and+Antibacterial+Activity&doi=10.1021%2Fjm201266b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A Click Chemistry Approach to Pleuromutilin Derivatives, Part 2: Conjugates with Acyclic Nucleosides and Their Ribosomal Binding and Antibacterial Activity</span></div><div class="casAuthors">Dreier, Ida; Kumar, Surender; Soendergaard, Helle; Rasmussen, Maria Louise; Hansen, Lykke Haastrup; List, Nanna Holmgaard; Kongsted, Jacob; Vester, Birte; Nielsen, Poul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2067-2077</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pleuromutilin is an antibiotic that binds to bacterial ribosomes and thereby inhibit protein synthesis.  A new series of semisynthetic pleuromutilin derivs. were synthesized by a click chem. strategy.  Pleuromutilin was conjugated by different linkers to a nucleobase, nucleoside, or Ph group, as a side-chain extension at the C22 position of pleuromutilin.  The linkers were designed on the basis of the best linker from our first series of pleuromutilin derivs. following either conformational restriction or an isosteric methylene to oxygen exchange.  The binding of the new compds. to the Escherichia coli ribosome was investigated by mol. modeling and chem. footprinting of nucleotide U2506, and it was found that all the derivs. bind to the specific site and most of them better than pleuromutilin itself.  The effect of the side-chain extension was also explored by chem. footprinting of nucleotide U2585, and the results showed that all the compds. interact with this position to varying degrees.  Derivs. with a conformational restriction of the linker generally had a higher affinity than derivs. with an isosteric exchange of one of the carbons in the linker with a hydrophilic oxygen.  A growth inhibition assay with three different bacterial strains showed significant activity of several of the new compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0isS_bIe9x7Vg90H21EOLACvtfcHk0lhIRkbVVpj6lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Ohtbs%253D&md5=ab32757d2e0c662ba7b3a5a034effa5f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm201266b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201266b%26sid%3Dliteratum%253Aachs%26aulast%3DDreier%26aufirst%3DI.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DS%25C3%25B8ndergaard%26aufirst%3DH.%26aulast%3DRasmussen%26aufirst%3DM.%2BL.%26aulast%3DHansen%26aufirst%3DL.%2BH.%26aulast%3DList%26aufirst%3DN.%2BH.%26aulast%3DKongsted%26aufirst%3DJ.%26aulast%3DVester%26aufirst%3DB.%26aulast%3DNielsen%26aufirst%3DP.%26atitle%3DA%2520Click%2520Chemistry%2520Approach%2520to%2520Pleuromutilin%2520Derivatives%252C%2520Part%25202%253A%2520Conjugates%2520with%2520Acyclic%2520Nucleosides%2520and%2520their%2520Ribosomal%2520Binding%2520and%2520Antibacterial%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2067%26epage%3D2077%26doi%3D10.1021%2Fjm201266b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madden, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choudhry, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gontarek, R. R.</span></span> <span> </span><span class="NLM_article-title">Biochemical Characterization of the Interactions of the Novel Pleuromutilin Derivative Retapamulin with Bacterial Ribosomes</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3875</span>– <span class="NLM_lpage">3881</span>, <span class="refDoi"> DOI: 10.1128/aac.00184-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1128%2FAAC.00184-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=16940066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOkt7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=3875-3881&author=K.+Yanauthor=L.+Maddenauthor=A.+E.+Choudhryauthor=C.+S.+Voigtauthor=R.+A.+Copelandauthor=R.+R.+Gontarek&title=Biochemical+Characterization+of+the+Interactions+of+the+Novel+Pleuromutilin+Derivative+Retapamulin+with+Bacterial+Ribosomes&doi=10.1128%2Faac.00184-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical characterization of the interactions of the novel pleuromutilin derivative retapamulin with bacterial ribosomes</span></div><div class="casAuthors">Yan, Kang; Madden, Lenore; Choudhry, Anthony E.; Voigt, Christine S.; Copeland, Robert A.; Gontarek, Richard R.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3875-3881</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Retapamulin is a semisynthetic pleuromutilin deriv. being developed as a topical antibiotic for treating bacterial infections of the skin.  It is potent in vitro against susceptible and multidrug-resistant organisms commonly assocd. with bacterial skin infections.  The authors report detailed mode of action studies demonstrating that retapamulin binds to the bacterial ribosome with high affinity, inhibits ribosomal peptidyl transferase activity, and partially inhibits the binding of the initiator tRNA substrate to the ribosomal P-site.  Taken together, these data distinguish the mode of action of retapamulin from that of other classes of antibiotics.  This unique mode of action may explain the lack of clin. relevant, target-specific cross-resistance of retapamulin with antibacterials in current use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXbpd6E__e-rVg90H21EOLACvtfcHk0lhIRkbVVpj6lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOkt7bE&md5=59aa9270f04fa0844ac7cc8cc819a849</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1128%2FAAC.00184-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00184-06%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DK.%26aulast%3DMadden%26aufirst%3DL.%26aulast%3DChoudhry%26aufirst%3DA.%2BE.%26aulast%3DVoigt%26aufirst%3DC.%2BS.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DGontarek%26aufirst%3DR.%2BR.%26atitle%3DBiochemical%2520Characterization%2520of%2520the%2520Interactions%2520of%2520the%2520Novel%2520Pleuromutilin%2520Derivative%2520Retapamulin%2520with%2520Bacterial%2520Ribosomes%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D3875%26epage%3D3881%26doi%3D10.1128%2Faac.00184-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Long, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poehlsgaard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobbie, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Böttger, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vester, B.</span></span> <span> </span><span class="NLM_article-title">Single 23S rRNA mutations at the ribosomal peptidyl transferase centre confer resistance to valnemulin and other antibiotics inMycobacterium smegmatisby perturbation of the drug binding pocket</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1218</span>– <span class="NLM_lpage">1227</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.2009.06596.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1111%2Fj.1365-2958.2009.06596.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=19154331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjslSlt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2009&pages=1218-1227&author=K.+S.+Longauthor=J.+Poehlsgaardauthor=L.+H.+Hansenauthor=S.+N.+Hobbieauthor=E.+C.+B%C3%B6ttgerauthor=B.+Vester&title=Single+23S+rRNA+mutations+at+the+ribosomal+peptidyl+transferase+centre+confer+resistance+to+valnemulin+and+other+antibiotics+inMycobacterium+smegmatisby+perturbation+of+the+drug+binding+pocket&doi=10.1111%2Fj.1365-2958.2009.06596.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Single 23S rRNA mutations at the ribosomal peptidyl transferase centre confer resistance to valnemulin and other antibiotics in Mycobacterium smegmatis by perturbation of the drug binding pocket</span></div><div class="casAuthors">Long, Katherine S.; Poehlsgaard, Jacob; Hansen, Lykke H.; Hobbie, Sven N.; Bottger, Erik C.; Vester, Birte</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1218-1227</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Tiamulin and valnemulin target the peptidyl transferase center (PTC) on the bacterial ribosome.  They are used in veterinary medicine to treat infections caused by a variety of bacterial pathogens, including the intestinal spirochetes Brachyspira spp.  Mutations in ribosomal protein L3 and 23S rRNA have previously been assocd. with tiamulin resistance in Brachyspira spp. isolates, but as multiple mutations were isolated together, the roles of the individual mutations are unclear.  In this work, individual 23S rRNA mutations assocd. with pleuromutilin resistance at positions 2055, 2447, 2504 and 2572 (Escherichia coli numbering) are introduced into a Mycobacterium smegmatis strain with a single rRNA operon.  The single mutations each confer a significant and similar degree of valnemulin resistance and those at 2447 and 2504 also confer cross-resistance to other antibiotics that bind to the PTC in M. smegmatis.  Antibiotic footprinting expts. on mutant ribosomes show that the introduced mutations cause structural perturbations at the PTC and reduced binding of pleuromutilin antibiotics.  This work underscores the fact that mutations at nucleotides distant from the pleuromutilin binding site can confer the same level of valnemulin resistance as those at nucleotides abutting the bound drug, and suggests that the former function indirectly by altering local structure and flexibility at the drug binding pocket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjJappF9TBlrVg90H21EOLACvtfcHk0lgL8MqdJ1WPOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjslSlt7g%253D&md5=2c6ee80f703c3514d3d0696bc82f26ed</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2009.06596.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2009.06596.x%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DK.%2BS.%26aulast%3DPoehlsgaard%26aufirst%3DJ.%26aulast%3DHansen%26aufirst%3DL.%2BH.%26aulast%3DHobbie%26aufirst%3DS.%2BN.%26aulast%3DB%25C3%25B6ttger%26aufirst%3DE.%2BC.%26aulast%3DVester%26aufirst%3DB.%26atitle%3DSingle%252023S%2520rRNA%2520mutations%2520at%2520the%2520ribosomal%2520peptidyl%2520transferase%2520centre%2520confer%2520resistance%2520to%2520valnemulin%2520and%2520other%2520antibiotics%2520inMycobacterium%2520smegmatisby%2520perturbation%2520of%2520the%2520drug%2520binding%2520pocket%26jtitle%3DMol.%2520Microbiol.%26date%3D2009%26volume%3D71%26spage%3D1218%26epage%3D1227%26doi%3D10.1111%2Fj.1365-2958.2009.06596.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hodgin, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogenauer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgin, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Högenauer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoegenauer, G.</span></span> <span> </span><span class="NLM_article-title">The Mode of Action of Pleuromutilin Derivatives. Effect on Cell-Free Polypeptide Synthesis</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1974</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">527</span>– <span class="NLM_lpage">533</span>, <span class="refDoi"> DOI: 10.1111/j.1432-1033.1974.tb03721.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1111%2Fj.1432-1033.1974.tb03721.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=4611767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADyaE2MXjvFShuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1974&pages=527-533&author=L.+A.+Hodginauthor=G.+Hogenauerauthor=L.+A.+Hodginauthor=G.+H%C3%B6genauerauthor=G.+Hoegenauer&title=The+Mode+of+Action+of+Pleuromutilin+Derivatives.+Effect+on+Cell-Free+Polypeptide+Synthesis&doi=10.1111%2Fj.1432-1033.1974.tb03721.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Mode of action of pleuromutilin derivatives.  Effect on cell-free polypeptide synthesis</span></div><div class="casAuthors">Hodgin, Louise A.; Hoegenauer, Gregor</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">527-33</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">The pleuromutilin (I) deriv. 14-deoxy-14-[[(2-diethylaminoethyl)thio]acetoxy]mutilin-HCl (I) [42301-75-7] interfered strongly with cell-free poly(U)-directed polyphenylalanine [25191-15-5] synthesis in an ext. from Escherichia coli.  II was unable to inhibit the assembly of initiation complexes and did not significantly influence Phe-tRNA attachment to the ribosomal A-site catalyzed by elongation factor T.  It reduced the puromycin release of formylmethionine from initiator tRNA bound to the P-site, however, indicating that either the peptidyl transferase was affected or the binding of puromycin was abolished.  The influence of II on protein synthesis by E. coli polysomes was less pronounced than the inhibition of polyphenylalanine synthesis.  The opposite effect was reported for chloramphenicol.  The formation of formylmethionylalanine [15183-28-5] coded for by R-17 phage RNA was also impeded by II.  The binding of Ala-tRNA to the A-site was affected in this reaction.  II apparently requires an occupied P-site in order to prevent binding of aminoacyl-tRNA to the A-site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfmH7vEbxNGrVg90H21EOLACvtfcHk0lgL8MqdJ1WPOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXjvFShuw%253D%253D&md5=a5dea25b9abef36caccc3f8c07e372bd</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1974.tb03721.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1974.tb03721.x%26sid%3Dliteratum%253Aachs%26aulast%3DHodgin%26aufirst%3DL.%2BA.%26aulast%3DHogenauer%26aufirst%3DG.%26aulast%3DHodgin%26aufirst%3DL.%2BA.%26aulast%3DH%25C3%25B6genauer%26aufirst%3DG.%26aulast%3DHoegenauer%26aufirst%3DG.%26atitle%3DThe%2520Mode%2520of%2520Action%2520of%2520Pleuromutilin%2520Derivatives.%2520Effect%2520on%2520Cell-Free%2520Polypeptide%2520Synthesis%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1974%26volume%3D47%26spage%3D527%26epage%3D533%26doi%3D10.1111%2Fj.1432-1033.1974.tb03721.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Högenauer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruf, C.</span></span> <span> </span><span class="NLM_article-title">Ribosomal Binding Region for the Antibiotic Tiamulin: Stoichiometry, Subunit Location, and Affinity for Various Analogs</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">260</span>– <span class="NLM_lpage">265</span>, <span class="refDoi"> DOI: 10.1128/aac.19.2.260</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1128%2FAAC.19.2.260" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=6751216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A280%3ADyaL3s%252FitFWlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1981&pages=260-265&author=G.+H%C3%B6genauerauthor=C.+Ruf&title=Ribosomal+Binding+Region+for+the+Antibiotic+Tiamulin%3A+Stoichiometry%2C+Subunit+Location%2C+and+Affinity+for+Various+Analogs&doi=10.1128%2Faac.19.2.260"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Ribosomal binding region for the antibiotic tiamulin: stoichiometry, subunit location, and affinity for various analogs</span></div><div class="casAuthors">Hogenauer G; Ruf C</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial agents and chemotherapy</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">260-5</span>
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    </div><div class="casAbstract">Equilibrium dialysis experiments with a highly purified preparation of labeled tiamulin, a semisynthetic derivative of the antibiotic pleuromutilin, and Escherichia coli ribosomes allowed the determination of two binding sites for the drug.  The binding reaction showed a cooperative effect.  Of the two subunits, the 50S particle was able to bind the antibiotic in a 1:1 stoichiometry.  Hence, the 50S subunit contributed predominantly to the binding energy which held the antibiotic to the ribosomes.  The 30S subunit, showing no strong affinity for the drug, may be needed for the generation of the second binding site in the 70S particle.  If depleted of ammonium ions, 70S ribosomes lost their binding capacity for the antibiotic.  The attachment sites for tiamulin could be restored by heating the ribosomes to 40 degrees C in the presence of either ammonium ions or the antibiotic.  Other pleuromutilin derivatives displaced labeled tiamulin from its ribosomal binding sites.  By quantifying this competition, the relative affinity of various pleuromutilin derivatives for E. coli ribosomes was determined.  The binding correlated with the minimal inhibitory concentrations of these compounds against E. coli.  When compared with the minimal inhibitory concentrations of these compounds against E. coli.  When compared with the minimal inhibitory concentrations against E. coli.  When compared with the minimal inhibitory concentrations against Staphylococcus aureus, the correlation was less strict, but the same trend prevailed.  These results suggest that the antibacterial activities of various pleuromutilin derivatives on a given test organism are mainly determined by the strength of binding to the ribosomes within the bacterial cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSXcTTs-omSE0odMGTatQ7LfW6udTcc2eaF_MtFN8F3prntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3s%252FitFWlug%253D%253D&md5=ac4edcdca65db5c9ed3e5fce09287046</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1128%2FAAC.19.2.260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.19.2.260%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25B6genauer%26aufirst%3DG.%26aulast%3DRuf%26aufirst%3DC.%26atitle%3DRibosomal%2520Binding%2520Region%2520for%2520the%2520Antibiotic%2520Tiamulin%253A%2520Stoichiometry%252C%2520Subunit%2520Location%252C%2520and%2520Affinity%2520for%2520Various%2520Analogs%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1981%26volume%3D19%26spage%3D260%26epage%3D265%26doi%3D10.1128%2Faac.19.2.260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dornhelm, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Högenauer, G.</span></span> <span> </span><span class="NLM_article-title">The Effects of Tiamulin, a Semisynthetic Pleuromutilin Derivative, on Bacterial Polypeptide Chain Initiation</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">465</span>– <span class="NLM_lpage">473</span>, <span class="refDoi"> DOI: 10.1111/j.1432-1033.1978.tb12699.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1111%2Fj.1432-1033.1978.tb12699.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=365525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADyaE1MXms1Grtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1978&pages=465-473&author=P.+Dornhelmauthor=G.+H%C3%B6genauer&title=The+Effects+of+Tiamulin%2C+a+Semisynthetic+Pleuromutilin+Derivative%2C+on+Bacterial+Polypeptide+Chain+Initiation&doi=10.1111%2Fj.1432-1033.1978.tb12699.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of tiamulin, a semisynthetic pleuromutilin derivative, on bacterial polypeptide chain initiation</span></div><div class="casAuthors">Dornhelm, Peter; Hoegenauer, Gregor</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">465-73</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">Tiamulin (I)  [55297-95-5], a water-sol. and highly effective semisynthetic deriv. of pleuromutilin led to the formation of physiolog. inactive polypeptide chain initiation complexes which readily decompd. and did not enter the phase of peptide chain elongation.  Once elongation began it continued even in the presence of I as was shown by measuring the formation of N-acetylphenylalanine-poly(phenylalanine).  The formation of abortive initiation complexes was obsd. regardless of whether AcPhe-tRNA of fMet-tRNA was used as an initiator or whether artificial messengers or a natural messenger, like R17 bacteriophage RNA, was used.  When this drug was acting on whole cells, it led to the disappearance of polysomes.  The only structures which could be detected were of the monosome size.  Therefore, polysomes seem to elongate the polypeptide chains in whole cells in the presence of this antibiotic, but since effective reinitiation is blocked, the polysome pool of the cell soon becomes depleted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_mj68-cgi2rVg90H21EOLACvtfcHk0ljn-3ltHTu_yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXms1Grtw%253D%253D&md5=82b5285c1ffcb795194b8155ee6de2ae</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1978.tb12699.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1978.tb12699.x%26sid%3Dliteratum%253Aachs%26aulast%3DDornhelm%26aufirst%3DP.%26aulast%3DH%25C3%25B6genauer%26aufirst%3DG.%26atitle%3DThe%2520Effects%2520of%2520Tiamulin%252C%2520a%2520Semisynthetic%2520Pleuromutilin%2520Derivative%252C%2520on%2520Bacterial%2520Polypeptide%2520Chain%2520Initiation%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1978%26volume%3D91%26spage%3D465%26epage%3D473%26doi%3D10.1111%2Fj.1432-1033.1978.tb12699.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span> </span><span class="NLM_article-title">Discontinuation of Altargo 10 mg/g ointment
(Retapamulin)</span>. <a href="https://gskpro.com/en-mt/updates/2018/july/discontinuation_of_altargo/" class="extLink">https://gskpro.com/en-mt/updates/2018/july/discontinuation_of_altargo/</a> (accessed March 30, 2020).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Discontinuation+of+Altargo+10+mg%2Fg+ointment%0A%28Retapamulin%29.+https%3A%2F%2Fgskpro.com%2Fen-mt%2Fupdates%2F2018%2Fjuly%2Fdiscontinuation_of_altargo%2F+%28accessed+March+30%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DDiscontinuation%2520of%2520Altargo%252010%2520mg%252Fg%2520ointment%250A%2528Retapamulin%2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biedenbach, D. J.</span>; <span class="NLM_string-name">Jones, R. N.</span>; <span class="NLM_string-name">Ivezic-Schoenfeld, Z.</span>; <span class="NLM_string-name">Paukner, S.</span>; <span class="NLM_string-name">Novak, R.</span></span>. <span> </span><span class="NLM_article-title">In Vitro Antibacterial Spectrum of BC-7013, a Novel Pleuromutilin Derivative for Topical Use in Humans</span>.  <i>In 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)</i>: <span class="NLM_publisher-loc">San Francisco, CA</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=D.+J.+Biedenbach&author=R.+N.+Jones&author=Z.+Ivezic-Schoenfeld&author=S.+Paukner&author=R.+Novak&title=In+Vitro+Antibacterial+Spectrum+of+BC-7013%2C+a+Novel+Pleuromutilin+Derivative+for+Topical+Use+in+Humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DBiedenbach%26aufirst%3DD.%2BJ.%26atitle%3DIn%2520Vitro%2520Antibacterial%2520Spectrum%2520of%2520BC-7013%252C%2520a%2520Novel%2520Pleuromutilin%2520Derivative%2520for%2520Topical%2520Use%2520in%2520Humans%26jtitle%3DIn%252049th%2520Interscience%2520Conference%2520on%2520Antimicrobial%2520Agents%2520and%2520Chemotherapy%2520%2528ICAAC%2529%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thirring, K.</span>; <span class="NLM_string-name">Ascher, G.</span>; <span class="NLM_string-name">Paukner, S.</span>; <span class="NLM_string-name">Heilmayer, W.</span>; <span class="NLM_string-name">Novak, R.</span></span>. <span> </span><span class="NLM_article-title">Mutilin Derivatives and their use as Pharmaceutical</span>. <span class="NLM_patent">WO 2007079515 A1</span>, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=K.+Thirring&author=G.+Ascher&author=S.+Paukner&author=W.+Heilmayer&author=R.+Novak&title=Mutilin+Derivatives+and+their+use+as+Pharmaceutical"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DThirring%26aufirst%3DK.%26atitle%3DMutilin%2520Derivatives%2520and%2520their%2520use%2520as%2520Pharmaceutical%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thirring, K.</span>; <span class="NLM_string-name">Heilmayer, W.</span></span>. <span> </span><span class="NLM_article-title">Pleuromutilin Derivatives and their use as Antimicrobials</span>. <span class="NLM_patent">WO 2009009812 A1</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=K.+Thirring&author=W.+Heilmayer&title=Pleuromutilin+Derivatives+and+their+use+as+Antimicrobials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DThirring%26aufirst%3DK.%26atitle%3DPleuromutilin%2520Derivatives%2520and%2520their%2520use%2520as%2520Antimicrobials%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thirring, K.</span>; <span class="NLM_string-name">Heilmayer, W.</span></span>. <span> </span><span class="NLM_article-title">Pleuromutilin Derivatives</span>. <span class="NLM_patent">EP 2176211 B1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=K.+Thirring&author=W.+Heilmayer&title=Pleuromutilin+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DThirring%26aufirst%3DK.%26atitle%3DPleuromutilin%2520Derivatives%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diep, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carleton, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mongodin, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sensabaugh, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perdreau-Remington, F.</span></span> <span> </span><span class="NLM_article-title">Complete Genome Sequence of USA300, an Epidemic Clone of Community-acquired Meticillin-Resistant Staphylococcus Aureus</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>367</i></span>,  <span class="NLM_fpage">731</span>– <span class="NLM_lpage">739</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(06)68231-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1016%2Fs0140-6736%2806%2968231-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=16517273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVejsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2006&pages=731-739&author=B.+A.+Diepauthor=S.+R.+Gillauthor=R.+F.+Changauthor=T.+H.+Phanauthor=J.+H.+Chenauthor=M.+G.+Davidsonauthor=F.+Linauthor=J.+Linauthor=H.+A.+Carletonauthor=E.+F.+Mongodinauthor=G.+F.+Sensabaughauthor=F.+Perdreau-Remington&title=Complete+Genome+Sequence+of+USA300%2C+an+Epidemic+Clone+of+Community-acquired+Meticillin-Resistant+Staphylococcus+Aureus&doi=10.1016%2Fs0140-6736%2806%2968231-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus</span></div><div class="casAuthors">Diep, Binh An; Gill, Steven R.; Chang, Richard F.; Phan, Tiffany HaiVan; Chen, Jason H.; Davidson, Matthew G.; Lin, Felice; Lin, Jessica; Carleton, Heather A.; Mongodin, Emmanuel F.; Sensabaugh, George F.; Perdreau-Remington, Francoise</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">9512</span>),
    <span class="NLM_cas:pages">731-739</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">USA300, a clone of meticillin-resistant Staphylococcus aureus, is a major source of community-acquired infections in the USA, Canada, and Europe.  The aim was to sequence its genome and compare it with those of other strains of S. aureus to try to identify genes responsible for its distinctive epidemiol. and virulence properties.  The genome sequence of FPR3757, a multidrug resistant USA300 strain, was ascertained by random shotgun sequencing, then compared with the sequences of 10 other staphylococcal strains.  Compared with closely related S. aureus, almost all of the unique genes in USA300 are clustered in novel allotypes of mobile genetic elements.  Some of the unique genes are involved in pathogenesis, including Panton-Valentine leucocidin and mol. variants of enterotoxin Q and K. The most striking feature of the USA300 genome is the horizontal acquisition of a novel mobile genetic element that encodes an arginine deiminase pathway and an oligopeptide permease system that could contribute to growth and survival of USA300.  This element, termed arginine catabolic mobile element (ACME), was not detected in other S. aureus strains.  A high prevalence of ACME was noted in S. epidermidis, suggesting not only that ACME transfers into USA300 from S. epidermidis, but also that this element confers a selective advantage to this ubiquitous commensal of the human skin.  USA300 has acquired mobile genetic elements that encode resistance and virulence determinants that could enhance fitness and pathogenicity.  The genome and e plasmid sequences are deposited in GenBank/EMBL/DDBJ under accession nos. CP000255-CP000258.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojfR14TSWS7bVg90H21EOLACvtfcHk0lh0io59CjbLPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVejsr4%253D&md5=61ce2595af508a0253ff48c1908df09d</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fs0140-6736%2806%2968231-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0140-6736%252806%252968231-7%26sid%3Dliteratum%253Aachs%26aulast%3DDiep%26aufirst%3DB.%2BA.%26aulast%3DGill%26aufirst%3DS.%2BR.%26aulast%3DChang%26aufirst%3DR.%2BF.%26aulast%3DPhan%26aufirst%3DT.%2BH.%26aulast%3DChen%26aufirst%3DJ.%2BH.%26aulast%3DDavidson%26aufirst%3DM.%2BG.%26aulast%3DLin%26aufirst%3DF.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DCarleton%26aufirst%3DH.%2BA.%26aulast%3DMongodin%26aufirst%3DE.%2BF.%26aulast%3DSensabaugh%26aufirst%3DG.%2BF.%26aulast%3DPerdreau-Remington%26aufirst%3DF.%26atitle%3DComplete%2520Genome%2520Sequence%2520of%2520USA300%252C%2520an%2520Epidemic%2520Clone%2520of%2520Community-acquired%2520Meticillin-Resistant%2520Staphylococcus%2520Aureus%26jtitle%3DLancet%26date%3D2006%26volume%3D367%26spage%3D731%26epage%3D739%26doi%3D10.1016%2Fs0140-6736%2806%2968231-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McDougal, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fosheim, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulens, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limbago, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearer, J. E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summers, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, J. B.</span></span> <span> </span><span class="NLM_article-title">Emergence of Resistance Among USA300 Methicillin-Resistant Staphylococcus Aureus Isolates Causing Invasive Disease in the United States</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">3804</span>– <span class="NLM_lpage">3811</span>, <span class="refDoi"> DOI: 10.1128/aac.00351-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1128%2FAAC.00351-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=20585117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht12ktLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=3804-3811&author=L.+K.+McDougalauthor=G.+E.+Fosheimauthor=A.+Nicholsonauthor=S.+N.+Bulensauthor=B.+M.+Limbagoauthor=J.+E.+S.+Shearerauthor=A.+O.+Summersauthor=J.+B.+Patel&title=Emergence+of+Resistance+Among+USA300+Methicillin-Resistant+Staphylococcus+Aureus+Isolates+Causing+Invasive+Disease+in+the+United+States&doi=10.1128%2Faac.00351-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Emergence of resistance among USA300 methicillin-resistant Staphylococcus aureus isolates causing invasive disease in the United States</span></div><div class="casAuthors">McDougal, Linda K.; Fosheim, Gregory E.; Nicholson, Anisley; Bulens, Sandra N.; Limbago, Brandi M.; Shearer, Julia E. S.; Summers, Anne O.; Patel, Jean B.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3804-3811</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">USA300 methicillin-resistant Staphylococcus aureus (MRSA) isolates are usually resistant only to oxacillin, erythromycin, and, increasingly, levofloxacin.  Of these, oxacillin and levofloxacin resistances are chromosomally encoded.  Plasmid-mediated clindamycin, mupirocin, and/or tetracycline resistance has been obsd. among USA300 isolates, but these descriptions were limited to specific patient populations or isolated occurrences.  The authors examd. the antimicrobial susceptibilities of invasive MRSA isolates from a national surveillance population to identify USA300 isolates with unusual, possibly emerging, plasmid-mediated antimicrobial resistance.  DNA from these isolates was assayed for the presence of resistance determinants and the presence of a pSK41-like conjugative plasmid.  Of 823 USA300 isolates, 72 (9%) were tetracycline resistant; 69 of these were doxycycline susceptible and tetK pos., and 3 were doxycycline resistant and tetM pos.  Fifty-one (6.2%) isolates were clindamycin resistant and ermC pos.; 22 (2.7%) isolates were high-level mupirocin resistant (mupA pos.); 5 (0.6%) isolates were trimethoprim-sulfamethoxazole (TMP-SMZ) resistant, of which 4 were dfrA pos.; and 7 (0.9%) isolates were gentamicin resistant and aac6'-aph2'' pos.  Isolates with pSK41-like plasmids (n = 24) were pos. for mupA (n = 19), dfrA (n = 6), aac6'-aph2'' (n = 6), tetM (n = 2), and ermC (n = 8); 20 pSK41-pos. isolates were pos. for two or more resistance genes.  Conjugative transfer of resistance was demonstrated between four gentamicin- and mupirocin-resistant and three gentamicin- and TMP-SMZ-resistant USA300 isolates; transconjugants harbored a single pSK41-like plasmid, which was PCR pos. for aac6'-aph2'' and either mupA and/or dfrA.  USA300 and USA100 isolates from the same state with identical resistance profiles contained pSK41-like plasmids with indistinguishable restriction and Southern blot profiles, suggesting horizontal plasmid transfer between USA100 and USA300 isolates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol7LRee8we8bVg90H21EOLACvtfcHk0lh0io59CjbLPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht12ktLzN&md5=41b38673ecc1425f8ba20c5579a2f89a</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1128%2FAAC.00351-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00351-10%26sid%3Dliteratum%253Aachs%26aulast%3DMcDougal%26aufirst%3DL.%2BK.%26aulast%3DFosheim%26aufirst%3DG.%2BE.%26aulast%3DNicholson%26aufirst%3DA.%26aulast%3DBulens%26aufirst%3DS.%2BN.%26aulast%3DLimbago%26aufirst%3DB.%2BM.%26aulast%3DShearer%26aufirst%3DJ.%2BE.%2BS.%26aulast%3DSummers%26aufirst%3DA.%2BO.%26aulast%3DPatel%26aufirst%3DJ.%2BB.%26atitle%3DEmergence%2520of%2520Resistance%2520Among%2520USA300%2520Methicillin-Resistant%2520Staphylococcus%2520Aureus%2520Isolates%2520Causing%2520Invasive%2520Disease%2520in%2520the%2520United%2520States%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D3804%26epage%3D3811%26doi%3D10.1128%2Faac.00351-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takadama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakaminami, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoshi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, N.</span></span> <span> </span><span class="NLM_article-title">Dissemination of Panton-Valentine Leukocidin–positive Methicillin-resistant Staphylococcus Aureus USA300 Clone in Multiple Hospitals in Tokyo</span>. <i>Japan. Clin. Microbiol. Infect.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1211.e1</span>– <span class="NLM_lpage">1211.e7</span>, <span class="refDoi"> DOI: 10.1016/j.cmi.2018.02.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1016%2Fj.cmi.2018.02.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=1211.e1-1211.e7&author=S.+Takadamaauthor=H.+Nakaminamiauthor=A.+Satoauthor=M.+Shoshiauthor=T.+Fujiiauthor=N.+Noguchi&title=Dissemination+of+Panton-Valentine+Leukocidin%E2%80%93positive+Methicillin-resistant+Staphylococcus+Aureus+USA300+Clone+in+Multiple+Hospitals+in+Tokyo&doi=10.1016%2Fj.cmi.2018.02.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.cmi.2018.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmi.2018.02.012%26sid%3Dliteratum%253Aachs%26aulast%3DTakadama%26aufirst%3DS.%26aulast%3DNakaminami%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DShoshi%26aufirst%3DM.%26aulast%3DFujii%26aufirst%3DT.%26aulast%3DNoguchi%26aufirst%3DN.%26atitle%3DDissemination%2520of%2520Panton-Valentine%2520Leukocidin%25E2%2580%2593positive%2520Methicillin-resistant%2520Staphylococcus%2520Aureus%2520USA300%2520Clone%2520in%2520Multiple%2520Hospitals%2520in%2520Tokyo%26jtitle%3DJapan.%2520Clin.%2520Microbiol.%2520Infect.%26date%3D2018%26volume%3D24%26spage%3D1211.e1%26epage%3D1211.e7%26doi%3D10.1016%2Fj.cmi.2018.02.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lolk, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pøhlsgaard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jepsen, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffansen, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparving, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vester, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, P.</span></span> <span> </span><span class="NLM_article-title">A Click Chemistry Approach to Pleuromutilin Conjugates with Nucleosides or Acyclic Nucleoside Derivatives and Their Binding to the Bacterial Ribosome</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">4957</span>– <span class="NLM_lpage">4967</span>, <span class="refDoi"> DOI: 10.1021/jm800261u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800261u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptl2hsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4957-4967&author=L.+Lolkauthor=J.+P%C3%B8hlsgaardauthor=A.+S.+Jepsenauthor=L.+H.+Hansenauthor=H.+Nielsenauthor=S.+I.+Steffansenauthor=L.+Sparvingauthor=A.+B.+Nielsenauthor=B.+Vesterauthor=P.+Nielsen&title=A+Click+Chemistry+Approach+to+Pleuromutilin+Conjugates+with+Nucleosides+or+Acyclic+Nucleoside+Derivatives+and+Their+Binding+to+the+Bacterial+Ribosome&doi=10.1021%2Fjm800261u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A Click Chemistry Approach to Pleuromutilin Conjugates with Nucleosides or Acyclic Nucleoside Derivatives and Their Binding to the Bacterial Ribosome</span></div><div class="casAuthors">Lolk, Line; Pohlsgaard, Jacob; Jepsen, Anne Sofie; Hansen, Lykke H.; Nielsen, Henrik; Steffansen, Signe I.; Sparving, Laura; Nielsen, Annette B.; Vester, Birte; Nielsen, Poul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4957-4967</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pleuromutilin and its derivs. are antibacterial drugs that inhibit protein synthesis in bacteria by binding to ribosomes.  To promote rational design of pleuromutilin based drugs, 19 pleuromutilin conjugates with different nucleoside fragments as side chain extensions were synthesized by a click chem. protocol.  Binding was assessed by chem. footprinting of nucleotide U2506 in 23S rRNA, and all conjugates bind to varying degree reflecting their binding affinity to the peptidyl transferase center.  The side chain extensions also show various protections at position U2585.  Docking studies of the conjugates with the highest affinities support the conclusion that despite the various conjugations, the pleuromutilin skeleton binds in the same binding pocket.  The conjugated triazole moiety is well accommodated, and the nucleobases are placed in different pockets in the 50S ribosomal subunit.  The deriv. showing the highest affinity and a significantly better binding than pleuromutilin itself contains an adenine-9-ylpropylene triazole conjugate to pleuromutilin C-22.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVooKVD0xfHrVg90H21EOLACvtfcHk0lgFIWOiOVkcpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptl2hsbY%253D&md5=3ba75a24fa6268f2ae3f9d02440ad92d</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm800261u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800261u%26sid%3Dliteratum%253Aachs%26aulast%3DLolk%26aufirst%3DL.%26aulast%3DP%25C3%25B8hlsgaard%26aufirst%3DJ.%26aulast%3DJepsen%26aufirst%3DA.%2BS.%26aulast%3DHansen%26aufirst%3DL.%2BH.%26aulast%3DNielsen%26aufirst%3DH.%26aulast%3DSteffansen%26aufirst%3DS.%2BI.%26aulast%3DSparving%26aufirst%3DL.%26aulast%3DNielsen%26aufirst%3DA.%2BB.%26aulast%3DVester%26aufirst%3DB.%26aulast%3DNielsen%26aufirst%3DP.%26atitle%3DA%2520Click%2520Chemistry%2520Approach%2520to%2520Pleuromutilin%2520Conjugates%2520with%2520Nucleosides%2520or%2520Acyclic%2520Nucleoside%2520Derivatives%2520and%2520Their%2520Binding%2520to%2520the%2520Bacterial%2520Ribosome%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4957%26epage%3D4967%26doi%3D10.1021%2Fjm800261u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span> <span> </span><span class="NLM_article-title">Mulin Acetate Comprising Substituted Squaric Acid, and Application Thereof</span>. <span class="NLM_patent">CN 103204787 A</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+Chen&title=Mulin+Acetate+Comprising+Substituted+Squaric+Acid%2C+and+Application+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26atitle%3DMulin%2520Acetate%2520Comprising%2520Substituted%2520Squaric%2520Acid%252C%2520and%2520Application%2520Thereof%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Česnek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holý, A. n.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masojídková, M.</span></span> <span> </span><span class="NLM_article-title">6-Guanidinopurine Nucleosides and Their Analogues</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2985</span>– <span class="NLM_lpage">2996</span>, <span class="refDoi"> DOI: 10.1016/s0040-4020(02)00186-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1016%2FS0040-4020%2802%2900186-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Cnu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=2985-2996&author=M.+%C4%8Cesnekauthor=A.+n.+Hol%C3%BDauthor=M.+Masoj%C3%ADdkov%C3%A1&title=6-Guanidinopurine+Nucleosides+and+Their+Analogues&doi=10.1016%2Fs0040-4020%2802%2900186-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">6-Guanidinopurine nucleosides and their analogues</span></div><div class="casAuthors">Cesnek, Michal; Holy, Antonin; Masojidkova, Milena</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2985-2996</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A general synthetic approach to 6-guanidinopurines, their ribonucleosides, 2-deoxyribonucleosides, acyclic nucleoside analogs and acyclic nucleoside phosphonates was developed.  The approach consists of reaction of the 6-chloropurine derivs. with guanidine soln. in DMF under DABCO catalysis.  This method was used to synthesize 6-guanidinopurine and 2-amino-6-guanidinopurine derivs.  Acyclic nucleosides and acyclic nucleoside phosphonates were also obtained by alkylation of the 6-guanidinopurine bases.  None of tested derivs. showed any noticeable cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ-hBRoZqlIrVg90H21EOLACvtfcHk0lhykqHer4BxtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Cnu7w%253D&md5=f77eeb21f1a0f1d5b7127c23b5874963</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2802%2900186-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252802%252900186-2%26sid%3Dliteratum%253Aachs%26aulast%3D%25C4%258Cesnek%26aufirst%3DM.%26aulast%3DHol%25C3%25BD%26aufirst%3DA.%2Bn.%26aulast%3DMasoj%25C3%25ADdkov%25C3%25A1%26aufirst%3DM.%26atitle%3D6-Guanidinopurine%2520Nucleosides%2520and%2520Their%2520Analogues%26jtitle%3DTetrahedron%26date%3D2002%26volume%3D58%26spage%3D2985%26epage%3D2996%26doi%3D10.1016%2Fs0040-4020%2802%2900186-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saá, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varela-Fernández, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varela, J.</span></span> <span> </span><span class="NLM_article-title">Formation of Indoles, Dihydroisoquinolines, and Dihydroquinolines by Ruthenium-Catalyzed Heterocyclizations</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">3285</span>– <span class="NLM_lpage">3295</span>, <span class="refDoi"> DOI: 10.1055/s-0032-1316539</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1055%2Fs-0032-1316539" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt12nsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2012&pages=3285-3295&author=C.+Sa%C3%A1author=A.+Varela-Fern%C3%A1ndezauthor=J.+Varela&title=Formation+of+Indoles%2C+Dihydroisoquinolines%2C+and+Dihydroquinolines+by+Ruthenium-Catalyzed+Heterocyclizations&doi=10.1055%2Fs-0032-1316539"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Formation of indoles, dihydroisoquinolines, and dihydroquinolines by ruthenium-catalyzed heterocyclizations</span></div><div class="casAuthors">Varela-Fernandez, Alejandro; Varela, Jesus A.; Saa, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3285-3295</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Indoles, dihydroisoquinolines, and dihydroquinolines were efficiently prepd. by ruthenium-catalyzed heterocyclizations of arom. homo- and bis-homopropargyl amines/amides in the presence of an amine/ammonium base-acid pair.  E.g., in presence of CpRuCl(PPh3)2, heterocyclization of 2-CH≡CC6H4NH2 gave 84% indole.  These regioselective 5-endo and 6-endo cyclizations most probably occur by nucleophilic trapping of key ruthenium-vinylidene intermediates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojaah-DPYj9LVg90H21EOLACvtfcHk0lhykqHer4BxtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt12nsg%253D%253D&md5=238d8eec5947409940c64543643608d8</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1055%2Fs-0032-1316539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0032-1316539%26sid%3Dliteratum%253Aachs%26aulast%3DSa%25C3%25A1%26aufirst%3DC.%26aulast%3DVarela-Fern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DVarela%26aufirst%3DJ.%26atitle%3DFormation%2520of%2520Indoles%252C%2520Dihydroisoquinolines%252C%2520and%2520Dihydroquinolines%2520by%2520Ruthenium-Catalyzed%2520Heterocyclizations%26jtitle%3DSynthesis%26date%3D2012%26volume%3D44%26spage%3D3285%26epage%3D3295%26doi%3D10.1055%2Fs-0032-1316539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pankey, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabath, L. D.</span></span> <span> </span><span class="NLM_article-title">Clinical Relevance of Bacteriostatic versus Bactericidal Mechanisms of Action in the Treatment of Gram-Positive Bacterial Infections</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">864</span>– <span class="NLM_lpage">870</span>, <span class="refDoi"> DOI: 10.1086/381972</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1086%2F381972" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=14999632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtlCksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2004&pages=864-870&author=G.+A.+Pankeyauthor=L.+D.+Sabath&title=Clinical+Relevance+of+Bacteriostatic+versus+Bactericidal+Mechanisms+of+Action+in+the+Treatment+of+Gram-Positive+Bacterial+Infections&doi=10.1086%2F381972"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of gram-positive bacterial infections</span></div><div class="casAuthors">Pankey, G. A.; Sabath, L. D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">864-870</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">A review.  The distinction between bactericidal and bacteriostatic agents appears to be clear according to the in vitro definition, but this only applies under strict lab. conditions and is inconsistent for a particular agent against all bacteria.  The distinction is more arbitrary when agents are categorized in clin. situations.  The supposed superiority of bactericidal agents over bacteriostatic agents is of little relevance when treating the vast majority of infections with gram-pos. bacteria, particularly in patients with uncomplicated infections and noncompromised immune systems.  Bacteriostatic agents (e.g., chloramphenicol, clindamycin, and linezolid) were effectively used for treatment of endocarditis, meningitis, and osteomyelitis-indications that are often considered to require bactericidal activity.  Although bacteriostatic/bactericidal data may provide valuable information on the potential action of antibacterial agents in vitro, it is necessary to combine this information with pharmacokinetic and pharmacodynamic data to provide more meaningful prediction of efficacy in vivo.  The ultimate guide to treatment of any infection must be clin. outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_xAGW1Cri1rVg90H21EOLACvtfcHk0lhykqHer4BxtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtlCksrc%253D&md5=4847394218daaf4fa66c1fce9e21f543</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1086%2F381972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F381972%26sid%3Dliteratum%253Aachs%26aulast%3DPankey%26aufirst%3DG.%2BA.%26aulast%3DSabath%26aufirst%3DL.%2BD.%26atitle%3DClinical%2520Relevance%2520of%2520Bacteriostatic%2520versus%2520Bactericidal%2520Mechanisms%2520of%2520Action%2520in%2520the%2520Treatment%2520of%2520Gram-Positive%2520Bacterial%2520Infections%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2004%26volume%3D38%26spage%3D864%26epage%3D870%26doi%3D10.1086%2F381972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siricilla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitachi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eslamimehr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemieux, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meibohm, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurosu, M.</span></span> <span> </span><span class="NLM_article-title">A New Combination of a Pleuromutilin Derivative and Doxycycline for Treatment of Multidrug-ResistantAcinetobacter baumannii</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2869</span>– <span class="NLM_lpage">2878</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01805</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01805" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkt1OiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2869-2878&author=S.+Siricillaauthor=K.+Mitachiauthor=J.+Yangauthor=S.+Eslamimehrauthor=M.+R.+Lemieuxauthor=B.+Meibohmauthor=Y.+Jiauthor=M.+Kurosu&title=A+New+Combination+of+a+Pleuromutilin+Derivative+and+Doxycycline+for+Treatment+of+Multidrug-ResistantAcinetobacter+baumannii&doi=10.1021%2Facs.jmedchem.6b01805"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A New Combination of a Pleuromutilin Derivative and Doxycycline for Treatment of Multidrug-Resistant Acinetobacter baumannii</span></div><div class="casAuthors">Siricilla, Shajila; Mitachi, Katsuhiko; Yang, Junshu; Eslamimehr, Shakiba; Lemieux, Maddie R.; Meibohm, Bernd; Ji, Yinduo; Kurosu, Michio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2869-2878</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Multidrug-resistant (MDR) Acinetobacter baumannii is one of the most difficult Gram-neg. bacteria to treat and eradicate.  In a cell-based screening of pleuromutilin derivs. against a drug sensitive A. baumannii strain (ATCC 19606), new mols. (2-4) exhibit bacteriostatic activity with 3.13 μg/mL concn. and 1 shows bactericidal activity with an MBC of 6.25 μg/mL.  The pleuromutilin deriv. 1 displays strong synergistic effects with doxycycline in a wide range of concns.  A 35/1 ratio of 1 and doxycycline (1-Dox35/1) kills drug susceptible A. baumannii with the MBC of 2.0 μg/mL and MDR A. baumannii (ATCC BAA-1800) with the MBC range of 3.13-8.0 μg/mL.  In vitro bactericidal activity of 1-Dox35/1 against A. baumannii is superior to that of clin. drugs such as tobramycin, tigecycline, and colistin (polymyxin E).  The efficacy of 1-Dox35/1 is evaluated in a mouse septicemia model; treatment of the infected C57BL/6 mice with 1-Dox35/1 protects from lethal infection of A. baumannii with an ED50 value of <2.0 mg/kg (a single-dose).  The frequency of resistance to 1-Dox35/1 is less than 1x10-10 for A. baumannii (at the 8xMIC concn.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzh89uMW0I9rVg90H21EOLACvtfcHk0lgysYFpvEhPLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkt1OiurY%253D&md5=5ec9df79c19e630e453e6a8d68174421</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01805%26sid%3Dliteratum%253Aachs%26aulast%3DSiricilla%26aufirst%3DS.%26aulast%3DMitachi%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DEslamimehr%26aufirst%3DS.%26aulast%3DLemieux%26aufirst%3DM.%2BR.%26aulast%3DMeibohm%26aufirst%3DB.%26aulast%3DJi%26aufirst%3DY.%26aulast%3DKurosu%26aufirst%3DM.%26atitle%3DA%2520New%2520Combination%2520of%2520a%2520Pleuromutilin%2520Derivative%2520and%2520Doxycycline%2520for%2520Treatment%2520of%2520Multidrug-ResistantAcinetobacter%2520baumannii%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2869%26epage%3D2878%26doi%3D10.1021%2Facs.jmedchem.6b01805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zamaraeva, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabirov, R. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeno, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando-Akatsuka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bessonova, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, Y.</span></span> <span> </span><span class="NLM_article-title">Cells Die with Increased Cytosolic Atp During Apoptosis: A Bioluminescence Study with Intracellular Luciferase</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1390</span>– <span class="NLM_lpage">1397</span>, <span class="refDoi"> DOI: 10.1038/sj.cdd.4401661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1038%2Fsj.cdd.4401661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=15905877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtV2kt7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=1390-1397&author=M.+V.+Zamaraevaauthor=R.+Z.+Sabirovauthor=E.+Maenoauthor=Y.+Ando-Akatsukaauthor=S.+V.+Bessonovaauthor=Y.+Okada&title=Cells+Die+with+Increased+Cytosolic+Atp+During+Apoptosis%3A+A+Bioluminescence+Study+with+Intracellular+Luciferase&doi=10.1038%2Fsj.cdd.4401661"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Cells die with increased cytosolic ATP during apoptosis: a bioluminescence study with intracellular luciferase</span></div><div class="casAuthors">Zamaraeva, M. V.; Sabirov, R. Z.; Maeno, E.; Ando-Akatsuka, Y.; Bessonova, S. V.; Okada, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1390-1397</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Apoptosis is a distinct form of cell death, which requires energy.  Here, we made real-time continuous measurements of the cytosolic ATP level throughout the apoptotic process in intact HeLa, PC12 and U937 cells transfected with the firefly luciferase gene.  Apoptotic stimuli (staurosporine (STS), tumor necrosis factor α (TNFα), etoposide) induced significant elevation of the cytosolic ATP level.  The cytosolic ATP level remained at a higher level than in the control for up to 6 h during which activation of caspase-3 and internucleosomal DNA fragmentation took place.  When the STS-induced ATP response was abolished by glucose deprivation-induced inhibition of glycolysis, both caspase activation and DNA laddering were completely inhibited.  Annexin V-binding induced by STS or TNFα was largely suppressed by glycolysis inhibition.  Thus, it is suggested that the cells die with increased cytosolic ATP, and elevation of cytosolic ATP level is a requisite to the apoptotic cell death process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHa_hTXp-IT7Vg90H21EOLACvtfcHk0lgysYFpvEhPLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtV2kt7zJ&md5=8a9259b700c52bffa561b9255cfb2133</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4401661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4401661%26sid%3Dliteratum%253Aachs%26aulast%3DZamaraeva%26aufirst%3DM.%2BV.%26aulast%3DSabirov%26aufirst%3DR.%2BZ.%26aulast%3DMaeno%26aufirst%3DE.%26aulast%3DAndo-Akatsuka%26aufirst%3DY.%26aulast%3DBessonova%26aufirst%3DS.%2BV.%26aulast%3DOkada%26aufirst%3DY.%26atitle%3DCells%2520Die%2520with%2520Increased%2520Cytosolic%2520Atp%2520During%2520Apoptosis%253A%2520A%2520Bioluminescence%2520Study%2520with%2520Intracellular%2520Luciferase%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2005%26volume%3D12%26spage%3D1390%26epage%3D1397%26doi%3D10.1038%2Fsj.cdd.4401661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antonescu, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlgren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoff, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergström, C. A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhoff, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artursson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffansen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, C. U.</span></span> <span> </span><span class="NLM_article-title">Acamprosate Is a Substrate of the Human Organic Anion Transporter (Oat) 1 without Oat3 Inhibitory Properties: Implications for Renal Acamprosate Secretion and Drug-Drug Interactions</span>. <i>Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">390</span>, <span class="refDoi"> DOI: 10.3390/pharmaceutics12040390</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.3390%2Fpharmaceutics12040390" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitlGgur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=390&author=I.+E.+Antonescuauthor=M.+Karlgrenauthor=M.+L.+Pedersenauthor=I.+Simoffauthor=C.+A.+S.+Bergstr%C3%B6mauthor=S.+Neuhoffauthor=P.+Arturssonauthor=B.+Steffansenauthor=C.+U.+Nielsen&title=Acamprosate+Is+a+Substrate+of+the+Human+Organic+Anion+Transporter+%28Oat%29+1+without+Oat3+Inhibitory+Properties%3A+Implications+for+Renal+Acamprosate+Secretion+and+Drug-Drug+Interactions&doi=10.3390%2Fpharmaceutics12040390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Acamprosate is a substrate of the human organic anion transporter (OAT) 1 without OAT3 inhibitory properties: implications for renal acamprosate secretion and drug-drug interactions</span></div><div class="casAuthors">Antonescu, Irina E.; Karlgren, Maria; Pedersen, Maria L.; Simoff, Ivailo; Bergstrom, Christel A. S.; Neuhoff, Sibylle; Artursson, Per; Steffansen, Bente; Nielsen, Carsten Uhd</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutics</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">390</span>CODEN:
                <span class="NLM_cas:coden">PHARK5</span>;
        ISSN:<span class="NLM_cas:issn">1999-4923</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Acamprosate is an anionic drug substance widely used in treating symptoms of alc. withdrawal.  It was recently shown that oral acamprosate absorption is likely due to paracellular transport.  In contrast, little is known about the eliminating mechanism clearing acamprosate from the blood in the kidneys, despite the fact that studies have shown renal secretion of acamprosate.  The hypothesis of the present study was therefore that renal org. anion transporters (OATs) facilitate the renal excretion of acamprosate in humans.  The aim of the present study was to establish and apply OAT1 (gene product of SLC22A6) and OAT3 (gene product of SLC22A8) expressing cell lines to investigate whether acamprosate is a substrate or inhibitor of OAT1 and/or OAT3.  The studies were performed in HEK293-Flp-In cells stably transfected with SLC22A6 or SLC22A8.  Protein and functional data showed that the established cell lines are useful for studyingOAT1- andOAT3-mediated transport in bi-lab. studies.  Acamprosate inhibited OAT1-mediated p-aminohippuric acid (PAH) uptake but did not inhibit substrate uptake via OAT3 expressing cells, neither when applied concomitantly nor after a 3 h preincubation with acamprosate.  The uptake of PAH via OAT1 was inhibited in a competitive manner by acamprosate and cellular uptake studies showed that acamprosate is a substrate for OAT1 with a Km-value of approx. 700 μM.  Probenecid inhibited OAT1-mediated acamprosate uptake with a Ki-value of approx. 13 μM, which may translate into an estd. clin. significant DDI index.  In conclusion, acamprosate was identified as a substrate of OAT1 but not OAT3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpngES3ZI8InbVg90H21EOLACvtfcHk0lg4CIci8maC_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitlGgur3O&md5=9128be10a15607b6ca51f8ae991dcbba</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3390%2Fpharmaceutics12040390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fpharmaceutics12040390%26sid%3Dliteratum%253Aachs%26aulast%3DAntonescu%26aufirst%3DI.%2BE.%26aulast%3DKarlgren%26aufirst%3DM.%26aulast%3DPedersen%26aufirst%3DM.%2BL.%26aulast%3DSimoff%26aufirst%3DI.%26aulast%3DBergstr%25C3%25B6m%26aufirst%3DC.%2BA.%2BS.%26aulast%3DNeuhoff%26aufirst%3DS.%26aulast%3DArtursson%26aufirst%3DP.%26aulast%3DSteffansen%26aufirst%3DB.%26aulast%3DNielsen%26aufirst%3DC.%2BU.%26atitle%3DAcamprosate%2520Is%2520a%2520Substrate%2520of%2520the%2520Human%2520Organic%2520Anion%2520Transporter%2520%2528Oat%2529%25201%2520without%2520Oat3%2520Inhibitory%2520Properties%253A%2520Implications%2520for%2520Renal%2520Acamprosate%2520Secretion%2520and%2520Drug-Drug%2520Interactions%26jtitle%3DPharmaceutics%26date%3D2020%26volume%3D12%26spage%3D390%26doi%3D10.3390%2Fpharmaceutics12040390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wiegand, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, R. E. W.</span></span> <span> </span><span class="NLM_article-title">Agar and Broth Dilution Methods to Determine the Minimal Inhibitory Concentration (MIC) of Antimicrobial Substances</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">175</span>, <span class="refDoi"> DOI: 10.1038/nprot.2007.521</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=10.1038%2Fnprot.2007.521" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=18274517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvVyls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=163-175&author=I.+Wiegandauthor=K.+Hilpertauthor=R.+E.+W.+Hancock&title=Agar+and+Broth+Dilution+Methods+to+Determine+the+Minimal+Inhibitory+Concentration+%28MIC%29+of+Antimicrobial+Substances&doi=10.1038%2Fnprot.2007.521"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances</span></div><div class="casAuthors">Wiegand, Irith; Hilpert, Kai; Hancock, Robert E. W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">163-175</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The aim of broth and agar diln. methods is to det. the lowest concn. of the assayed antimicrobial agent (minimal inhibitory concn., MIC) that, under defined test conditions, inhibits the visible growth of the bacterium being investigated.  MIC values are used to det. susceptibilities of bacteria to drugs and also to evaluate the activity of new antimicrobial agents.  Agar diln. involves the incorporation of different concns. of the antimicrobial substance into a nutrient agar medium followed by the application of a standardized no. of cells to the surface of the agar plate.  For broth diln., often detd. in 96-well microtiter plate format, bacteria are inoculated into a liq. growth medium in the presence of different concns. of an antimicrobial agent.  Growth is assessed after incubation for a defined period of time (16-20 h) and the MIC value is read.  This protocol applies only to aerobic bacteria and can be completed in 3 d.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd1uwvRDLPQ7Vg90H21EOLACvtfcHk0lg4CIci8maC_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvVyls78%253D&md5=a235d207868342de52085d4100062471</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2007.521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2007.521%26sid%3Dliteratum%253Aachs%26aulast%3DWiegand%26aufirst%3DI.%26aulast%3DHilpert%26aufirst%3DK.%26aulast%3DHancock%26aufirst%3DR.%2BE.%2BW.%26atitle%3DAgar%2520and%2520Broth%2520Dilution%2520Methods%2520to%2520Determine%2520the%2520Minimal%2520Inhibitory%2520Concentration%2520%2528MIC%2529%2520of%2520Antimicrobial%2520Substances%26jtitle%3DNat.%2520Protoc.%26date%3D2008%26volume%3D3%26spage%3D163%26epage%3D175%26doi%3D10.1038%2Fnprot.2007.521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HL7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HL7','PDB','5HL7'); return false;">PDB: 5HL7</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i51"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01328">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_46785"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01328?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01328</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings for conjugates <b>10</b>–<b>44</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01328/suppl_file/jm0c01328_si_001.csv">CSV</a>)</p></li><li><p class="inline">Experimental procedures that are not covered in the main text for compounds <b>8</b>–<b>9</b>, <b>48</b>–<b>89</b>, and <b>92</b>–<b>97</b> and <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra and HPLC profiles (254 nm) for conjugates <b>10</b>–<b>44</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01328/suppl_file/jm0c01328_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01328/suppl_file/jm0c01328_si_001.csv">jm0c01328_si_001.csv (5.13 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01328/suppl_file/jm0c01328_si_002.pdf">jm0c01328_si_002.pdf (17.83 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01328&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-24%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01328%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01328" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67998f91dfeb3da6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
